var title_f1_61_2000="Undifferentiated pediatric shock algorithm";
var content_f1_61_2000=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F81356&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F81356&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 531px\">",
"   <div class=\"ttl\">",
"    Approach to the classification of undifferentiated shock in children",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 511px; height: 604px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_61_2000=[""].join("\n");
var outline_f1_61_2000=null;
var title_f1_61_2001="Merkel cell carcinoma";
var content_f1_61_2001=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F70535&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F70535&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Merkel cell carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD5WxRinUhzVAFFKuaTB96LgB60AGnKueuafs9OaVx2IiD6UoWpCopyjBzSuFiMKOwpyqO9PIA5AoIwcDrSuVZDQvFBGO1LjtzR14ANILDBnmgrzxUixM/QHNbejeF9U1dgtlaTSc9QvFJyS3LjBy2Rglcn3pyxMxwBzXsvhz4I6telZL5hAh6gDmvWPDHwY0XTNj3CGeQdS9ZOskbrDy6nzDoPhDVtZkC2VpI4PcjAr0zwz8C9RvXVtSkWFO4AyTX0zpeh2NhGFtYERQOwArUGEGFFZuq2zVUoQPKPDvwd0HS2VpLdZ5F6tJzXd2uhafZxhYreNQOmBW4XjMfIqs5QEZY4qSubsVRDGnRRj0FIYTuyARU7MABx170i/NIBuAPejQm7GLGF+8Mk+tMfIGVGasjG7HJxRhBkkEgmmBXRC2OcHvUoj3HBxgcFql2hV4OBQQGGRzTSJbIxCBjGQKciKFwDk9etSqgOfmqJognRsjNMAUK3GPmA5PWnFRuBOKZFCVk3gnB7VJMrngYx14NAmLJGFOQVJJ6UhAxjJ+tMUEtlsGp1XOeQB70A9CNyoXhdzetRR+YzYkPy9sVZSMoclif4uefwokxkYGPcUguIs2xtgUjHelO4pnPtTwoILFhj6YoI3T5XGeBQSyELJkjke9SxgbflYZ9f6VKWYAqwAJ9arspUrwNw7imLclCgHr9aWSP5d643Y7HNKfmXa459RTk2AYDc+1AFaAByPMTJ6VIuEJXHT2qaNdjbyBimSOgc46e9IL3ZFIGI3EjFNhQsMk/KPepWUSKoBzg9qeyNCoKgYxzQHkM34YhWBqN5s/d49qaGiySOSRSBtj52deRzQVYejsRgg56mgoNmep9KfC6KuwKB7k/zpGZtpGQufSgkp3FxJEOCyqOODU1vvKhpGzk1Iyh0KsFJ7+9EMZTClcelFxtqxOx+TIbGKrSMrAYA6ZJIqwiFB8wOBTHRMZRvwNMSGQhTgjJHv0NTg7lwTgDjmogVG0bcHFLM+QB0FANH5ybfTNKB9aUHjOaUH3rrucoAd6XbQfXH40hPPBpXGOwATSgj3phPBFAJPA5oD1DOaXt05p8VvLKwWNCST0ArqdF8AeIdWCm3sJtjdGZcCpbSLUHLZHJZOeKesbHAA5r3Hw18BtQutralKIV67VHP516l4c+DGhaZtaaLz5R3cZrN1V0No4d9T5Y0bwvquqyqtpZzSE98cV6Z4c+BuqXgV9QkWEHkqOTX07Y6DY2CAW9vGgA7LWku1VHQYrJ1WzZUoLzPJPDvwW0LT0U3EfnyDu/PNeh6T4c03TI1S2t40C9MCtKecDGPyqLzGxye9ZNt7mqdloTDYgwmMD06CgyDAAH41VLYyCTTc8DrTSuS2WvNHpk1E0xAHBxVdmxgqaRZS3GBimhEzOWOSflxikwDyBUeMHk/hSk4HAOc0xDup56mnDGB8uT70hXDA8VKZFHOMMOtNITELLuJxzSBgwC4PHemdSCxyT/doDN5pCjvyaYEnl9BjqOTTDGUJ2ntngU/eVzuOQBxQ8+DgUrC1GhjubLDK4xgU6I7jjt71EJg+XBxnoKRN2/cCAccN6Ux2LceTuHOaWNQGDOrEd6gikdWAYcjjNMnuHWTYDkelFyVFvQtOo4dD8p6DqKjb5Zd3J7AVGjeVHyQPYVLH8oLE9ecGgLWAOG5GQR0NSxL5jHB5+tIjAtkqMD0qRF+cEY5oJYiqCWRwuRU0ILDgYaq9zGFkBLHnt61Ztx12r9QaCXtcZlyzdx71HxjBzn1pbhmyfLXI5yfSoQVbaTkEepplJEy+YrAkBlPenOsMg+T5WPcdjQZCVAUBqaFQOABjP5UiSR2YYUfdA5xVZkZiSASe+asoecKcD1NRu5y3zDGMdaAQ2AlecDjkipppSwwoKfWqsSZdcsfzqzM6kFRw+O9MGtSrtGQVH4CpliwwJXr3z0qMsYzwRnHSnx7nJKnn0pFO47ywDkHIPrRjGN54Hf1qORsso565I7VOXCx8YweRQSQhvmyow3OKnDjYQ/X/wCtTA6lCB8vvSB12fL6c96YrCSzMI9uQBjGabGq7V3HOOnNRyMCpAGSKWOYOpG0YpF2HM21gQARQ5UN83OT27UuAUyOKiY7ZAxGfagEfnVzxzTh0969e0v4F69dbTM0cK45yCTXY6R+z2oCteXjk9wFwK3dWKM1h5nzkFYnABq3aaZeXjhbeCSRj0wua+ttI+CmgWbKZIRKR2bmu50rwfo+nIBb2kSY44QVm6/Y0WHS3Z8i6B8KvEWrFWW0MSHvJxXpfhz4Agur6rctz1VBivoyKCGFcRoigegpk0iKQQwFZupJmipwXQ47w/8AC/w9oyqIbRGYd2GTXYwWVtaRhYY0UD2qB7sBSVYse2Kpy3TuCFBz61DkaJM1mlWNeMYHpUMt4oXIFZe+UqAzgGm7TgAkmlcdkaBvsrwcmmGR3GQSAaiRBsyRxQzAjC5A9QaYm+w5txfOQBT1YEjFRKBuGScin+ZyAMU0QOY5HSkTcV7Cgnj9KaH2jrimIcdq8d6On8PXrUTSDcRjn1pxUsOTxSuh2JcMeQOD0prAoOe5z1qJiANuSPxqMsxwOTtNDY+XqTlyMcdajEp8zGOD2pYVJyGGBUqqqyYIU474pJBcWNiACyhfTmnjLnO7bnvSOyEHAye3FIMMPl3AnrmrJHFUXIPJHcU3ALYwQPU9aiaPZLw/1qQZ+Y55PrQHoTmMbBxx7moShLEFsDpTRI4Q5yB2xRGcnDAk9smi4bEsbrgqyjI4HvT0UDflQSajkcYBEe33qRdyqOpBoFYPL3csPwNADRDc+Gz29aIpw42OQCDUxwcbSTk/hTFcYMSDPT8etSxOwAGRx15pu6N42DEKw9qqj74O5T6ECgWjLksAeQurHgZ60kUrsSAxwOuaRiwQAHHbcKI8LGQGJOe9AuhIsrrnkHI7VG0uQd3DE9hR5i4+XBJ6imNKCc4A+tAJXLUUsbgbRhh3pXZNu3nis2KRWZjIRgHHBqyDG3qBj160CcdSwsfOGIxzjnrVZo1JbGeOxp7IFK7XYDGRSSvg5AyQOooFqEXykA/nTJpeGYHDYxnFIjmRtx4PY0uASTxjpimUvMiiZl+ZuV9amQ8EhyCagmkAO1RznoPSlV8EsemaRViwx28EA8dakJXywSQMiqwVnGVzz0NKNo4LcjrQS0K6kn5G4p8ceNvzcnrUDFt5AYY96IicEOeeoxTHYkZN0hAY4xzTRD5YByBnv60FiqruJOOuBTmKzDAY8dqQtUPLqOvfvnFKAGGT0J61EWCgBu3enCRSuOo9KCWhv2qJflyB9KY9+gOBk49KxlGGHGTVlSBgsv4isjqZc/tEqTtQ59DUL3ssjEsQgFRhst82B7imMAScjNMSY9rhSvzSNk9hTdyZzkmoXVCpKgZphJjGQhbtxQG5YL44ximuG2jJ5boKAhZQSpUVIcLxjJ7EmiwXIcHAzzUqqX6khaXftOdo5oDuzjao+maGgvcP3jIBHzxUSRvuJbHFWRvZuQAPY9KeUxxwaaVxN2ICpDHP0qUDAGWwKexbAOQP1qJwWU85IPansJO42VTu5c/hQuGjKsj57U1Fd25BUVMUYfxfgaWo3oR/u/vOrY9qerZUgA7fWm+WwXO8ZI6ZpgL7cYHvRbuBOVAIIAJpoOHO4g56cU3PycDPsOtSCNiq7gPbmnYQNHkZU49qVFAOdw+hpD8mCMelPLAnqMj2piG5feRnn0AoeZ4ixwAp46cihmxjCEY6kGkjdTk7ckjvzQAxJgwyGDkeopTNLjPAX+dSW4RH5CD60km7ltykA5GOlLbUd0SRTEjgDaevPNSeZuABVcdc5xVFm3bSNoI7YqxDIpB8yPgcfSmmJonDBnG4bQQehzSmTD5BBXFRuYWVAjMv0GaabcyNgbc9eTTEDKFy2cc/xLT42J27SGI560pBCBMtkH7ueKZKdvKcY68dKQbkpmQDATLd6Ekj3AAAkjPSoQzHBUj6inqiq28srZ5wRimIkjc/NnAwehpZZAjDcMGoXYcsqjntTcKc7g+R1oHYmRkZgwyAOCakmaN1+9nHt1qqJdsm3+EcqSOpqdlJOV27uvTFACpbRGA55PtUbFYo8hsnOMGplyBlhgY6igLG6ZBVgeQDTJQ2J2wMAE1FcEs5Xbt4zjPJpSAAAhIAzUf3vmc9ehz+lBVhq3WJFQjANTSSsB0H1Peq5RcAqMOOckUG6MqELgFeGBpdBW1B5UaVWYYJ7irOxXGDznoaqqdy7cDOcirMIA2ls/ShajZIjKPlwynHHFR7gMllBGetSh85Cn5Rxg1W5dirHA9QKBLUnc5GVAwe9AXI5bBpiqYlwGyB70zcwbI4z60wJZ8CPGQD6Cq4kEY3Fhg/pSsxOWflelMIVzjGAexpDSHRuG+ZjkGpm2lFycZqu0flgMQdvemO7HHOcdMUBa5TGQNqmgbsjIOP5UemRzSnGMZ596zNLiknAbI+hp5ZiSAnPt3qLdgfMCKRWy+QSfpQBOI+QM4+velKMAeOOoINMWXqDye2aRJ0BBDYI4oCw9WZyAxGOxPFOCHd0J91NAuFbILj347e1RG5gDDCtgcfWqvZCsyWUH+LHHTIqLduGc4PQ/SmmQyhiAxprMQOSwx6LUtlcpaO7KvvypHpTypAzuK46Cqq3DFMYI4/u9acZEABAfJ74ouJpkzOSpGCQP4vWkEpTGCGPv2qEkgBVLYbvikP3TxuPp0p3Ykiw0pK5BBz1GOlPaUEBQAarI22MfMMntSl12/K3P0pXCxZTBPUf/XpYQrBjIGA9QOtVwScYL8d+1KrMkm48g+gppsTJNqJJjecnt0qQAB8be3rVZyHZiemOuOlSxHK4V0PHQincLD/AJeBwMmiUlV+XkeuKi8woQ204PY8ipCylCw4BHI6Ci6sKwxHfkMePSnbsABUYDpmojIi9VPTIKmkLtgYBIIzU3ZVrlpX2gZGWHoeTUOYmb5g4A9BTFlV12uOncDmovulsKTgZ707sSRaxAwyS4PQHtinKGUkbxtPdqpgsFyRlfek89cbduDnNFx2bLg4YeWqk9x609ZEkk2qSh9Caz/PIJ4bJ6YqNDmUsWZiPSnzMOTuax3KcsQDnoetK8jqysQOe2ODVWKc/ecbweB6inyTI6KFLfRqdybCyHIJ27T2Ip8e54wCBnqSe1Rbt+N4I6dDUvmMML1j75HWjqBMI8xgjcB35qutwVYgNuX0I5qTopXlQelNMmwfd49DzTEOkkdETcAVPqOtDSAspbIHtUDmRT0OOoHUUisrElUPmd8HiobLUS2Azj5W6HjnmlEZHVMj0B5qshkMTHY2fUCpPNYIArE/XrTRLRYXaqt+7bdj1602VUGGALD6/pUO7C5cnkUNIoC55wegqhWHBn3ttJUY6GqjRby5AAb1qyCpbf8ANtPXJqOOUl2CqVpDsVoS8Mp43j0xVm2maWUsV2pjgU1SwkyefUU+Upu+YFAe3pSTsNq7JHkK5x+IpEztZlzyPWoom64cbR39aRJMHGDjPBouHLbQsgj5s9R60MwI+bt3pEcbTkAEnrUcrBW9aolCdF2n7pOfpQG54pgYkBgP1pd4IGMA0DJ2bgbuvpUTJhhjPHIpjseMNim78MCTyOhFLmQcpRVskqrc1E6sM7mGR6mmu21gvk89ueap3E0qt8oVAcDLGs7m0YN7FkygDBYj2yKmVlIIV8Ec43VmoZSwMqIw/MVOzA7QYlVunAIouVKHQ0S+UH8R9D1pQwdFwrhj1qiFJ+ba4UdMGlM6ICCsgIx1NFybWWhdfhcN1H51BDuD4bJ56g8YpVuImIIYjjv2o2h5N0UoIHqKNxarclfoGGQueoNJjc4xk8c84phIYjcAvPWkUklshXXP8J5FAIkjBHRnx0yT0qRgUX5sEVGfLXkM0THpu6UuCSQ2T7q1A3qTIS+FXaac4j27VYo2e/eqM0/lkCVTu/hPSi3umkfHBA6hqLoTpvcneE5yGVh7dqejKIwpzn3FNYrtGAAaYrgEkFs+9NE6suAbVGHGeoGagnyVOYjlepHFIWyoOVyOvvSLLyFZSc/pVMS0GqxcL03dOKkAKk8HOeeadMvyjBUOe9QKxwQ2CM/eFKwJ3LPnIIvk27hwaiDg+/0zUK8oSpIPoaZkp8zg++OmKl6Giiiy5B/iwcYGDSgwoowznHqKotPEx27lFN80K3PGKXMXyF1n3oG6fQ1A0rIMgjHvVZpD945x2qtJeR78B+SOM0uYuNO5prOxBAYj8eKjeXOAeSO9Z32tliIYKT2qE3wxnpzRcapM0zMDzuxUiSksA208cEVjy3QAxjk9/So47mRG+Vs4oH7K6udDGwPAkK4PrUrO67S4yvYisWO7BXcfyqxDf4I/eZAHajmM3TZrR3CZ5XIB7UkU22Xodvoay0uI5JMD5WHPPepBO8cp3HI7g07i9ma8bmQ7c5X37VLIxxnh1HTb1rOSTcgCck1YUkOqqSD2qr6GLhZlgYfGCT6UpYbw+0cdcdaaT5eRLuV88MOlRrIWdlJyR/EKA1JoyN7nOB6GmgNHgtnnuO9RyBldSTlT3qYyM0Q4ViOPqKpCsPHzcKQR1INR7owxxz22kUjEYVj8jdBUcrsOTtb3obElcdIcRnBGB6VAJCj5YkA0SgPyvp0NII1Uhict6Gpv1Lsi3MgwHznHoMVGxLx4JyOnNJK+wYJzn9KhWTCgKSabZMU9xY0X5sfKfepEPB7EetII1ABZie9BTHKnOaVupTd2Tux5BfOenFQnK9eQT2pjSAKQcgetNj+6Tu+lHMCiTKxORnjrxSsDnJwD71XR1+XBzU5cMABRfQTVhkpwe1N80AgcUSBiSRx9ai2Yz8xpFJKxTmTcMOxxnu1VngR1HIz3z3qXa7EhRx2yaCzAAOoKj05NBauthsUXl9JF56AHOabOc43jJzxzUseG5VRg8fdFPZlVdhO3d/s5pBzWZGnlPnYWDZ6bqX50z5kJZD/EPWkCbgEWbceyleKhLMp+ZuAOBk0DtcmSNX+YKPcZxUsaKCu5woPY1SZ2OCsg2/3anguZXUoWQgdMqOn40RCabRalck7XUOB6f41AEUyAxs2D2anq2Itsmdn8JHUUxt6IQrZjzxnmmRHQn+cDkt/OpIiVP3VYDt0JqKGZpgowhI4PbFIMPkMSH/Si49eoSIpjIbcAOoIBFLFBtHy4c+o4p/lsgU7sk8keopxQ/fRiMYyBRYOYTOQoywb36VOSAMNjd9KiUkrnPOeMU6RguOxPHIqomcibajLygJx97NRxuMsCTzwARUiEhQijryeetRMMOFZW3dSV6YpyEhVYow6gjp3pWV5YzJsGWO3g4pR8oyJCfm6NUMjAI6k7dx6Ke9SO19gMEaF8v859+lV7nasRUFuR96j7XKJwhUFSMCoJkDtkEjjkH1pM0grPUy45pUu8MQVPQ9sVLLdIHYdCOetOu0UR4Zjmsi5KsjHdyTjJH8qmx3JKo7l9rkOGKtVVgyvv3E56YrFuJCkp2Oy+nOc0+1uJTMgkfp1AFUoq5uqTitDXkmDRbCQuB1I61QS4mMnEY8tepznNTqyOuGkXGeAeCajW3mSVioKAjAwRiq5ewo2W4+SRnjQhuvf0qGS5ePATnPfNPyEGDtLL2Xn61QnDqdjhsHJBFFilG+5bXUmTIdl9vap7KcMx2yYJPBNc/tQZBxu75pguvIdXTcR02qM1m0aeyXQ7aNiwznJFX47jMbeYQw7g1ythqSygYOG7jNbEU4HzKfrmkcdSm76mvb3SJmNcHI6HqK1o5mEO3Kuh/SuKvZmGHjYAirOg601xI0UylSvRuxoTsZzw7lHmR15ZgwO8MvA2mojuWRio2ZNVJJ9r8AYx3qyJgUAwCG61V7nLytDkdgxX1P4GpVY7wAQo9KiUqQVAOB0NJuB4J4pk7liVwXC9MHr1pr4BIJGPUdxVdpCjBSeOvrUoYFcsoP0oC1hyKj5+YiiWMgj58getNWQD7hwfpTS3zkONpzihaBq2IDuYqWHWgDZ3GKbKu2TMZz60okABzgZ9aYegv2hg4AwV96mDK+RyM1QbBmHUgVaIYKpXIOKSCSSJG4QAcg9jVad9keAQCaVp12lecj1qsWDEbxkdiKT7FwjYsxgeUM8f1p0XzOMnpUAkVlG0/LiiNTjDZwDnjilcbReL7lOTmmnG0EHmoSTnj/DNOWTIIxgjrVGfL2MdJA7cjaAfSp512AMq7vpSOpbLeZkZ656/WnKsrLnqOmfSgtvqQ7pNp4wfQCpI5OR82049ADUbySoAC4Qj2pn2x1bDSKSec7QRSCzZKHBYks278MUNOv8AEAx6DK1Ak5UlSYx6ErjNPELkM3lCRc5byz1PrTC1twYxyISgKOex6UQozvjcCQOnQkU+CMnOShU84c7WFOlhQsFJLdxg4Yf40WFcdBvdPkDqw5C4+99KUSEMcHJHJB4/Cjc8a7WO/H8LdR9DUMsm4sXJJ/vdx9aGStWTyQjeJY84YcjtUh3HIDBmH8Pt61SinKKu05Q+nQ1Y8xQ8cgO5f5Uro0sydsPCpIwxzyO1OwwDZPCnBweajV90RAbI9CKbBIVd1bhWHcd6ZFrosASJ+83BlbvSxvu3I+GOM7j6Uy3f5ypI6dDzQzfP8gBPtTJaHOcKPmA9MdaesgBLMSwTg+h+tRk5bhc9sU0KBISAUGcbQeaBItIVKFo0PP48UTneS2NoAxwKZbIBIxMhU44P+NLMzRlmLK2eOBQHUqMIlJK4yPfrUUkgwQcDiklcsp3gEdDzzVC4dIxtLEADqTmpbNoRuNlYSlsdMHGaxL6Vo4eBnnHXpVuZy0gxwo5rPuZ1BkDYCsOhqonbSTT0IbaENIQTuY9z2+lWhBArlozJlQQxA71kJHKbgMGYe46VtRowmIWQuAuWwvI9qtI6Jpp3uFwiXEeYzgrjdnvTbeM4CqcnoQOamjQOVQ7k3nP0qWS38gF4y/ucYB9xTRk5W0uQy2yyIXGY5V4+XofrVDy5ljySN2cfNzWpGjPGWb5sDI2nioiSVYbVKjrxzRa41O2hkSxICQjfMxyT1xWfPFNbRs0bd+SRW1HHgkBAQT1H8qrXz7Nx6n0pOKNYzadjBgne4ldgdpVucDGa6OznJAKlhnqM1mNChlVgNrtyQKmty8ErEkkH8sVjZoqbUtjZNwGwG6nr71LEAiAhQMHOQKyi5I3Jz6ZrZswZ7bryBQjnm+Q0be8eTYrpkEYGa1rZypG7kdOlZtlEPKXccsP1q9FJtQHHfBo2Zy1LPYtx7vvI2QTjHSnBhuYA89w1VC53OF2468HpTElB2jqadzFxsXsfKDhlbB/GmIXDqAACaM8L19hUVyXZl7D27U2Smy1Io55wcdKplncBs5QHGD1pqStvKlt3fPemlgrHaRSuUo20L6kMgKMQR/CRxTS2TlhVSOXGADgVaDK6tlunNPoS1ZjY2RZcjvSyyPtJU8ewqqJVDHDHb7c1Ik8bRkdSPShClcRnTGByT1qRCnl4xiqiSEvIxAxjj1qQEYznr70rF3JyVU9KkjkGD6VTDY6kk1IpwpJHNCG1cuLFKUWUriN32KSQMmmXcptphE6eW4HIJzu9x7Vdto0u7SLzornMQKhok3gjOfwPNZGslzdxoIZYY40CIJBhiMk5P4k03oroiHvSsyu0chJkESqh5BUngVJHIqgheCOx6VDBIxVW8xwMcDFWwz5/hYHtjpQEvMqXKHdkNGQeuKqTTNGCVVCPQHmr00bgbkUZxg//AKqoXJIX94pUngbaRpC3Umsj5w5WP5vu7u1W1VoMh7dJCcABSQR9CKr6LDGFeR7hgx9ev4VdkJjPzxuyHoy8ZPY1eljKb96wkTI+VWQopPEc67h+DU1leGQh12KTwc7l/A1MuyVSUkDHHKs3NROTDEVjb5CPmQ9qRPUZdEqQxYSA/wB7n9arHBQgEg54ye1PLIUbGVPXHaqyEEkOuB29qGXEkiCxxyddnGcf0p8bmNuNpRh07fWmxnMb7wCQMgioYWyW7A9qllx1NK13I7OhUAKcqacrL5n3CQDhvaq0kxkKP3wAeKlEqmQbFIYjjPQ+tFxeZYK/6QVGVIJ429fepRIW/diPBUA+/FNdyXDOcPweD+lLJMoCsckn8waozeo4zh1GV2nqTURzcEkP8w5Ge9JLzIuM7T3HUVMsSAncTux94DrQFkgcuHZZMr0JwOv0onjJh+UksD830pu51TCASA8jIwRTbi4VVB5zjnjGKOgrO+hSlPA3cMey9Kzb2YLkYz2yadqkkysrQYKEZIHWs2e9UrkkMcDgjpStodtOHUSR95ba3zfWsTUFJuGLKSvXbWlM21SV7VTnLPE3OCBu9zTOqm+Vm1p09s9qECxryCVxk5q5aNHLuUBVaRtuAuc+wrl9OuQp3k7cD5kxya6fw3fWwvIGuuDkHPvWq2Ma0XFNo7LRfC9u0Ia7j3ov3cHp9PWkl0iCCSW3nhaUODsY8EfSuostVs5E5k27RnLjr+NR6vc2rEAyguV+TaeQc9c9qdla54nt6spe8ef3+hXenzo0BEkcilgQOlY04eFnVjxn5iRXe215tj+yzN+9HG8c/Ln+dcj42mgjcrEcSE7zxww9aV7HoUKsptQkvmc/PMEVQxAP+yKx5w5uXY52jke9Q/bt8/lk5B457U5phI21twCjHFS5JnpqLiyGecFjnKnHGD0ojmYqyMPmP3fp3qKXDzLjlBx+FNhVRNvDcg8A9T7VmzS6sascgVFVua2dLlyD5Q5x3Nc3O2GWtHSpzHJj+tTc56iujq4V5XdkeymrzghVVjgYyOetZkL/ACqTkDirkpZlyMsPU0zibs0h3nRkfKAD05pEX94CqkL35qv80jKhVVXOcirUMojLITuJ6UluOastC2ZOQoY8Co/MbnP4Go2chSwPHvUKzgYZSMY5BqjEV5x8zAjeBj61nXWpmNAjLjB+8B1p9xh2Jxz6LVRcYxIMH0NFjohbdmlYXIZA5BK9jmrSTKGfnGe1YSz+XLsVRj3q28mQxK4zSRM431LLTxxvtDAbjimeYok2oeT1xWUzee4YcBRgepqaOdVdFIBJ96tolRNa4YRwKVzyaLdsqp6D1qATEnawBxUoX7oHTNZspKyLByoJznPpUgclSDwMd6gwU9adHM0LK6YJU7hkZH5UCeuxsrNE9jagaktuyKVMfzepOTjvWfeELIoF0twMffGePbmn/wBtXJwMW+T/ANMU/wAKrXtzJdOHl2BwMfKgUY+gqpWaMoxcXr/X4FaOQxBQ6856pj+VWHljYKxb5jkE9MVXKmWRJHVlfpgEYPpTJnw+QhVR/CaCnqTytuAxKqkDuarSufJ2uindj5lOabPMsxVEiWNgM8mgyBQiN5YJODx/WgtRstQV22fIxPqNnIq3Y3DM+1bgsTwFwMj86pyfOPnjlK4wGQ5qSFLGY4WaQyYG1jwfpihBNKxqSQB8qxUOOQcYrPmwkxidjyPlcHj9akdpLePaMSqB97JDVWE6SrtIU45weTmmzKMXuGxotxdyfVqhXMkmXIUjp70s8q7hg9qrrMrFu5B6UjRJ2Lsb7WYBuT196RgAC+cNwcEVBDOQ+MDHXpT3OQw+8OoNIErMuxuHtmCocg7j6igMPKUGM4Dfe9DVeElQrISDggjGamTDRlsnB5PtSDY0A4kjTaqs6k4PrTnZWiEhRhgjcB2NVYlOTghiTgAcVIsgJAkBVumB3qjNqw4u2DjO0nPzDkirB3LsdCdoIGM8iq4LRS/OVdCBxTy0MkpUysmedoPei4mrksoYyIxYKSOrDGahujtIMilCehX7pp0s0kYVJdsi9ge9PLicBGAVBnHtTJ1Wpl31sjjdIpDjoVPNcvqFuGkzuGc5HGK67UIBCoDMcAdeoB+vpWDexSLGzsA0YONwHQ0rHVQqWMcO2471DE9ecVDcAtHtHIHoc1NOqgna3uc1SMiLJkgqOuCaZ2J31I2Vbd/M3sGYcnqKQzMJVYvufqFHFOlkgUhgwZj2NV1i3TfMeexXoKo1T0uzsY/HlzcaWllJbxB1G0SbfnFbNrfSy2aeecM/SRjjFcdpltFvy0e+QfxDOD9a3YpZBbMscgCk8qRkVaV1qcFSnTWkET3V95Tlorh5CRgkjk/jXI+IL2SYf67g8cntWneXJIMeQF6HIrm7yUPK4AQFDkcUpbHTh4qLuU7cLG4MhySM9OlW1mwrFQcZ7d6qXMUjAOp+XriljuYwmBlTjoelYLTQ6pyvqS+crEEI2Peq0jukhyGIz0/pU6Sqo+Yj1qrcXAT5kOGZuvoKbMuYsR3XmOvoOCDWhp8v7zglTnoawQ2DkZOea1tNf5h3561KIk9DtLBy8SjdkDtWpFIQuMcdx61g20v+r2fnWtE+VBb7xq0cM1qWDNEoYggr6elV2uV3DyzhhkVDdbhHvx3xn2qOCLaxZSMnsaLFcqSuaiyloOQOaz7sMzlVbYCMjipnn27V5xjqKjKl3B4KjmmZpW1KP2sxYWTce2RUizb2zIvTkGpp0VieASapyjAaPlePvGkzojaSHrKksxbduA9quMS+M5KkdazrbbEvzBTmtCNshdvegzqKxHKqqpKZ3DnANZBLfa0kIG0HvW5MuFJyOf0qisI+0KAC2KLjpvlTZoR8AEjnvV9HAUAk461XiUKgLDB96kQ7h14pGLdx08hVSRk8VThuTISHJAqWZsgqOAOvvUG1U3EdKk1itDTisprhYDFET5xKxknAJHX8vWpbtDbItvJbxrJtDearlt4z19CO34VLYXEjaS8sdrKZIIXhE24BAhJJOOpYZPSq2qS/vooVieOKKIKgfBYr1zx65q+hjrzWZWV5yrFkifjaCDjP/wBehZGEY2hkc8bW5X/61SW8beRkE7c5wRzWn5EckChzlsDpxTsTKSTMee1M+A8TqE6lWztpY0mjYRTANEQCrEZ/Or5WTKFRJlflzj7v19qtyKRA/mIM9iKLaFe1toZ8NquQYeWx8x9farKmGWIbgCqjAIAyvsRWbPcmMGQFw6nG5fvfiO9OF6u/d8sbt1dejUkwlF2JXgMIJEhXJ4U8/pVO5s5AT+7KsDkYPUfSrqPkblb5Sc0yWYbySRnPNMlSaMmdZFPzoDjvUatGhLbce+KuXdxExxxyOaySwJYbjgng+lBtF33LcDx53bt2Dg9qnJO7C4245GapCQeVwAcc+lXd26MMMA4wcilYHoTxylRG3bpmrMLKA4UcnPHrWeuRt25JHFWopP3e7v3PtSIZOp27cDo2ce9TmQShg4AOc5zmqYucBcdM9Klg2vhmQHPcHBpktWLLKhYA7lI6+9R3MILK7DCheGU9/emzMyy4G/PBPemMrlchwVJ5FAlcngnYF0mXPAIIHOKWZ12AgMQOVb+JfaoJnXchC7GIxk96sFm8hQAsUw6HoG+tFwfcrtdmPFvdgyQN1I4I96papbyQRuYSJ7fG4snPHvS6heuLpDLFhs4ZR0bjqKinkWFt0btEjgj5TkD6imikrO5hXvliE/Ngk5xWNcDG07lIxmtjUn+UtthOe6cfpXOTgFDhs/WhnbSZG04mf5sBQcevNWLe4IOMnaOpK8VQjZQSAVUgkgE8Vds75EmzJGrI2NwOMY9qUXqdD20Oh0154mVo3U5PGG7fSrd1O6DzJWUHuQcVz13NEcvZsUTGQBVSO9ZlKsc7TznkVtzWMHDm1Na4umYboiCvcmsW4xuwMfNyG70s85GcYwegFVWdZMb8q/JxUSdy4e6PudohaQZ3qOOep+lZ0Nws0R53ED5vrUkswJIJJweOeKzbgBbkFWKhl52+tYy30NotNaluW+Q7YydqjjNCyFm3Fdy8gAnpWbKrOmepByGNNtrp1bCkmUH7xHU1NzObVtDYVmVQCMSH1rX0eRlkB6HvWEk7zsqzD5h3PWt7TozwepHFXHU53K511oRiMKoOetawHzg7Tjp9KyLDG9B1AHar/wBoOcZxVnO2y1KVeLyyRjqeaghDIX5BX+VUXkKynAbpUsTFlYhiDTKS0IpLk/asOSI+1acaZTK856VltbtJy2cjmrtqzBQpY4HpRJCltoT+WScHHFVb6AsVK8nPUnpVlZecNx7mo3mAHbg0loJN30Me7U26tz8x6ZNXrYs8SHdj5QSaiu4BcMrPng1biQRYBxyOncUM1crofKNyKjHIJq1BGsaLwDjv3qmJozMccmrULbwOeKRlO9iZnQjg8/XFIhAB3HioZHAY9MfSmpICMdQKCUh7HfnA4FQMrEEEVaRiRxgAc1CzHJ5+tTYqMrGzpT28lvGs0ksMkdvJAAYmZW3HO4Y7+v0qrqcyNJDFH5hSKIRq7rtL8k5x6c1ciuL2XSrWLTL5YmiDCSN5gh3ZJzz2x6U++vTNp8gur2K5ZY0jwrbszBsll9tvBPQmtGtDFyfNcqxiREHluJEPTPBqSWWOZBGjNHIOoxiqNrKAwjZuGPBPSiaRA22U8Dow7UCaNFLhrd/MDK6kYcdM1HJcjloHKgjleorLnuCsfzKWQ/xLz+dZcl1+7cQlgw69xSvYcaV9TXuX82VXTAk7jPB+tVppgxfaqq+cMhHFYdvdT+dsKnA59vzq1OWdBIGOR1B6/hSWpvy20LI1IKxQ42ioje7j8uOe9UYwH3ZAPueSKn2QhVPlsp9c8U7A4pEkzl8b1HPeo4/L3tgEN9aTOF5z9MU6MgMSFBz2NAJ2JIVG7d1A4JHpU8zsgVBnYe9QREbCoYDjkH1qWZd8ESxSYZTyPWgTfclhDZAd+i5XJxn2q0hfogKoQTVJCWk2qdpxjnpU8UpdyFAHXPpQJjoy7LlVDZ5ANTw3O5Bt4YNgqeKZjMW4FcDAxTTtbJA560g3RoLMFmI6A+/FRkMFcgZCn7pPT3qMF3BVguSMcjmmbJBCxJ4UZznnFBCJJHjKrtZgR13c1Mbho7c+YqsoPBI5H+NVIm+6ccEY3jn8xSSzGOUKSu0nllGB+VJFNdAkSKf5o5DuByEYYx9DWZqHmqkkEyn39RV2UorszAshPDrS6harOm5Z1mXb948N9PrVxEpWZw98lxkrv28demRWTI5QYl5Y+ldJqSPEzpKDt9SK5/UUQJnOfpUyj1R106vQz/NAlZVOHYbRkZBzVUyvFKv8Jz1PSkmkQEoxCsejHoDUX2yYboGAlQclT/Q1ik7nXGomrGpLcSsR5q4CjhVP8qa0xjUCJwc9qzzI7hV2N6gA/wBKb5qBgT0XgjPNXdks03mJUNgk+1V5pnPys2G7Y7VUN4BwM7D0yelQSMZdgBw2erGhsS8yzHMSoLYyKqzSZkXa+0g5BPaqzTlWyPuHNNnlVj9aBSlbYt/aVgUA4kY8EdhUcRM9wGUAE+naqSksAhyFPcVp6XERIpI3HPUUNX0OeUzcsIRtUsDv6ZNdJYxoU6baybaMlwB/EM9a37OFVA5OR2rZRsc7kadqdq5jBzjFPf5UAPXrTYXEbcEZPB9qkfbIDk07AmN8xgATn2qzGuE3Hv6VS3BfwOOak8znO7kUnuaPVGgASAW449aQMFY9BiqbXIYng4HGaVphsLPnFJ6mdht1OfMBzj0psQMgOc8UmQ4GR+VT24IHOVpFXsSpt2gSDgVFcvwGVeMYHrU+4BiOn171Qut7ZH3fShjjvcsWQVV6ZJ9auqVA9MVhwyeW6gcmtaJv3Y7UIU073HTy7V7c1EhEY9aTLTSbdo2r3qdo0wAQCRSFsKHCKG70hcMhKnrUUq7sAnAFNkOxBtpCsdVpSqNPtkitbeaSaCRg8kYYtMpzt/75A496peIF2z27Pbpbu0KlokQLsOT1Hv1/Gm2CwR6baTJp81877i7xyMAjA424XocY596qapKpuN32SS1Yr9yRmJb3+bn/APVWktjKKfNdEBk3goTwPuvjFQPeiItHONyMeHHFUEWUSNsYunYd6gkuwvyTDIJ4DcYptaGqirhJdSW7t5MhIzxnrmqv2ozSuZMKT3x1p7rtBa3Kg54DAMPzqJZJRjz4VK+oUc1m0bqyARNGwdGZGJwDklau+dIF2So7cDBDcYqtFOgTJRAD0x/hUguI1xsxz0GaaRLdyzDIoJIkwO4IxUjszgGJ8D61VjlQk7yuDwQDTI/MaTcpOwdjxVeRmy585b94QTjPBzTkXapJw2R+VQ5x8wUq/b3p0WCGYP8AMO1FkImAiWVs4YEdxjBqQKrElCcqeOOarJKSxLJ07k5qWJweQ2QaGrE2ZMZVIxJxkCld1h2bTtXHaoJMFl+Xnk4NIFbau4571JaRfjdGRct1/WlATztyZGOxqkCgO7ueCBU0DHOGO4Z4PcUhWLqyqxO/k9ipp6ySMSGb+HrWW0mZmCtsfPIHerMVw4BLDOOKBONiRdrDAJVweDnioxI6nbJ15ORTRLExLFWRm7g0qloz8yhgfegY8PHhkXByMFDxk1VaFyrvC4H95AajuGJYgcj9RUYZl2vnJHdf61SFYiluZYoyr7ZIm4KsMiuY1aJGjZ4Bg/xJnp9K6i6kiuIP3gPsw4/OseeCFkIkU7h0kTr+I71dr6DT5dTgtQ/dksepqk13OVOyQpuG1iOMj3rotb06SNixjcK3R8cGubntnRC3p1FYONmawqDRdS8JvJ2dFz1/Golu5EVsMVBPaoGhcAkZ49KYSY1IIwfTFCNfaF0ys5yGyO/ammVTjrx1zVA5Bz1NSDceTzmiwpVCSe4VX+Qce9NjzMRnODUTQM5+UZrSt7TbbKygE7sNk4x7UzKUxYoiVA7Dg4rdsoWiwpwSBmobSOMxxGINv/jDDj8DWrajdtTZtOTz61SVzBybLtkpKZbqBW3ZyHbnoO9Z8EO1B/FVyIAKQCADWlrDjqWkuAX4HTvUouQQ2Oe1ZsrbYyEyRmmwTtHKqKOvNGxdtTXjfzM7uT7VLGVXdxg1Ut9yOzZGD/DT958wKwPrmoZSdyTG4fMevSnI2IyGxz2prFd4XJWog4H3mHXA5oGh8M/+kFQSCKsLOcnJ796pPlEZlUA9iKoWk808j72xg4waTKcbq500TLu+fk4qR0U9cfSqNspjXlu1XBJlQR0FBg9CjLbOLguoGKtoCwVWpZmzgA0xSvck4oKu2i2kYXplaSR9jHIzUZk+UEHJPamNlzluAaCF5knmBxkdR61C4MnVgKaziNgO1TQSm3mjniYb0O4AjIz9D1pWK22N20miGlWMSa0bKSJSGiVXwcsTk4781n6mwa6TF79u+X/WEMNvt835/jUx8R33Z7c57fZ0z/Ksm/1Ge/n33BTcF2jYgUYz7VbasZRjK+v9fgY6SMGxHMpI6A8GovtJeRllXeR1BGQKoifMZZkPHG7IammdVwyjdnglCQRTep0lxWtt3zNsJ7qcgfhUyxnYzQXAYY6stVJJVdQEjJ4/jGabDcQ7hlArdxzSSE7lmczYzLErgj7yDNV90LHad6e4Of0qSSUouQWwT1U/0o+Zoy2Vc/rTcQUiaKGMxn55NwPap5ZFVgGwR2OMVVh+ZFfYwPXg1a3sQAT8oPWmombkK7owPz/TFNwxQqoDfTikuVGAVK8nrVYO0Ckq2QPxFDBalsOwwuMZGcVaVlEQZD83oP51jhy2JA2TnsetWvPDQjGVGeD61LQ7FwzFgpPr1pyyqZCrDAHQjoapRzKVIUkYGc0BhvILZz2FSM04MNJhMeuDT0YCTkY7Z7VnpLtxtHbrU0U7hSjgY9cdKYMlZRvBzz61I7krzkMT1BxUcpBCiPOeuc1G4cp83zAc5XqKQJ3LClsBTsOOfQ0rMR988e1VIpSWw2SBzupXnAVUJyvtziqSExxkdX3Zx6HFRS3Aj5bgnoAODVedwFZSzE9qrR+a8xCMMgfdbiq8h20LwkiLkzAlGGPlODVJkZFbyyHAH3WGDT42DthlIyM/jTZmMf3jv5xigllCdZpExGTt/wCeZbp+FY17Yggq8RjkPcDrXRlElcnO3Pr2pjogLJMokTsQeadrmbOJl08kYdSffFUri1dlyUDAcEpXbTW8YB8okd8N0rPktU5YqEc9CDwaXIJTaORS0Dfw7e+D1qxHYkNllyo610JtAzfMqk/3qT7Ey8q/H8qnkK5rmIbBVGR1Pp1FENrkkj5yOOK2XAQDbtZulFrERLuHyv0NLlvsCeglnGQh2qPTpWpax7HGFwAKSOIKw3jOe6mrLNsQDfnjvVxVguSeYgb5sDHcGkknDuFRsL3NZNzckk7hgD071Np7mePKghfQ0Xu7GkVbU0SwDfI+7PHNWEZAwyMnHHtUKRqqcgb196VWy6leR3obC9zWiOQOMACpFJZht7daqxyLtC5wRTklO1ijdfwqbBsWt6bsHr61TmkAkxg8Uvm4Bzwe1VWm/fk7WZcdhU3NIot+aDgE9aZDb4uNwHy9KqyTBNv59at29wDuJHarJ5n0NEOIx8xz25qSGdDwODWRLcsXRccHvUkEn73nORyM1O7DlNJ2ChsdahUkgYPPpUcrluSR6UqyBR6EU7B0LiMFwMZLdfalmb+6RnPSqzSqQG71UluCrAc5z1FIVrstM438ryKkjnMcqPtSQIQdkgyrex9qz/Mcn5hnNOEoVdo60htHa2EUlzZi6az0G3jZS4EwYHYDgtjPTNYnieFra/jV0s1JiDf6GDswc4OT1P0q3p928en6dNdW+bVw9iW80L5iMScgHkbSTz0qp4p/cXUNrHA8UMEIjjLOHLrkndkcEEk9K0aujCN1I89jiuowXh+YZ6NxVmKW52FTC3PUof8ACqltdXODuiztHsRSNeOMeWwSQZ4XvUq250Ns1PtKxgFncseNpyDThcJMu4KhA9G5rNj1F5dqzB3x1GwUNPAzDKMh744xVX7EGuDIFKxvvUjoe1SISiHzIsg/xAVlpIpXKSMPqanS7kRcCTeuORQiW+hoeYuV2SYP5U2e5+XcCC3cY5ql56OnzbSex6YqFkckGJtwIz1qiSzLebxgHH16015SigBslsGqwmjdtkgw3QnFPkUoucBkB4OaTGnYsRGLYQzBWJ6jrUrcYWI5H909qz44cYJzuPcdKtGVI9oK4wMbvWpsVzal0FV2g4ORgAdc02QnBG3C9j61XWYOxDjjjBpCGJLJLx/dJ70MpaluJ9suUO9COmcYpskuWIDde1VCQAAxKufQ0ScuBJ8pHO4VNhmjDP5bYc5zxn0qWO45xGSOMZ9ay0kzlS+cc4x0p3mhQcjnOeKaRLZed5Ef91wMfN7097gLxsB+lVxJGU+UkOB07GmznymUk7MjjH8qqwr6iTsGc7DuP6ioIpcEjdvPcHg4pl5LJneoBX1xVaKdGI80cetFy1sXIbkCUouQe+R0qdixPKKw+vaskntvDgc5btVmOZiQFGVHQg9aSd9yZqxbRTztOSOSCaaJBuKyZ3HtUYnTb86nJ7g4xSF1fJUEjtzVGbHSYMZCnfnse1VTGp4c8H07VOTsXuFHOD1qPcJFY5DDoOeaZDRB5ZROFJH94dKhfaWJHXuQeKtBW/5ZucfxA1VnTLnA2n270m30KREwDtnb8w71Ko2g8ZHvxTo0OCrcsOmeKjkkCA7jgjqtJDZahwVwOD9aguCr5X86ijuRkAfMB146VTnuSz/vM7eowOabYluF5I0cRUODjgjHNWdPnDhQjYz2xWdIwkB2HB9+tLp85DKOnPUcYqOpd9LHSqSoAJ69jUsa4XrxntVS2lEo57VaUgsPQVQtiVWDkjPQYp0bYwufmPBqCWWNeAP/AK1QWsw8484z0pdbFx1NQgNESWxjgUgQEfK/OKpm4J6evSk8/agyeTRZDuwukCgMxqxayAqOccVk31wGjO0nPvSaZd+amGPIPY0r6lW0NksVcN1AzTPO2/OSQc1Ua4x8vB56UofcRkYx2pMaLiXHmOQSQB3qx5ytgKcYrOT7x4606TejKyZouJo0sggcgZ6U1xufa3GO4qsGLIfmINOV3wBvXPqVpEk7fKD3/pTFR5rhIYUaSVztRV5JPtUDEkZLc+1NGQ24Md3YjigaZ1Wl2b6npNn9u0nV3W3VkhuLMKVdNxOCG9CTyKq+ITMlxbxPZT2MMEAjhin++UyTuJ9yTT1n0zS9D0yS70+5uJ7lGkLrdMiYDEdv4uOn+NXtZs7GfSmubK2ubd0tI7sebMXyrPsKnPQ55BHUVouxg5e9fp/XmeYRpcR5KvH68tVW8u3CAmFGbPXqKQwzJIcvvX06VVulnVxhCD2ANDuOM7blpbzcufJdGxncBRFKZCPMRip5Vs8496pNPcwjlT785xU1peByfNRR2HYmouPm0uayMwAO9ZB6N2pXljLZYtG+edoxWY2FfMZKt/dNAumJ8u4UlG4yasla6l9iyjrkZzmpIGAIIfII6VXZtqbkkYe2cioVlLLh15NMlsuyuryHhgcdaYlw8a8ruUcA571RlkdQxL8jpmpFm+T94Ac9cc1Ny0XPPJQmNyCTVhZWbglSB1+lZyMpACYyPzFOnfaoKOFk7hu4ouMvS3IYEBSo9c8U1ZmUAkZ4qiJQMAnYTxz0NWI3DKdpBx6Uk7jvYuRzKyY3cnkip0PmchsAfwntWWrAneMH9DUvm/LtLbT696q4rk8pfepCjnsDU6SDaSOCOxrMWYxs24HnuKtLN5igna7YxjHIFJMdyzHdIXKuuH7DtUf2gSysD24CnvVOXIzxt/2jULPKi8EY7E022O6NGZS4wr7c/wAPY1XXHIbhh+tMilV4lyf3mOcGmzOAwTG7370r9R8wyFmWdiQQvbjipEkZXJ5AY4yKIwsin94F9Nw61PGuEwQMdc0JEuQ8MWOX+4e4NTIBwV4x7VXRQqgqvI9TRJNnPIU4qrEXLoJlUrnPGOarSKISMArj0PFRrN8uF+XPbtUbXDBhlvqRzQSmX1wUJbDehFQEqAM/r2pnnBiNp5NNYFkII+YH1phfuK64JIJ575qjPJ8wSVSVJ+9VsdM5yR6VBOP3eB365oDmuVgyxE4YEfWo32u2/O3IximvaBSWxgeuc1HLG6opOCBzx2qHdFJobJA5yRnPrijT4yGJYgkHFSo7OON2zGKVWK4C5PPfrU21uWmaUDlThQfrVxJDs4rNjkwBgkGpkmKoGYde1UmJj7qXaeOexqmtwwUjndngVYYhjlv/ANdM8lQ7Hb+VJrUqLSQ6Fy54JzViSXEYz6YzVbAjXjrTbhtsTHrzSbGmNlYlQpGc0kEQUFkyppkLtkE/NUk0vAAWkXzX0B5isy7gcZ7Vft23Dc3QniqKx7sHJz6VZB2AMKErsHK5oFssAMDNMlmwBk8dMVCk29WK8EiqspYcnGachJ6mmkoJAFT4yc5zgdjWTbSYXk9elXdxEYyO3WhailuLI5HCnr2pEL7SD0AqIMOWB/A00SbuT+GKLMLna6LqCaHpNs17f3v+mAzRW0EcbhFyV3nzAQCSD09KzPE99exukQ1O4u9Pv1W7QyAKzdVww9QVxgcccVUsvEAgso7S80+z1CGIkw/aAd0eeSAwIOPaq3iWW5uJLC8umh2XNsHhihTYkCB2UIB/wEn8aq+hil712cc95hSrAgdAarSXIAzu3J7mhhNFFyPk65AzVZ5lMuZkDDp0xVamWnQuGeOXmHEeOxoUxkHezKx/vDOT9aasdvLCSMZ9Mf1qHYGwqMyr1weaTuO5YCMIfklJ9mGaJPM8tVJDHqQDiq/lyw/OGOPWnGYsNsoGf7w60FKRYSSVNmQWj689hVgvHOSynn0FVIHnK/uR5g9D1qCSSJyDJuR+RnpilsF7lpxlvmGAPTvVkT+XEA2SDWYkdwp3KwdPr0qyJI9ql1ZXHHAPNJMpliV1CgkZHYjiohPJI2BhwByD1ApjllHyvnI4qONyTtm+QjnetAkPLNIwRTwOx61dtpFRMEnjv3zVSJ8Jl0D54LDjFSJ8o3BmOOcntSt2KvculsFdjKfc0jTq42NlTVQMJAWHc1CjMvDfMuaNQNASsmFZtwPtVpDGzLgkdsCqce9QWQBgeo60ol3N8g2kDkkY4qkrakuRdllIXYRgH15FVVmbJTepXjIpq3OeOwOM1JI2VGVUj24NMExFETEFm24zjFLJkoGGRjowpiBcbSPlPr1pShUld3y9cHtSsHMKk44Q5zng44qyJGRMswLdaphwjA8Y9KWSRWUEfKf5U9hc1y2lw2flJPoDTJZUkO0kBgM9KrLIcbmOQOrU3zhvBI3J7UCZZ3iNB1KmoUZV3lCxz/CfWop5Vk/1RCenvSCRlGWHzYoC5YtXXzDuZl479KtBum089we9ZccpL/vMjPX0qxFIc7VJYA9u1C0EXo9pJO7HsabKyg7SDg1WEmCdxPHSmq7OwKtknsaYhc7cgHcD0qLzFLEKx989KdM5U8LjHUCqguB8xUAD0NIpPQuAjaARtFQyHP3WGOmR2qIvlcuec05GUZIyB60mhpk0ZKAIevapUm3uwGcVQWfePU1JDKVJG3GepNSWWhOQxXt61ZV8puU9az5XCDd94HtU0UoKDnj0qkK5K0pLDtj0FD8qOQaiMmIy2M9sVXD7gWyQe4qGUmWyfl5AB61XVmL5JyKkRxtAYZpikLIdmeevtQCdiyHJIwcUhmJbapz6n0pgddvHFQBgJWctx7d6FuNM1Y3/AHeB1qq0xMhGOPWm/aDtPQn0pyLhNxHOaqSuEX3LEIwoLDkdjVtWKoN3NU0kbBGAfc1JJIAoOefSjZA5XHmUdBx6g96ltp4o7iJ54fOiRgXi3Fd49M9vrWdLKc54q1odq2qazZ2Il8s3Eqx7+uMnrikrsltdTabWdAdj/wAU0T/3EH/+Jqj4i1eHUDZLaWf2O3tYPISPzDIcbmbOSAerGpJL/wAKW0zxDSdTm2sU8yS9EbHHfaFwPpVLxPaWtjJZz2DTm0vbYXMaTgeYgJZdpx15U4PcEU3cSaucgL2dFIYbh35qsblZHJaNc56YqtFcY4kL5PrTcxO3L4J960MWrF1WhI+aMr7qTQGBP7mTGOgY81TcooBjlBI6Coi/sQc9Qc0gNLz5UXBIyex6U1ZTnLxkZ/I1US4fgMVYehGKsiWMIdyNt9VoAuNNCcYcxMPQ4qG4djGrblkwc4qrK0buAjD8aQybD0yAOq80MIlm2dAQSSrdDz1/CrO5y25xlf51lq4fDFSR29amR5FGVPB52txU2LuaCyREjy5CvTg0xmLSZfDL/s1WMkUi5PyNmnRO4xjGe2KLB5l0SAKVXlT39KSMkMRG5IODj1qvHdYIxhW69OPypwkB5bqejCmkLmJdw35AKHoRnipZmKoHXg9DnpVEON3z4J9zStM2D825egosHMy3HdAMSMKfQ9KcbxZAR3PQDg1m74pJD5x28YyvrTnHzDytxAHXvUu5SsaIYO48plK9eTzUrzbMBwceo7VmwyEDKfK3X60rSkn5shs8n1prYXU1Fnc8Fhx3pGuChPzZOeCaoC4zjtx1okmbPGGU9eKLsDRJLjOFznqKaXCKwfkL1z6VSecqmV6e1Pa43lCoXgcg9/eqEPSUsxEYwhHBohxjk7T7VFPcIVyuFbOCoqAyMHOeh6YosTcuSjdFlkOR0K0iSL5WWO89x3qF5sR4DEcVXEh35UjHtSsUi6kmBkE4zkg/yqwkoI+QhQOMis933EHJUnmpIyu3bnnqRQItyzOMrt3HsajglYnk/kcVWnJbBUkMOoNSwMPKBbliaYieUyBuSMEdzVeZkKnau31z3psshDcAbhwBmoZZskK+Q9A0TFjtIYHCjt/hSRSKVO7IpjNtQZbJ9R2qOQY4z8x/lUu/QtWJQ7mfAAwB1FXl3JjcQ4H51nQt5X3gcVN9oDcAnPtSSBsnYM7MBj6VPEu1QWJUdhVDeA3J59R3qyt4pQB/woYJssnIUqD75qu/ynhvlPpVaW42Hhhg+1CuC21mxmpLLkbjYpHNIW2kknFV+SB7Uxpxu2uSAKYFlWDhtpz9KiDN5h9B0FRRSbQ3I+nrSpIjnpg4pAWrVdzdenPNXDIET5jyKrRfKq5onYsgUj8aroRfUnguQ44HTipXYEdcVTiKRgDOTjrRLOR0xQth63Ee524AHB4zVnTvOmvraK0cLcu6rGxfYA2eDuPTnvWcu0sWP1xVizje7njtoEaW4lcJEg6sxOAPzpRG9j06aLx2jMlzDo7Tr1knFqZQfUk85+tcR4qg1aPUg+vzLNeyRhgyyq42cgAbeAODxWlqWi3F9LCNX8QeHUvbeIW5V7nL4XgB2VSCR0zntXO63pt1o9z9lvFjG5BJG8Th0kQ9GVhwRx+lW0ZR0OF84qcZ4xxkU5Qr5JA/Cq4lOQpIJPY1YDxBRvXaaojmExjoOnapUdM4Bb8RVaSTBOOVx2psM0Z9cmkVdGjvDIQAh9T3polm2YjYFR/Diqhwx/dnB6E5qHcUY/3vUUAaX2kO/wC9TB6dMUrSxuBsBGR2NUEnZsCYbl9RzUg8v/lnIB7GgLlpWdANpyAc464p/mhs4Y8HvVMM49+M8GkScYKvSHctvMwGWAI+lKJQwHluVPGVP+NUmY4Gwk8YFNEil8MpB9QaCuhpC4ZflYDB7kU7zkjYBGyMZx1FUDJtGPvCmthlyDj2FMTRoNcA85IY+opsczA8fd7hqol9vfPHSnI5I65HvQJGihVye2ecd6epAfapOAO/aqAcAAb85pSc45OB6HmlYexe35OG4B6GmyygLsY8HowqqZyp5IJ6dKiklHXODnpSsCLiS9QeVHpUkcoJ4YfTtWQ0h3Aqdv8AI1LC5KHPB7e9PQGaDTZkwCR3x2NTJKGzzg9jWcj7V3E05ZSeG6DoaBFl33Pg9KlVscqxOOxqlLJ0CHj9akSXIwFBwKED1J55sgjGD7VSDksF6j1HFPY4JLZ/A0zgKc9aYIvLLtwB90+vNSKRuznn61mIfn+v6VZ81RjIG31xS1HsX/NBxvXJ9c0kj8D5s8Z+lUTOCRt696DcBR0wT3pk26k80uFznLHpioYnY/NKxz6GoJHZnyOg9KVmYjNItMuBh15z60hclMgceorMd2L4zxip45CuDk89RmgRdLMBgNn61DHKcnJxio2dXPzEqaa4C4z09qQ46lmOUs3zZp0hzjnHrzVVZdmSOlSRzAnkdfUVLRaVidnUgccDmnRszsGyMHtTFwUB24HpUoPyg44oSByJEYhjk5z2psnzMQc7RULvgiojcHdjsDVbk3ZYZscYxVm0Q5zkYHaqSsHJwKmjbbnaxz70CuayyKABxj1zUEkmXHPfrVBpN6gDr9aYshUkZ+uaLgi7cTqmFQ5PeoZJy20Kee+apTScgD7xqQ5KYGM+tSy1ZEn2nDEEcetWNG1S40zW7G+tQJZreZJEjIyGIPT8elZh4atTwxqMOkeIdN1KeMyx2twkrIO4B5x70JMG0dprGi6JpVut5rGgeKdNjmYkIHheNSedu4jI+jc1z3i69e5OktBYtZactmEskkkEjPEHfLs3qX30Qa8dE8Q3os7x9X0i4OJ0nVlW7jbk7lPRhk/N1BGRR48vtImOiwaBcy3FnbWXlfvlw8bGWR9jepAYDI61XoZ2d1c8zjuCcBkyAOeaeJ1z8j4HYGssOAwy2Bn1qdWRgWLjHbA6Vu0cvMX3uVRQXQEeoqFXQnI3DvVFiwfAbKZ+tODZx84H4UrD5jQLnaBESM+vFRrclA6Ecn+KqgndM5IfmgXCvnPAPQGiwKRqRyfKDxmnrIhxuXn16Gsl24UnkduaQXJx0JPalysrmNZ3K8IxbnoaRZsr84A7c1lidhgr971qYXAZR5g2nPpRyhzFosw+62Cal8/oHwfwqr5pRcDayn0qLz0ZssSPUGlYfMaBkIHyfMo9eKYJhn5jtb2qtuKrkcr6imvKrqD2H50coc5dEp/iAK+tShg2PLB96oRTY+64IP8ACetODc5UfXFFhplyST5gOn4U9XdeQOKoCQ9TyO1EkzKBn9KVh8xfMg68YqtcS/MMcg8/SqrTgEMw2t69qhaVSxLY+gNPlDnNRJF2AEZWlaQfKBnBNZyzBRhPvEY21MswxnOD6Ypcouexoq3ycnPtUUk2wADJ9sVXDAE7WIJPc0wuxJyT3p2FzlmGbcxPPHY1cWRWHXB6VlRlR1zuqUS7fuHcBz9KViuY0VkI4HOf1phl7ZP0ql54dMg5xxmhXzlv1pFKRcWXB4NSeaPL25Oc1RLgsvOfpT2kxnJzx0oC6ZOsg5C5yO9SGQ7eefaqUZKfNnn0oaZQ/XB70BcuB84HTvxSmVlPYiqvm7gCTxS+YB0PHvSKdix8rNgn5jTxgE5z+FUt/wA2ST+FSK4AYnv0oFcsbxnk5HajO7pwO9VS2cE9e1TRkAZPNIaJGPYcY706JieGNRswI4705GweDinYq5cjk2rgYxjipPOIJAOR2xVEOQTT94wCDzRYhsmZztOeQKqjJOVJx706STK7e1MDA9OB6UWBMuW6gt/nmpnB2cj6CqkchUgDgVJJNnODwKAHEY2kN+GKbNIF459s1CZGPI6elMZt7HcOMUrDRLCONznOf0qRnIUlDwfWqoLeopM+vTPIpjbuWfMGMCltYpbu8htbVGlmmdY40H8TE4A/M1VeQZB6Vf8ADGqDRvEmm6kyGRLW4SZlHUqDyB74zSFtsdU3h3R7a+i0yebWbrUJVbEtjbo0OVyG2BiGkUFWGRjO04rlfEmmzaLf/Z3mjnikjWeCePISaJhlXGeR9DyCCK9M/s61ub7SdVtorq+XTI4kt7m1vIUt5UiOYjKXIaFgMBxg9CR1rhPH2p2+oapbQ2syXMdnB5LXEYISWRpHkkKZ/gDSEL7AVTVkTFts8sjHXJJ4HWlkOxBj1oorpOUAzOdpJHHarJO1RiiigCtcnABHBPPFOjcv97FFFIOoshKsACQDSoxIOcdcUUUDGK7byM8U9nOOefrRRUsADEAYOM9aexO0N3oopAh4kYKMd6dIxCJ7jmiigYh4jDDg5pwkZQMHFFFA0SFmZDk9+1R7iSQSTiiikgZDcE7cjjg9KoLIwl6miiqiQzQwNgPepY2JAyc0UUFErSME61KxzGx6EdxRRUi6jFkZozuOdpGKSRiokwcYOPrRRS6Fjrb5kfIHFSK5JIOCB04oopFLYduwG4HrUTSNwc85AoopMESSu3lk5wQajRywyeTRRTAl3kFR2oeRlQYxRRSGQQzu5GSOa0Sdp4oooY0MU1IzkL26elFFIpbj4nLKCcZoLENRRSGLvO484qWMYjHvRRTExpJ2k55ApiOcZoooGWAx8rOaa5OAc0UUnuKImTRkgCiijoUIWOB9ad1J9qKKEAyX7uahRj0oooYD2wckgZ+lRsxBIoopCP/Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This blue-red, dome-shaped nodule is a Merkel cell carcinoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_61_2001=[""].join("\n");
var outline_f1_61_2001=null;
var title_f1_61_2002="Bilateral port wine stains in SWS";
var content_f1_61_2002=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F73343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F73343&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bilateral port wine stains in a child with Sturge-Weber syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 325px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bilateral port wine stains are present on the face of this patient with Sturge-Weber syndrome.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_61_2002=[""].join("\n");
var outline_f1_61_2002=null;
var title_f1_61_2003="Gastrointestinal stromal tumor in the small bowel";
var content_f1_61_2003=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F78991&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F78991&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gastrointestinal stromal tumor in the small bowel",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 415px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Gastrointestinal stromal tumor of the small bowel detected during double balloon enteroscopy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Hiroto Kita, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_61_2003=[""].join("\n");
var outline_f1_61_2003=null;
var title_f1_61_2004="PFPS anatomy";
var content_f1_61_2004=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F54565&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F54565&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 562px\">",
"   <div class=\"ttl\">",
"    Key structures involved in patellofemoral pain syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 542px; height: 560px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_61_2004=[""].join("\n");
var outline_f1_61_2004=null;
var title_f1_61_2005="Multiple ring shadows PA";
var content_f1_61_2005=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F60655&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F60655&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Carcinoma of the cervix metastatic to the lung",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 356px; height: 276px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph shows multiple ring shadows that permeate both lungs diffusely, producing a coarse reticulation. The cystic cavities likely represent pulmonary air spaces carpeted by tumor cells rather than cavitating metastases.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_61_2005=[""].join("\n");
var outline_f1_61_2005=null;
var title_f1_61_2006="Major deflections on ECG";
var content_f1_61_2006=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F59933&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F59933&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 518px\">",
"   <div class=\"ttl\">",
"    Formation of the major deflections on the ECG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 498px; height: 472px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The electrical impulse is initiated in the sinus node and then activates the right and left atria, generating the P wave. Impulse conduction through the atrioventricular (AV) node and bundle of His, which are small structures, does not generate any ECG activity; this period of \"electrical silence\" is the PR interval. The first part of the ventricle to be depolarized is the left side of the interventricular septum, producing a small septal Q wave, followed by depolarization of the remainder of the ventricular myocardium, generating the full QRS complex. The T wave represents ventricular repolarization. A U wave may be present, representing repolarization of the His Purkinje system.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_61_2006=[""].join("\n");
var outline_f1_61_2006=null;
var title_f1_61_2007="Porokeratosis histopathology 2";
var content_f1_61_2007=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F61211&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F61211&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Histopathology of porokeratosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A thin vertical column of parakeratosis, known as a cornoid lamella, is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_61_2007=[""].join("\n");
var outline_f1_61_2007=null;
var title_f1_61_2008="Treatment of adults with snoring";
var content_f1_61_2008=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of adults with snoring",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/61/2008/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/61/2008/contributors\">",
"     William Beninati, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/61/2008/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/61/2008/contributors\">",
"     Robert C Basner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/61/2008/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/61/2008/contributors\">",
"     April F Eichler, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/61/2008/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 27, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Snoring is a sound produced by vibration of the soft tissues of the upper airway during sleep. It usually occurs during inspiration, but can also occur during expiration. Habitual snoring is common, occurring in 44 percent of males and 28 percent of females who are between 30 and 60 years of age in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/1\">",
"     1",
"    </a>",
"    ]. Occasional snoring is almost universal [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Snoring is indicative of increased upper airway resistance. It can be a sign of obstructive sleep apnea (OSA), a sleep disorder characterized by obstructive apnea and hypopnea that occurs when upper airway resistance is severe. Snoring can also be associated with conditions that narrow the upper airway, including obesity, nasal congestion, craniofacial abnormalities, hypothyroidism, acromegaly, and adenotonsillar hypertrophy. In these situations, the treatment of snoring should be directed at the OSA or the associated condition. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/48/2826?source=see_link\">",
"     \"Management of obstructive sleep apnea in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Snoring can also occur in the absence of any condition known to increase upper airway resistance. Previously called primary snoring, simple snoring, or benign snoring, these terms are no longer used [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/2\">",
"     2",
"    </a>",
"    ]. Treatment of such snoring is the subject of this review. Its physiology, consequences, and evaluation are described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/32/22022?source=see_link\">",
"     \"Overview of snoring in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the absence of obstructive sleep apnea, treatment of snoring is indicated for patients who want to minimize disruption to their bed partner's sleep or to relieve themselves of any embarrassment caused by the snoring.",
"   </p>",
"   <p>",
"    Routine treatment cannot be justified at this time to improve daytime symptoms, hypertension, or risk of ischemic heart disease because these findings do not appear to be more common among snorers than non-snorers [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. There is evidence that snoring may contribute to carotid artery atherosclerosis; however, this needs to be confirmed before treatment is suggested for the purpose of preventing carotid disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/32/22022?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of snoring in adults\", section on 'Potential consequences'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CONSERVATIVE APPROACHES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Weight loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;Weight loss is recommended for obese patients who snore since it may improve snoring and has additional health benefits. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/45/13016?source=see_link&amp;anchor=H12#H12\">",
"     \"Overview of therapy for obesity in adults\", section on 'Benefits of weight loss'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An observational study enrolled 20 asymptomatic obese men who snored heavily [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/5\">",
"     5",
"    </a>",
"    ]. Baseline polysomnography was performed and then repeated on a night that the patients used",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/54/33632?source=see_link\">",
"     oxymetazoline",
"    </a>",
"    nasal spray and slept in the lateral position. The nasal spray and lateral sleeping position did not improve snoring frequency. Nineteen of the patients subsequently completed a six month weight loss program and polysomnography was repeated at its completion:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among 12 patients who lost any amount of weight, there was a nonstatistically significant reduction in the mean frequency of snoring (232 versus 328 snores per hour).",
"     </li>",
"     <li>",
"      Among nine patients who lost &ge;3 kg (6.6 lbs), there was a significant reduction in the mean frequency of snoring (176 versus 320 snores per hour).",
"     </li>",
"     <li>",
"      Snoring was virtually eliminated in three patients (mean 14 snores per hour). These patients lost an average of 7.6 kg (16.7 lbs).",
"     </li>",
"     <li>",
"      The frequency of snoring increased in two patients, despite a mean weight loss of 17.5 kg (38.5 lbs).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The results suggest that most patients who lose weight will have a reduction in their snoring frequency, but this is not universal and cannot be predicted. A limitation of this study is that it did not report how many of the adults had snoring related to obstructive sleep apnea (OSA) or an alternative condition associated with increased upper airway resistance.",
"   </p>",
"   <p>",
"    Additional support for the concept that weight loss reduces snoring comes from the observation that weight loss improves OSA [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. Since OSA and snoring are both due to increased upper airway resistance, any intervention that improves one can reasonably be expected to improve the other. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/48/2826?source=see_link&amp;anchor=H6#H6\">",
"     \"Management of obstructive sleep apnea in adults\", section on 'Weight loss'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Tobacco and alcohol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking cessation is recommended for all patients. Elimination of alcohol consumption, especially during the several hours prior to bedtime, is recommended for patients who snore. Both interventions may reduce snoring and have numerous other potential health benefits. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/33/18968?source=see_link&amp;anchor=H2589684#H2589684\">",
"     \"Benefits and risks of smoking cessation\", section on 'Benefits of smoking cessation'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/61/38874?source=see_link\">",
"     \"Overview of the risks and benefits of alcohol consumption\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The effect of smoking cessation on snoring has not been tested in randomized trials or observational studies. There is observational evidence that current smoking is associated with snoring. Whether former smoking is also associated with snoring is uncertain because the evidence is inconsistent:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An observational study of 811 adults found that the risk of snoring after adjustments for potential confounders was 2.3 times greater among current smokers, compared to never smokers [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/9\">",
"       9",
"      </a>",
"      ]. The risk of snoring was not significantly greater among former smokers, compared to never smokers.",
"     </li>",
"     <li>",
"      Another observational study of 15,555 randomly selected men and women found that snoring was significantly more common among current smokers (24 percent) and former smokers (20 percent), compared to never smokers (14 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In both studies, the risk of snoring correlated with the amount of smoking. It is not known why smoking is associated with snoring, but nightly nicotine withdrawal and nasal congestion have been proposed as etiologies. Neither study reported how many of the adults had snoring related to OSA or an alternative condition associated with increased upper airway resistance.",
"   </p>",
"   <p>",
"    The impact of reducing or eliminating alcohol consumption on snoring has not been evaluated in randomized trials or observational studies. There is observational evidence that alcohol consumption is transiently associated with increased airway resistance and snoring [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/11-14\">",
"     11-14",
"    </a>",
"    ]. The likely cause of the increased airway resistance during sleep is decreased tone in the pharyngeal dilator muscles [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Sleep position",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sleeping in the lateral position is a low risk intervention that warrants a trial in most patients who snore, although the evidence that this approach improves snoring is inconsistent:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In an observational study of 21 individuals whose snoring was unrelated to obstructive sleep apnea (OSA) or an alternative condition associated with increased upper airway resistance, sleep in the lateral position led to significant reduction in the time spent snoring and the intensity of the snoring [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In contrast, a crossover trial enrolled 20 asymptomatic male snorers [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/16\">",
"       16",
"      </a>",
"      ]. Baseline polysomnography was performed and then patients were randomly assigned to sleep in the lateral position, receive",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/54/33632?source=see_link\">",
"       oxymetazoline",
"      </a>",
"      nasal spray, or both for one night each. Polysomnography was performed each night. At baseline, all of the patients had their most frequent snoring when sleeping supine. Sleeping in the lateral position did not change the frequency of snoring, although the frequency of obstructive apneas and hypopneas fell significantly. A limitation of this study is that it did not report how many of the adults had snoring related to OSA or another condition associated with increased upper airway resistance.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Approximately one-half of patients who are encouraged to sleep in the lateral position will learn to do so and will maintain the behavior [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/17\">",
"     17",
"    </a>",
"    ]. A number of devices have been developed to reduce the likelihood of sleeping in the supine position, including posture alarms, special pillows, and modified nightshirts. A simple device that can be made at home is a snug-fitting T-shirt with a pocket sewn over the spine and tennis balls placed in the pocket. Obese patients may benefit from a harder type of ball, such as a baseball. The discomfort associated with rolling into the supine position is generally enough to prompt the patient to roll back into the lateral position without awakening.",
"   </p>",
"   <p>",
"    Neck flexion increases upper airway resistance and is associated with increased snoring in some individuals. A cervicomandibular support device and a head-positioning pillow were developed as potential therapies for neck flexion-related snoring, but neither improved snoring nor OSA in clinical studies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     NASAL PATENCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following observations provide the rationale for attempting to reduce snoring by improving nasal patency. The anterior nasal valve is one of the airway segments with the smallest cross sectional area. It offers the greatest resistance to airflow during sleep. Conditions that partially obstruct the already narrow airway (eg, allergic rhinitis, vasomotor rhinitis, anatomic factors) can further increase resistance and contribute to snoring. The negative pressure in the lower airways that is required to overcome high nasal resistance may promote partial or intermittent collapse of the pharynx, worsening snoring.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Decongestants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal congestion can impair airflow through the nose. We suggest that individuals who snore only during a common cold receive a trial of decongestant therapy before bedtime during colds. Intranasal (topical) decongestants are less likely to cause systemic side effects than oral decongestants. However, topical decongestant use should be limited to two to three days because more prolonged use can induce rebound rhinitis or rhinitis medicamentosa. The former refers to increased nasal congestion when the intranasal decongestant is stopped, while the latter refers to rhinitis caused by overuse of intranasal sprays. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/17/30999?source=see_link&amp;anchor=H7#H7\">",
"     \"An overview of rhinitis\", section on 'Topical nasal medications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Intranasal glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;A trial of intranasal (topical) glucocorticoid therapy is reasonable for snorers with chronic nasal congestion. Those patients whose snoring improves may benefit from chronic therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12250?source=see_link&amp;anchor=H16#H16\">",
"     \"Chronic nonallergic rhinitis\", section on 'Intranasal glucocorticoids'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/60/37834?source=see_link&amp;anchor=H25107347#H25107347\">",
"     \"Pharmacotherapy of allergic rhinitis\", section on 'Intranasal glucocorticoids'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Nasal dilators",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal dilators are devices that attempt to dilate the anterior nasal valve. External and internal dilators exist and the impact of each on snoring has been evaluated. Given the low risk and burden of the intervention, a trial of using an external dilator is reasonable for most individuals who have snoring that is not associated with OSA and who continue to snore despite the conservative interventions described above.",
"   </p>",
"   <p>",
"    An external nasal dilator is a stiffened adhesive strip that is applied externally across the nasal alae. It retracts and stabilizes the nasal alae, dilating the anterior nasal valves. External nasal dilators increase nasal cross sectional area and decrease nasal airflow resistance, but these effects are highly variable [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One study of 30 snorers evaluated the intensity of snoring via polysomnography before and after application of an external nasal dilator [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/21\">",
"     21",
"    </a>",
"    ]. The intensity of snoring was lower after application of an external nasal dilator in 22 of 30 patients (73 percent). The benefit was greatest among patients whose snoring was not associated with another condition, compared to patients whose snoring was a sign of OSA. In contrast, a systematic review of four observational studies (including the study just described) found mixed results about the efficacy of external nasal dilators [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An internal nasal dilator is a device that is inserted into one of the nares and left in position during sleep. An observational study of 15 snorers evaluated snoring via polysomnography before and after insertion of an internal nasal dilator [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/22\">",
"     22",
"    </a>",
"    ]. The device had minimal impact on the frequency and duration of snoring. This study has been criticized for having so many obese subjects (mean body weight 106 kg [233 lbs]), since such individuals might not be representative of most snorers [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical procedures to improve nasal patency have been tried in an effort to treat snoring. There is little evidence that nasal surgery is effective in most individuals, regardless of the preoperative nasal resistance or even if postoperative nasal resistance is reduced [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/24-26\">",
"     24-26",
"    </a>",
"    ]. An exception is patients who have significant anatomical obstruction (eg, septal deviation); such patients may benefit from surgical intervention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     MECHANICAL APPROACHES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Oral appliances",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral appliances (OA) increase the size of the upper airway during sleep, which decreases snoring. They are indicated to treat snoring when the above therapies have failed or are inappropriate for the individual patient [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/27\">",
"     27",
"    </a>",
"    ]. OA typically work by advancing the mandible, changing the position of the soft palate, retracting the tongue, or a combination of these mechanisms. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/42/1704?source=see_link\">",
"     \"Oral appliances in the treatment of obstructive sleep apnea in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    OA are highly effective when used properly. A systematic review identified eight studies that evaluated objective measures of snoring before and after treatment with an oral appliance [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/28\">",
"     28",
"    </a>",
"    ]. Snoring frequency was reduced in seven studies and snoring intensity was reduced in four. A limitation of these studies is that most did not report how many of the adults had snoring related to OSA or an alternative condition associated with increased upper airway resistance. Mandibular repositioning appliances appeared to be more effective and easier to use than other OA.",
"   </p>",
"   <p>",
"    Few patients discontinue OA because of side effects [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/29\">",
"     29",
"    </a>",
"    ]. In a case series of 132 snorers who used a mandibular advancement splint, side effects were reported in 81 percent after a mean of one month, but they were mostly minor and only led to discontinuation in only 8 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/30\">",
"     30",
"    </a>",
"    ]. Reported side effects included excessive salivation (30 percent), xerostomia (23 percent), temporomandibular joint pain (27 percent), dental discomfort (27 percent), facial discomfort (25 percent), and bite changes (12 percent). Most of these changes are reversible.",
"   </p>",
"   <p>",
"    OA should be fitted by dentists with expertise in sleep-related breathing disorders. Fitting includes fabrication in a dental laboratory from impressions of the patient's bite or custom molding from a prefabricated device. Follow-up polysomnography is not indicated when snoring alone is treated with an oral appliance. Dental follow-up is recommended every six months for a year and then annually to assess for dental complications and stability of the treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Continuous positive airway pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Continuous positive airway pressure (CPAP) is an effective, safe, and reversible therapy for snoring, even if the snoring is unrelated to OSA [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/31\">",
"     31",
"    </a>",
"    ]. However, many patients without daytime symptoms do not accept CPAP because of its inconvenience and most insurance policies do not cover the cost of CPAP for patients if snoring is the only indication. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/62/44006?source=see_link\">",
"     \"Adherence with continuous positive airway pressure (CPAP)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     OA versus CPAP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Randomized trials indicate that CPAP is more efficacious than OA at treating OSA, but similar trials have not evaluated the effect of these interventions on snoring. Since OSA and snoring are both related to increased upper airway resistance, it is reasonable to expect that CPAP will also be more efficacious than OA at treating snoring. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/48/2826?source=see_link&amp;anchor=H17#H17\">",
"     \"Management of obstructive sleep apnea in adults\", section on 'Comparisons'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SURGICAL APPROACHES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Uvulopalatopharyngoplasty",
"    </span>",
"    &nbsp;&mdash;&nbsp;Uvulopalatopharyngoplasty (UPPP) involves surgically removing tissue from the soft palate and tonsillar pillars. UPPP should be considered on a case-by-case basis only after conservative therapies (eg, weight loss, sleep position, tobacco and alcohol avoidance) and an external nasal dilator fail in patients who prefer surgery over a chronic noninvasive therapy, such as an oral appliance or continuous positive airway pressure.",
"   </p>",
"   <p>",
"    There is uncertainty about the impact of UPPP on snoring because most of the evidence favoring UPPP used subjective outcome measures, which are notoriously unreliable [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/20,32\">",
"     20,32",
"    </a>",
"    ]. In one study of 69 snorers, UPPP was not associated with improvement of snoring frequency or intensity when measured by polysomnography [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/33\">",
"     33",
"    </a>",
"    ]. However, most patients reported subjective improvement in snoring and sleep quality following UPPP and fewer bed partners reported disrupted sleep after UPPP. The discordance between objective and subjective outcomes raises doubt about the validity of other studies that employed only subjective outcome measures to evaluate UPPP. A limitation of this study is that it did not report how many of the adults had snoring related to OSA or an alternative condition associated with increased upper airway resistance.",
"   </p>",
"   <p>",
"    UPPP is initially painful and there are potential complications, including nasal reflux, pharyngeal stenosis, dysphonia, infection, bleeding, and transient velopharyngeal insufficiency. In addition, UPPP may reduce snoring without eliminating the risk for OSA, potentially masking current or future OSA. Patients who undergo UPPP require periodic evaluation by a sleep specialist to be evaluated for the development of OSA and to determine whether OSA is indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Laser-assisted",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laser-assisted uvulopalatopharyngoplasty (LAUP) is a modification of UPPP. It is usually an outpatient procedure that requires only local anesthesia and conscious sedation, sometimes in several stages. A laser device is used rather than a scalpel and the operation is confined to the soft palate and uvula.",
"   </p>",
"   <p>",
"    Snoring-related outcomes after LAUP are comparable to those after UPPP, including side effects [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/34-36\">",
"     34-36",
"    </a>",
"    ]. Patients should undergo polysomnography prior to LAUP, since there is a lack of evidence that LAUP effectively treats sleep disordered breathing [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/36\">",
"     36",
"    </a>",
"    ]. Patients who undergo LAUP require periodic evaluation to determine whether OSA has developed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Radiofrequency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Radiofrequency palate surgery is a newer modification of UPPP that involves temperature-controlled radiofrequency tissue volume reduction (ie, somnoplasty). Radiofrequency palate surgery is generally less painful than LAUP or UPPP, probably because the mucosa is not disrupted [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Early experience with this technique suggests that its short-term results are comparable to those of LAUP [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. As an example, a trial randomly assigned 26 patients with snoring to undergo radiofrequency palate surgery or sham surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/42\">",
"     42",
"    </a>",
"    ]. Subjective snoring assessment demonstrated greater improvement in snoring among patients who underwent radiofrequency palate surgery compared to those who underwent sham surgery, when assessed six to eight weeks after the procedure.",
"   </p>",
"   <p>",
"    The long-term effects of radiofrequency palate surgery are less certain. This was illustrated by a study that included 29 patients with disruptive snoring and an apnea hypopnea index (AHI) &lt;10 events per hour of sleep by full-night polysomnography [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/43\">",
"     43",
"    </a>",
"    ]. The study found a decrease in the median subjective snoring score at six months; however, by three to four years only 25 percent of patients were satisfied with the outcome of the procedure and another 25 percent had sought additional therapy. A novel finding in the study was that, among ten patients who underwent pre-operative palatal electromyography, none of the six patients with normal studies benefited from the procedure long-term, while three of the four patients with an abnormal study benefited from the procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Palatal implants",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pillar procedure involves the deployment of braided polyester filaments into the soft palate through a needle. It is generally performed as an outpatient procedure. The pillar procedure appears to provide a short-term benefit that is not sustained. More comprehensive data are required to firmly establish its safety and efficacy before it can be recommended for routine clinical practice [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An observational study followed 40 patients who had undergone the pillar procedure for one year [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/45\">",
"       45",
"      </a>",
"      ]. Snoring was assessed preoperatively and at 90, 180, and 360 days postoperatively via polysomnography, sensory nerve action potential (SNAP) recordings, and several subjective measures. Polysomnography and SNAP data failed to find any clinically significant changes. However, bed partner assessment using the subjective visual-analog scale indicated improvement in snoring at one year. There were no serious adverse events, but 13 of the 120 palatal implants spontaneously fell out without harmful consequences.",
"     </li>",
"     <li>",
"      A similar observational study of 25 snorers also reported improvement in subjective snoring following the pillar procedure [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/46\">",
"       46",
"      </a>",
"      ]. When assessed 90 days after the procedure, 75 percent of the snorers and 90 percent of their bed partners recommended the procedure.",
"     </li>",
"     <li>",
"      A prospective cohort study followed 26 patients for four years following the pillar procedure [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/47\">",
"       47",
"      </a>",
"      ]. Snoring was assessed by interviewing the bed partner. On a ten point scale, the mean snoring scores were 9.5 pre-operatively, 5 at one year, and 7 at four years. These findings suggest that the benefit of palatal implants is clinically insignificant. Only 22 percent of patients said that they would recommend the procedure to a friend.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     OTHER",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Lubricant nasal spray",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nasal sprays that lubricate the upper airway are not recommended at this time for the routine management of snoring because they have not been shown to improve snoring in heterogeneous populations of snorers [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. There is weak evidence from a small subgroup analysis that snorers with low body mass index might benefit from upper airway lubrication; however, this evidence is insufficient to alter clinical practice [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Homeopathic preparations",
"    </span>",
"    &nbsp;&mdash;&nbsp;A randomized trial suggested that a homeopathic preparation containing Nux vomica, Belladonna, Ephedra vulgaris, Hydrastis canadensis, Kali bichromicum, Teucrium marum, and Histaminum hydrochloricum was effective for snoring [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/49\">",
"     49",
"    </a>",
"    ]. Given the biologic implausibility of any benefit from a homeopathic preparation, we would not use this preparation for the treatment of snoring.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9125610\">",
"    <span class=\"h2\">",
"     Musical performance",
"    </span>",
"    &nbsp;&mdash;&nbsp;It has been hypothesized that individuals who sing or play wind instruments have less snoring, possibly due to pharyngeal muscle conditioning. This was assessed in a cross sectional study that measured the snoring of 245 musicians from five professional orchestras using a survey instrument [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2008/abstract/50\">",
"     50",
"    </a>",
"    ]. Worse snoring was associated with male gender, increasing age, and increasing BMI, but not with the instrument type. No exercises have been proven to prevent or improve snoring.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following is applicable only to patients who have snoring that is NOT related to obstructive sleep apnea or a condition associated with increased upper airway resistance.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Conservative therapies should be encouraged for all patients who snore. These include smoking cessation, weight loss, alcohol avoidance several hours before bedtime, and sleeping in the lateral position. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Weight loss'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Tobacco and alcohol'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H6\">",
"       'Sleep position'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Decreased nasal patency can contribute to snoring:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For patients who snore only during common colds, we suggest a trial of decongestant therapy at bedtime during colds (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Intranasal decongestants may have fewer systemic side effects than oral decongestants, but they should not be used for longer than two or three days. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Decongestants'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with chronic nasal congestion, we suggest a trial of intranasal glucocorticoids (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Patients who respond may benefit from chronic intranasal glucocorticoid therapy. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Intranasal glucocorticoids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who continue to snore despite conservative therapy and relief of any nasal congestion, we suggest a trial of an external nasal dilator (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Nasal dilators'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that most patients NOT undergo surgical procedures to increase nasal patency for the purpose of improving snoring (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). An exception is patients who have significant anatomical obstruction (eg, septal deviation). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients who continue to snore despite both conservative therapy and interventions to improve nasal patency, we suggest continuous positive airway pressure (CPAP) rather than an oral appliance (OA) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). An OA is an acceptable alternative for patients who are unwilling to accept the burdens of CPAP therapy. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'OA versus CPAP'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other surgical approaches should be used as a last resort for patients who do not want to receive chronic mechanical therapy, such as CPAP or OA, and who continue to snore despite both conservative therapy and interventions to improve nasal patency. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Surgical approaches'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/1\">",
"      Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328:1230.",
"     </a>",
"    </li>",
"    <li>",
"     International classification of sleep disorders: Diagnostic and coding manual, 2nd ed, American Academy of Sleep Medicine, Westchester, IL 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/3\">",
"      Jennum P, Hein HO, Suadicani P, Gyntelberg F. Risk of ischemic heart disease in self-reported snorers. A prospective study of 2,937 men aged 54 to 74 years: the Copenhagen Male Study. Chest 1995; 108:138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/4\">",
"      Trotter MI, D'Souza AR, Morgan DW. Simple snoring: current practice. J Laryngol Otol 2003; 117:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/5\">",
"      Braver HM, Block AJ, Perri MG. Treatment for snoring. Combined weight loss, sleeping on side, and nasal spray. Chest 1995; 107:1283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/6\">",
"      Suratt PM, McTier RF, Findley LJ, et al. Changes in breathing and the pharynx after weight loss in obstructive sleep apnea. Chest 1987; 92:631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/7\">",
"      Smith PL, Gold AR, Meyers DA, et al. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 1985; 103:850.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/8\">",
"      Harman EM, Wynne JW, Block AJ. The effect of weight loss on sleep-disordered breathing and oxygen desaturation in morbidly obese men. Chest 1982; 82:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/9\">",
"      Wetter DW, Young TB, Bidwell TR, et al. Smoking as a risk factor for sleep-disordered breathing. Arch Intern Med 1994; 154:2219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/10\">",
"      Franklin KA, G&iacute;slason T, Omenaas E, et al. The influence of active and passive smoking on habitual snoring. Am J Respir Crit Care Med 2004; 170:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/11\">",
"      Issa FG, Sullivan CE. Alcohol, snoring and sleep apnea. J Neurol Neurosurg Psychiatry 1982; 45:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/12\">",
"      Block AJ, Hellard DW. Ingestion of either scotch or vodka induces equal effects on sleep and breathing of asymptomatic subjects. Arch Intern Med 1987; 147:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/13\">",
"      Bloom JW, Kaltenborn WT, Quan SF. Risk factors in a general population for snoring. Importance of cigarette smoking and obesity. Chest 1988; 93:678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/14\">",
"      Mitler MM, Dawson A, Henriksen SJ, et al. Bedtime ethanol increases resistance of upper airways and produces sleep apneas in asymptomatic snorers. Alcohol Clin Exp Res 1988; 12:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/15\">",
"      Nakano H, Ikeda T, Hayashi M, et al. Effects of body position on snoring in apneic and nonapneic snorers. Sleep 2003; 26:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/16\">",
"      Braver HM, Block AJ. Effect of nasal spray, positional therapy, and the combination thereof in the asymptomatic snorer. Sleep 1994; 17:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/17\">",
"      Cartwright R, Ristanovic R, Diaz F, et al. A comparative study of treatments for positional sleep apnea. Sleep 1991; 14:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/18\">",
"      Skinner MA, Kingshott RN, Jones DR, Taylor DR. Lack of efficacy for a cervicomandibular support collar in the management of obstructive sleep apnea. Chest 2004; 125:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/19\">",
"      Michaelson PG, Mair EA. Popular snore aids: do they work? Otolaryngol Head Neck Surg 2004; 130:649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/20\">",
"      Meoli AL, Rosen CL, Kristo D, et al. Nonprescription treatments of snoring or obstructive sleep apnea: an evaluation of products with limited scientific evidence. Sleep 2003; 26:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/21\">",
"      Todorova A, Schellenberg R, Hofmann HC, Dimpfel W. Effect of the external nasal dilator Breathe Right on snoring. Eur J Med Res 1998; 3:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/22\">",
"      Hoffstein V, Mateika S, Metes A. Effect of nasal dilation on snoring and apneas during different stages of sleep. Sleep 1993; 16:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/23\">",
"      The nasal dilator Nozovent and its effect on snoring and apneas. Sleep 1993; 16:681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/24\">",
"      Woodhead CJ, Allen MB. Nasal surgery for snoring. Clin Otolaryngol Allied Sci 1994; 19:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/25\">",
"      Low WK. Can snoring relief after nasal septal surgery be predicted? Clin Otolaryngol Allied Sci 1994; 19:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/26\">",
"      Virkkula P, Bachour A, Hyt&ouml;nen M, et al. Snoring is not relieved by nasal surgery despite improvement in nasal resistance. Chest 2006; 129:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/27\">",
"      Kushida CA, Morgenthaler TI, Littner MR, et al. Practice parameters for the treatment of snoring and Obstructive Sleep Apnea with oral appliances: an update for 2005. Sleep 2006; 29:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/28\">",
"      Ferguson KA, Cartwright R, Rogers R, Schmidt-Nowara W. Oral appliances for snoring and obstructive sleep apnea: a review. Sleep 2006; 29:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/29\">",
"      Schmidt-Nowara W, Lowe A, Wiegand L, et al. Oral appliances for the treatment of snoring and obstructive sleep apnea: a review. Sleep 1995; 18:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/30\">",
"      Pantin CC, Hillman DR, Tennant M. Dental side effects of an oral device to treat snoring and obstructive sleep apnea. Sleep 1999; 22:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/31\">",
"      Berry RB, Block AJ. Positive nasal airway pressure eliminates snoring as well as obstructive sleep apnea. Chest 1984; 85:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/32\">",
"      Hoffstein V, Mateika S, Anderson D. Snoring: is it in the ear of the beholder? Sleep 1994; 17:522.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/33\">",
"      Miljeteig H, Mateika S, Haight JS, et al. Subjective and objective assessment of uvulopalatopharyngoplasty for treatment of snoring and obstructive sleep apnea. Am J Respir Crit Care Med 1994; 150:1286.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/34\">",
"      Carenfelt C. Laser uvulopalatoplasty in treatment of habitual snoring. Ann Otol Rhinol Laryngol 1991; 100:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/35\">",
"      Wennmo C, Olsson P, Flisberg K, et al. Treatment of snoring--with and without carbon dioxide laser. Acta Otolaryngol Suppl 1992; 492:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/36\">",
"      Littner M, Kushida CA, Hartse K, et al. Practice parameters for the use of laser-assisted uvulopalatoplasty: an update for 2000. Sleep 2001; 24:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/37\">",
"      Blumen MB, Dahan S, Wagner I, et al. Radiofrequency versus LAUP for the treatment of snoring. Otolaryngol Head Neck Surg 2002; 126:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/38\">",
"      Ferguson M, Smith TL, Zanation AM, Yarbrough WG. Radiofrequency tissue volume reduction: multilesion vs single-lesion treatments for snoring. Arch Otolaryngol Head Neck Surg 2001; 127:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/39\">",
"      Tatla T, Sandhu G, Croft CB, Kotecha B. Celon radiofrequency thermo-ablative palatoplasty for snoring - a pilot study. J Laryngol Otol 2003; 117:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/40\">",
"      Stuck BA, Maurer JT, Hein G, et al. Radiofrequency surgery of the soft palate in the treatment of snoring: a review of the literature. Sleep 2004; 27:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/41\">",
"      Franklin KA, Anttila H, Axelsson S, et al. Effects and side-effects of surgery for snoring and obstructive sleep apnea--a systematic review. Sleep 2009; 32:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/42\">",
"      Stuck BA, Sauter A, H&ouml;rmann K, et al. Radiofrequency surgery of the soft palate in the treatment of snoring. A placebo-controlled trial. Sleep 2005; 28:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/43\">",
"      Hultcrantz E, Harder L, Loord H, et al. Long-term effects of radiofrequency ablation of the soft palate on snoring. Eur Arch Otorhinolaryngol 2010; 267:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/44\">",
"      Choi JH, Kim SN, Cho JH. Efficacy of the Pillar implant in the treatment of snoring and mild-to-moderate obstructive sleep apnea: a meta-analysis. Laryngoscope 2013; 123:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/45\">",
"      Maurer JT, Hein G, Verse T, et al. Long-term results of palatal implants for primary snoring. Otolaryngol Head Neck Surg 2005; 133:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/46\">",
"      Romanow JH, Catalano PJ. Initial U.S. pilot study: palatal implants for the treatment of snoring. Otolaryngol Head Neck Surg 2006; 134:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/47\">",
"      Rotenberg BW, Luu K. Four-year outcomes of palatal implants for primary snoring treatment: a prospective longitudinal study. Laryngoscope 2012; 122:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/48\">",
"      Wijewickrama RC, Blalock D, Mims JW. Study of lubricant-induced changes in chronic snorers (SLICCS). Otolaryngol Head Neck Surg 2004; 131:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/49\">",
"      Lipman D, Sexton G, Schlesser J. A Randomized Double-Blind Placebo-Controlled Evaluation of the Safety and Efficacy of a Natural Over-The-Counter (OTC) Medication in the Management of Snoring. Sleep Breath 1999; 3:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2008/abstract/50\">",
"      Wardrop PJ, Ravichandran S, Hair M, et al. Do wind and brass players snore less? A cross-sectional study of snoring and daytime fatigue in professional orchestral musicians. Clin Otolaryngol 2011; 36:134.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7707 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.167.4.114-2B3BC00349-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_61_2008=[""].join("\n");
var outline_f1_61_2008=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H24\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CONSERVATIVE APPROACHES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Weight loss",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Tobacco and alcohol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Sleep position",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      NASAL PATENCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Decongestants",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Intranasal glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Nasal dilators",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      MECHANICAL APPROACHES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Oral appliances",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Continuous positive airway pressure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      OA versus CPAP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SURGICAL APPROACHES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Uvulopalatopharyngoplasty",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Laser-assisted",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Radiofrequency",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Palatal implants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      OTHER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Lubricant nasal spray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Homeopathic preparations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9125610\">",
"      Musical performance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/62/44006?source=related_link\">",
"      Adherence with continuous positive airway pressure (CPAP)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/17/30999?source=related_link\">",
"      An overview of rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/33/18968?source=related_link\">",
"      Benefits and risks of smoking cessation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/61/12250?source=related_link\">",
"      Chronic nonallergic rhinitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/48/2826?source=related_link\">",
"      Management of obstructive sleep apnea in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/42/1704?source=related_link\">",
"      Oral appliances in the treatment of obstructive sleep apnea in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/32/22022?source=related_link\">",
"      Overview of snoring in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/61/38874?source=related_link\">",
"      Overview of the risks and benefits of alcohol consumption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/45/13016?source=related_link\">",
"      Overview of therapy for obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/60/37834?source=related_link\">",
"      Pharmacotherapy of allergic rhinitis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_61_2009="Arterial puncture and cannulation in children";
var content_f1_61_2009=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Arterial puncture and cannulation in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/61/2009/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/61/2009/contributors\">",
"     Lalit Bajaj, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/61/2009/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/61/2009/contributors\">",
"     Anne M Stack, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/61/2009/contributors\">",
"     Adrienne G Randolph, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/61/2009/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/61/2009/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/61/2009/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arterial punctures permits measurement of blood gases and provides information essential for the care of patients with critical illness and respiratory disease and is also performed when blood cannot be obtained by venipuncture. Arterial cannulation is helpful when multiple arterial blood gas measurements are necessary over time and in patients for whom continuous blood pressure or cardiac output monitoring is desirable.",
"   </p>",
"   <p>",
"    The procedures for obtaining and handling arterial blood gas specimens in children are reviewed here. The technique for arterial blood sampling in adults and the interpretation of blood gas results and pulse oximetry are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15894?source=see_link&amp;anchor=H2#H2\">",
"     \"Arterial blood gases\", section on 'Arterial sampling'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=see_link\">",
"     \"Oxygenation and mechanisms of hypoxemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9736?source=see_link\">",
"     \"Pulse oximetry\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/41/27288?source=see_link\">",
"     \"Simple and mixed acid-base disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ARTERIAL PUNCTURE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17361471\">",
"    <span class=\"h2\">",
"     Indications, contraindications, and precautions",
"    </span>",
"    &nbsp;&mdash;&nbsp;In children, arterial puncture is frequently performed to assess acid-base status and oxygenation, to correlate arterial with less invasive measurements (eg, venous blood gas or pulse oximetry), or to obtain a blood sample when venipuncture is unsuccessful.",
"   </p>",
"   <p>",
"    Arterial puncture should not be performed at arterial sites with overlying skin infection.",
"   </p>",
"   <p>",
"    Arterial cannulation instead of puncture is advisable in patients for whom multiple arterial measurements or continuous arterial blood pressure monitoring will be required. (See",
"    <a class=\"local\" href=\"#H3876994\">",
"     'Indications, contraindications, and precautions'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17361270\">",
"    <span class=\"h2\">",
"     Site selection and equipment",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest that children have arterial puncture performed at the distal radial arterial site (",
"    <a class=\"graphic graphic_figure graphicRef77612 \" href=\"UTD.htm?40/6/41060\">",
"     figure 1",
"    </a>",
"    ). The radial artery can be tested for collateral circulation using the modified Allen test (",
"    <a class=\"graphic graphic_figure graphicRef70306 \" href=\"UTD.htm?3/61/4049\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef79685 \" href=\"UTD.htm?39/52/40771\">",
"     picture 1",
"    </a>",
"    ) and is easily accessed in most children [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Positioning and restraint of the upper extremity is also more easily accomplished in the uncooperative child. Finally, the risk of complications following arterial puncture at the radial site is low, especially compared to the femoral or brachial sites [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Testing for collateral blood flow with the Allen or modified Allen test is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15894?source=see_link&amp;anchor=H5#H5\">",
"     \"Arterial blood gases\", section on 'Collateral circulation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Alternative sites include the posterior tibial (",
"    <a class=\"graphic graphic_figure graphicRef66126 \" href=\"UTD.htm?39/42/40609\">",
"     figure 3",
"    </a>",
"    ), the dorsalis pedis (",
"    <a class=\"graphic graphic_figure graphicRef74882 \" href=\"UTD.htm?8/11/8371\">",
"     figure 4",
"    </a>",
"    ), the brachial, and the femoral (",
"    <a class=\"graphic graphic_figure graphicRef57455 \" href=\"UTD.htm?1/36/1604\">",
"     figure 5",
"    </a>",
"    ) arteries. Of these, the dorsalis pedis can be tested for collateral circulation. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Site selection and equipment'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15894?source=see_link&amp;anchor=H5#H5\">",
"     \"Arterial blood gases\", section on 'Collateral circulation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The femoral, and if absolutely necessary, the brachial arteries may be used for arterial puncture in children if other sites are not available but they have less collateral arterial flow, are more difficult to access in the uncooperative patient, and especially in the coagulopathic patient, femoral arterial puncture can lead to retroperitoneal hematoma.",
"   </p>",
"   <p>",
"    The following equipment should be assembled prior to the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Antiseptic solution (eg, povidone-iodine solution) and sterile gauze, or prepackaged antiseptic wipes",
"     </li>",
"     <li>",
"      Gloves (sterile preferred)",
"     </li>",
"     <li>",
"      A one inch butterfly needle with tubing or a prepackaged blood gas needle &ndash; The needle size for puncture is selected based upon the child's weight (",
"      <a class=\"graphic graphic_table graphicRef74881 \" href=\"UTD.htm?2/20/2380\">",
"       table 1",
"      </a>",
"      ). Proper needle size is an important means of avoiding vessel thrombosis. If using a butterfly needle, the clinician will need to prepare a heparinized syringe by drawing up 1 mL of heparinized saline (1000 units",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/39/7801?source=see_link\">",
"        heparin",
"       </a>",
"       /1",
"      </span>",
"      mL), drawing back the plunger to coat the barrel, and then pushing it out through the butterfly needle and tubing. It is important to rapidly expel all of the heparin solution to avoid inaccurate measurement of pCO2.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18834970\">",
"    <span class=\"h2\">",
"     Technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;To obtain a single arterial blood gas specimen, perform the following steps [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ensure that the selected site has",
"      <strong>",
"       no",
"      </strong>",
"      signs of infection and, if applicable, adequate collateral circulation (radial and dorsalis pedis sites). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15894?source=see_link&amp;anchor=H5#H5\">",
"       \"Arterial blood gases\", section on 'Collateral circulation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If time allows, in conscious patients, place a topical anesthetic over the site or alternatively, infiltrate the skin with 1 percent buffered",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/57/37776?source=see_link\">",
"       lidocaine",
"      </a>",
"      . (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43817?source=see_link\">",
"       \"Topical anesthetics in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33689?source=see_link&amp;anchor=H2#H2\">",
"       \"Infiltration of local anesthetics\", section on 'Lidocaine'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Use clean or sterile technique throughout the procedure. Sterile technique is necessary if blood cultures are being obtained.",
"     </li>",
"     <li>",
"      Use the gloved index finger of the nondominant hand to locate the most easily palpated portion of the artery. Depending upon the chosen site, position the extremity to bring the artery closer to the surface:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Radial artery &ndash; Slightly extend the wrist beyond neutral until the maximum pulsation is palpated (",
"      <a class=\"graphic graphic_picture graphicRef64776 \" href=\"UTD.htm?9/14/9443\">",
"       picture 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Posterior tibialis &ndash; Dorsi-flex the foot and evert the ankle",
"     </li>",
"     <li>",
"      Dorsalis pedis &ndash; Plantar flex the foot with the ankle in neutral position",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Have an assistant restrain the patient without grasping the extremity so tightly that the arterial pulse is diminished.",
"     </li>",
"     <li>",
"      Using a small gauge butterfly needle (eg, 23 gauge) or prepackaged blood gas syringe with needle, puncture the skin at a 30 to 45 degree angle from horizontal and advance towards the arterial pulse until blood flow is obtained. The angle of entry for successful arterial puncture may be closer to 30 degrees rather than 45 degrees, especially in infants and young children. Too steep of a needle angle risks missing the flash of blood from the smaller artery in these patients. Transillumination with an approved fiberoptic light source may assist in identifying the more superficial radial, posterior tibialis, or dorsalis pedis arteries.",
"     </li>",
"     <li>",
"      If a butterfly needle is used, attach the hub to a standard blood gas or heparinized syringe",
"      <strong>",
"       after",
"      </strong>",
"      blood flow is obtained.",
"     </li>",
"     <li>",
"      Note that in young infants, the arterial blood flow may not appear pulsatile. Bright red blood that is easily withdrawn by syringe suggests an arterial sample in this circumstance.",
"     </li>",
"     <li>",
"      Obtain a minimum of 0.3 mL of blood into a commercial 1 mL blood gas syringe or 3 mL syringe that contains a small amount of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/39/7801?source=see_link\">",
"       heparin",
"      </a>",
"      . Remove any air bubbles, cap the syringe and place on ice for transport to the clinical laboratory and analysis within 15 minutes. (See",
"      <a class=\"local\" href=\"#H17361639\">",
"       'Specimen handling and analysis'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Hold pressure over the sampling site for a full five minutes after the sample is obtained.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H903487\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arterial puncture may cause local hematoma, temporary arterial spasm, and transient pain [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/1\">",
"     1",
"    </a>",
"    ]. Rarely, permanent arterial injury or, with femoral arterial puncture, injury to the developing femoral head can occur.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     ARTERIAL CANNULATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3876994\">",
"    <span class=\"h2\">",
"     Indications, contraindications, and precautions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arterial cannulation is indicated in the following circumstances:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Frequent arterial blood gases are necessary, such as with acute respiratory failure.",
"     </li>",
"     <li>",
"      The blood pressure must be monitored closely, such as during shock, major surgery, hypertensive emergency, or vasopressor therapy. This is particularly true if the blood pressure abnormality is acute or the blood pressure is labile.",
"     </li>",
"     <li>",
"      Continuous monitoring of cardiac output is necessary.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Depending upon the chosen site, the collateral flow to the artery should be assessed prior to cannulation using the modified Allen or Allen test (radial artery) or assessment of great toe perfusion after dorsalis pedis artery occlusion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15894?source=see_link&amp;anchor=H5#H5\">",
"     \"Arterial blood gases\", section on 'Collateral circulation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Indwelling arterial catheters should not be placed in arterial sites with overlying skin infection or abscess.",
"   </p>",
"   <p>",
"    Procedural sedation may be necessary to allow safe placement of an arterial catheter, especially in the femoral or axillary sites. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43384?source=see_link\">",
"     \"Procedural sedation in children outside of the operating room\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Site selection and equipment",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest that children have arterial cannulation performed at the distal radial site (",
"    <a class=\"graphic graphic_figure graphicRef77612 \" href=\"UTD.htm?40/6/41060\">",
"     figure 1",
"    </a>",
"    ). Relative to other sites, the radial artery has the following advantages:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Collateral flow can be readily assessed. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15894?source=see_link&amp;anchor=H5#H5\">",
"       \"Arterial blood gases\", section on 'Collateral circulation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Risk of ischemic complications is low, especially when compared to femoral artery cannulation [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Complications'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Aseptic technique and line management is easier to maintain.",
"     </li>",
"     <li>",
"      In children with congenital heart disease, right radial artery measurements of blood gases more accurately reflect cerebral oxygenation and perfusion pressure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The radial artery is also the preferred site for perioperative and intensive care cannulation in children, accounting for 68 to 82 percent of all intraarterial catheters in two large observational studies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. The radial artery is palpable between the distal radius and the tendon of the flexor carpi radialis and usually can be more easily accessed with the wrist extended. The modified Allen test should be used to demonstrate collateral flow through the superficial palmar arch prior to cannulation (",
"    <a class=\"graphic graphic_figure graphicRef70306 \" href=\"UTD.htm?3/61/4049\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_picture graphicRef79685 \" href=\"UTD.htm?39/52/40771\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Alternate arterial sites include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Femoral",
"      </strong>",
"      &ndash; The femoral artery site is located midway between the symphysis pubis and superior iliac spine and approximately 2 cm below the inguinal ligament",
"      <strong>",
"      </strong>",
"      (",
"      <a class=\"graphic graphic_figure graphicRef57455 \" href=\"UTD.htm?1/36/1604\">",
"       figure 5",
"      </a>",
"      ). This site is often used in older children but is less commonly cannulated in neonates and young infants. The patient&rsquo;s hip should be flexed and externally rotated and a towel roll placed to improve the approach to the femoral artery prior to the procedure (",
"      <a class=\"graphic graphic_figure graphicRef57455 \" href=\"UTD.htm?1/36/1604\">",
"       figure 5",
"      </a>",
"      ). The femoral artery can be palpated just below the midpoint of the inguinal ligament. The needle should be inserted just below the inguinal ligament, at a 90 degree angle toward the pulsation. Arterial catheterization via the femoral route may lead to thrombosis and distal embolization to the foot and must be accompanied by close monitoring of distal pulses. (See",
"      <a class=\"local\" href=\"#H1861506\">",
"       'Arterial obstruction (vasospasm)'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H1861546\">",
"       'Arterial thrombosis and embolism'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      <strong>",
"       Posterior tibial",
"      </strong>",
"      &ndash; The posterior tibial artery",
"      <strong>",
"      </strong>",
"      (",
"      <a class=\"graphic graphic_figure graphicRef66126 \" href=\"UTD.htm?39/42/40609\">",
"       figure 3",
"      </a>",
"      ) is palpable just posterior to the medial malleolus and is preferred to the femoral site in neonates and young infants. Cannulation of the artery may be facilitated by holding the foot in comfortable dorsiflexion with eversion of the ankle. The most accessible area is a point between the medial malleolus and the calcaneus tendon (",
"      <a class=\"graphic graphic_figure graphicRef78072 \" href=\"UTD.htm?42/46/43744\">",
"       figure 6",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Dorsalis pedis &ndash;",
"      </strong>",
"      The dorsalis pedis artery",
"      <strong>",
"      </strong>",
"      (",
"      <a class=\"graphic graphic_figure graphicRef74882 \" href=\"UTD.htm?8/11/8371\">",
"       figure 4",
"      </a>",
"      )",
"      <strong>",
"      </strong>",
"      is located lateral to the extensor hallucis longus tendon and has collateral flow from the lateral plantar artery through an arch system similar to that in the hand. It is preferable to the femoral site in neonates and young infants. Collateral flow should be checked by occluding the dorsalis pedis artery, compressing the nail bed of the great toe, and confirming a rapid return of color when pressure on the toe is released.",
"     </li>",
"     <li>",
"      <strong>",
"       Brachial",
"      </strong>",
"      &ndash; The brachial artery can be accessed at the point of maximal pulsation just above the antecubital fossa on the medial aspect of the arm. The author&rsquo;s approach is to avoid this site for arterial cannulation because of limited collateral flow to the distal arm, especially in neonates and young infants [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/1\">",
"       1",
"      </a>",
"      ]. However, if absolutely necessary, this site can be used. As an example, no serious complications or permanent damage was reported in a large perioperative series of neonates and young children undergoing surgery for congenital heart defects, and complications were not more frequent than in children undergoing radial artery cannulation despite duration of insertion of several days [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/4\">",
"       4",
"      </a>",
"      ]. Of note, these patients needed assessment of preductal arterial oxygenation. Thus, cannulation of an artery in the right upper extremity was essential.",
"     </li>",
"     <li>",
"      <strong>",
"       Axillary",
"      </strong>",
"      &ndash; The axillary artery is a continuation of the subclavian artery and is palpable medial to the pectoralis muscle high up in the axilla when the arm is abducted to 90 degrees and the dorsum of the hand flat on the stretcher near the ipsilateral ear or placed under the head [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/1\">",
"       1",
"      </a>",
"      ]. This site may be used in older children with poor perfusion when cannulation of other sites is unsuccessful. It is typically avoided in neonates and young infants. Good collateral flow to the arm occurs through the thyrocervical trunk and subscapular artery. Thus, the risk of ischemic complications to the arm is low. The clinician should ensure puncture at the point of maximal impulse to reduce the risk of inadvertently damaging the terminal branch nerves of the brachial plexus (",
"      <a class=\"graphic graphic_figure graphicRef69782 \" href=\"UTD.htm?18/5/18520\">",
"       figure 7",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following equipment should be assembled prior to the procedure:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Antiseptic solution (eg, povidone-iodine solution) and sterile gauze, or prepackaged antiseptic wipes",
"     </li>",
"     <li>",
"      Sterile gloves, eye protection, and surgical mask",
"     </li>",
"     <li>",
"      Sterile drapes",
"     </li>",
"     <li>",
"      Intravascular catheter or prepackaged arterial cannulation kit &ndash; The catheter size for puncture is selected based upon the child's weight (",
"      <a class=\"graphic graphic_table graphicRef74881 \" href=\"UTD.htm?2/20/2380\">",
"       table 1",
"      </a>",
"      ). The use of a separate or integral guidewire is suggested. (See",
"      <a class=\"local\" href=\"#H902584\">",
"       'Guidewire method'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Stopcock",
"     </li>",
"     <li>",
"      Pressure transducing device",
"     </li>",
"     <li>",
"      Extension tubing flushed with heparinized (eg, 2 units of",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/39/7801?source=see_link\">",
"        heparin",
"       </a>",
"       /mL)",
"      </span>",
"      saline or, in patients for whom heparin is contraindicated, 1.4 percent sodium citrate solution and connected to a continuous pump system to increase duration of catheter patency and decrease ischemic complications of arterial thrombosis [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/2\">",
"       2",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Complications'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      4.0 or 5.0 nonabsorbable suture (",
"      <a class=\"graphic graphic_table graphicRef63622 \" href=\"UTD.htm?36/14/37099\">",
"       table 2",
"      </a>",
"      ) to secure catheter to the skin",
"     </li>",
"     <li>",
"      Topical antibiotic ointment",
"     </li>",
"     <li>",
"      Transparent sterile adhesive dressing for the arterial catheter site",
"     </li>",
"     <li>",
"      Arm board and tape",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H902504\">",
"    <span class=\"h2\">",
"     Techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arterial cannulation can be accomplished using a separate guidewire (Seldinger technique), an integral guidewire, or direct cannulation with an intravenous catheter. Ultrasound assistance, when available, may result in a higher success rate for cannulation, depending upon the clinician&rsquo;s experience.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H903781\">",
"    <span class=\"h3\">",
"     Ultrasound guidance",
"    </span>",
"    &nbsp;&mdash;&nbsp;In trained operators, use of ultrasound guidance for arterial cannulation may decrease the number of attempts and increase success. Either B-mode or color duplex imaging can be used to identify the vessel, although visualization of needle placement is better with B-mode imaging due to less artifact. An echogenic needle system also improves visualization under ultrasound guidance.",
"   </p>",
"   <p>",
"    In a small trial of 30 infants undergoing neurosurgery, ultrasound guidance was associated with a significantly better success rate on first attempt and fewer total attempts than placement using palpation alone (success rate on first attempt 67 versus 20 percent, total attempts 20 versus 34, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/6\">",
"     6",
"    </a>",
"    ]. In this study, the procedure was performed by anesthesiologists who were experienced with pediatric arterial cannulation by either ultrasound guidance or palpation. In a separate trial of 152 children undergoing radial artery cannulation by inexperienced operators, the success rate on first attempt was low (14 percent) regardless of whether ultrasound guidance or palpation was used [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/7\">",
"     7",
"    </a>",
"    ]. Thus, ultrasound guidance appears to only be beneficial for pediatric arterial cannulation if the operator has proper training and experience.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H902584\">",
"    <span class=\"h3\">",
"     Guidewire method",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest that, when equipment and expertise are available, children undergoing arterial cannulation have the procedure performed using a guidewire. In addition, we advocate changing to a guidewire approach if difficulties are encountered with the direct puncture approach. In an unblinded trial of 100 children undergoing radial artery cannulation, use of a guidewire was associated with significantly fewer cannulation attempts, shorter procedure time, a higher rate of success, and more frequent ability to perform satisfactory blood pressure monitoring [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The technique for placement of an arterial cannula using a separate or integral guidewire is as follows [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ensure that the selected site has",
"      <strong>",
"       no",
"      </strong>",
"      signs of infection and, if applicable, adequate collateral circulation (radial and dorsalis pedis sites). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15894?source=see_link&amp;anchor=H5#H5\">",
"       \"Arterial blood gases\", section on 'Collateral circulation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      If time allows, place a topical anesthetic over the site or alternatively, infiltrate the skin with 1 percent buffered",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/57/37776?source=see_link\">",
"       lidocaine",
"      </a>",
"      . (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43817?source=see_link\">",
"       \"Topical anesthetics in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33689?source=see_link&amp;anchor=H2#H2\">",
"       \"Infiltration of local anesthetics\", section on 'Lidocaine'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For radial artery cannulation, secure the hand and distal forearm to a padded armboard with tape and extend the wrist so that a maximal radial pulse is felt.",
"     </li>",
"     <li>",
"      Sterilely prepare the puncture site and maintain sterile technique throughout the procedure. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Site selection and equipment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Identify the cannulation site using ultrasound guidance (suggested) or palpation. (See",
"      <a class=\"local\" href=\"#H903781\">",
"       'Ultrasound guidance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If using a separate guidewire, proceed as follows (",
"      <a class=\"graphic graphic_figure graphicRef74903 \" href=\"UTD.htm?14/17/14616\">",
"       figure 8",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/9\">",
"       9",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Ensure that the guidewire passes easily through the needle of the intravascular catheter. The clinician can assess this without damage to the guidewire if it is passed in a retrograde fashion through the needle.",
"     </li>",
"     <li>",
"      Using an 18 or 19 gauge needle, make a skin nick just distal to the cannulation site to prevent dermal plugging of the intravascular catheter when it is advanced through the skin.",
"     </li>",
"     <li>",
"      Insert the intravascular catheter (",
"      <a class=\"graphic graphic_table graphicRef74881 \" href=\"UTD.htm?2/20/2380\">",
"       table 1",
"      </a>",
"      ) and needle at a 30 to 45 degree angle slowly until pulsatile blood return is observed.",
"     </li>",
"     <li>",
"      Once pulsatile blood return is observed, lower the angle of the intravascular catheter and needle and advance them together to ensure that the catheter itself enters the vessel lumen.",
"     </li>",
"     <li>",
"      Stabilize the intravascular catheter with the nondominant hand and remove the needle from the intravascular catheter.",
"     </li>",
"     <li>",
"      If pulsatile blood return occurs after the needle is removed, advance the guidewire through the catheter. If pulsatile blood return does not occur, gently withdraw the catheter until pulsatile blood return is obtained and then advance the guidewire. If properly positioned within the arterial lumen, the guidewire should move with little to no resistance.",
"     </li>",
"     <li>",
"      Advance the guidewire while maintaining the distal end well beyond the distal end of the catheter and then advance the intravascular catheter over the guidewire, into the artery, and up to the hub. Proceed with steps following discussion of the integral guidewire system.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If using an integral guidewire system, proceed as follows (",
"      <a class=\"graphic graphic_figure graphicRef74903 \" href=\"UTD.htm?14/17/14616\">",
"       figure 8",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Using an 18 or 19 gauge needle, make a skin nick just distal to the cannulation site to prevent dermal plugging of the intravascular catheter when it is advanced through the skin.",
"     </li>",
"     <li>",
"      Insert the integral guidewire system (",
"      <a class=\"graphic graphic_table graphicRef74881 \" href=\"UTD.htm?2/20/2380\">",
"       table 1",
"      </a>",
"      ) at a 30 to 45 degree angle slowly until pulsatile blood return is observed.",
"     </li>",
"     <li>",
"      Stabilize the needle-catheter-guidewire unit with the nondominant hand while advancing the guidewire tab to push the guidewire into the artery.",
"     </li>",
"     <li>",
"      Advance the outer catheter over the guidewire, into the artery, and up to the hub.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Once, the catheter is advanced to the hub, attach flushed extension tubing, a stopcock, and syringe to the hub and gently flush the catheter.",
"     </li>",
"     <li>",
"      If it is not clear whether an artery or vein has been cannulated, a small disposable direct pressure transducer, if available, can be applied to the flushed extension tubing and the wave form directly analyzed on the monitor.",
"     </li>",
"     <li>",
"      Secure the catheter with nonabsorbable suture (",
"      <a class=\"graphic graphic_table graphicRef63622 \" href=\"UTD.htm?36/14/37099\">",
"       table 2",
"      </a>",
"      ) and a transparent, clear adhesive dressing.",
"     </li>",
"     <li>",
"      Attach the syringe to a pump to provide continuous flushing at a low infusion rate (",
"      <a class=\"graphic graphic_picture graphicRef60408 \" href=\"UTD.htm?0/41/661\">",
"       picture 3",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H902563\">",
"    <span class=\"h3\">",
"     Direct method",
"    </span>",
"    &nbsp;&mdash;&nbsp;The technique for arterial cannulation by the direct method is as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Using an 18 or 19 gauge needle, make a skin nick just distal to the cannulation site to prevent dermal plugging of the intravascular catheter when it is advanced through the skin.",
"     </li>",
"     <li>",
"      Prepare and locate the arterial site as described above. (See",
"      <a class=\"local\" href=\"#H902584\">",
"       'Guidewire method'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Advance an intravascular catheter (",
"      <a class=\"graphic graphic_table graphicRef74881 \" href=\"UTD.htm?2/20/2380\">",
"       table 1",
"      </a>",
"      ) at a 30 to 45 degree angle until pulsatile blood is obtained.",
"     </li>",
"     <li>",
"      Once blood return is observed, lower the angle of the intravascular catheter and needle and advance it over the needle. Stabilize the catheter with the nondominant hand and advance the catheter into the artery and up to the hub.",
"     </li>",
"     <li>",
"      Alternatively, advance the needle and catheter until blood flow stops, remove the needle, and gently withdraw the catheter until pulsatile blood flow resumes and slowly advance the catheter into the arterial lumen [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Once, the catheter is advanced to the hub, attach flushed extension tubing, a stopcock, and syringe to the hub and gently flush the catheter.",
"     </li>",
"     <li>",
"      If it is not clear whether an artery or vein has been cannulated, a small disposable direct pressure transducer, if available, can be applied to the flushed extension tubing and the wave form directly analyzed on the monitor.",
"     </li>",
"     <li>",
"      Secure the catheter with nonabsorbable suture (",
"      <a class=\"graphic graphic_table graphicRef63622 \" href=\"UTD.htm?36/14/37099\">",
"       table 2",
"      </a>",
"      ) and a transparent, clear adhesive dressing.",
"     </li>",
"     <li>",
"      Attach the syringe to a pump to provide continuous flushing at a low infusion rate (",
"      <a class=\"graphic graphic_picture graphicRef60408 \" href=\"UTD.htm?0/41/661\">",
"       picture 3",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of arterial cannulation in children in descending order of frequency include arterial obstruction, hematoma formation, infection, arterial thrombosis, arterial embolism, and iatrogenic blood loss. Rare complications include air embolism, pseudoaneurysm and arteriovenous fistula.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1861506\">",
"    <span class=\"h3\">",
"     Arterial obstruction (vasospasm)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transient arterial obstruction has been reported in up to 37 percent of femoral and 54 percent of radial artery cannulations [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. The risk of arterial obstruction is increased with younger patient age and longer duration of cannulation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/13\">",
"     13",
"    </a>",
"    ]. Transient arterial obstruction may cause dampening of the arterial waveform, blanching, pain, induration, and, rarely skin necrosis. However, cutaneous signs of arterial obstruction are often not present.",
"   </p>",
"   <p>",
"    When transient arterial obstruction occurs, warming of the arterial site with a hot pack or administration of 0.5",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    of intravenous",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/57/37776?source=see_link\">",
"     lidocaine",
"    </a>",
"    may be beneficial [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Topical",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/7/34934?source=see_link\">",
"     nitroglycerin",
"    </a>",
"    ointment may also be useful if these methods fail. For example, in four neonates with radial artery catheters, application of a thin film of 2 percent nitroglycerin ointment to the wrist, palm, and fingers in a dose of 4",
"    <span class=\"nowrap\">",
"     mm/kg",
"    </span>",
"    was associated with rapid improvement of hand color and perfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. Although transient decrease in blood pressure was described, no patient had serious hypotension.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1861514\">",
"    <span class=\"h3\">",
"     Hematoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hematoma formation occurs in 4 to 14 percent of arterial cannulations [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/2,4,17\">",
"     2,4,17",
"    </a>",
"    ]. Hematoma formation may be a risk factor for hand ischemia in patients with radial artery catheters [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/2\">",
"     2",
"    </a>",
"    ]. In most patients, hematomas resolve without specific interventions. However, unrecognized retroperitoneal hematomas after femoral artery cannulation have been described in adults and can result in significant blood loss. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/51/26424?source=see_link&amp;anchor=H17#H17\">",
"     \"Arterial catheterization techniques for invasive monitoring\", section on 'Site-specific'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1861538\">",
"    <span class=\"h3\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infections occur in 1 to 7 percent of children with indwelling arterial catheters that have been in place for prolonged periods [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/2,17,18\">",
"     2,17,18",
"    </a>",
"    ]. Although debated, radial artery cannulation may be associated with a lower risk of infection than the femoral site [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/2\">",
"     2",
"    </a>",
"    ]. The risk of infection is increased with younger age and increased duration of cannulation.",
"   </p>",
"   <p>",
"    Meticulous attention to sterile technique during arterial cannulation and when drawing blood from the arterial line is important for reducing infection [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/2\">",
"     2",
"    </a>",
"    ]. Limiting the duration of arterial cannulation as a means to reduce infection risk is also appropriate, especially in high risk patients (eg, immunocompromised patients). However, the risk of infection from an indwelling arterial catheter is low, and routine removal and replacement is not indicated if the patient&rsquo;s clinical condition requires ongoing intraarterial access.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1861546\">",
"    <span class=\"h3\">",
"     Arterial thrombosis and embolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arterial thrombosis is described in up to 23 percent of children with indwelling arterial catheters and occurs more frequently in younger patients and those cannulated with larger catheters [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/2,3,18-20\">",
"     2,3,18-20",
"    </a>",
"    ]. Arterial thrombosis is common with radial artery catheters but embolic complications (eg, skin necrosis, permanently compromised circulation, amputation) are rare (&lt;1 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/3,18\">",
"     3,18",
"    </a>",
"    ]. By contrast, the risk of ischemic complications of thrombosis after femoral artery cannulation in children is approximately 13 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Embolization of thrombi from smaller arteries (radial, dorsalis pedis) may cause digital emboli with distal discoloration, skin necrosis, and, rarely, amputation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/2\">",
"     2",
"    </a>",
"    ]. Emboli from larger vessels (femoral, brachial, axillary) may also produce distal limb ischemia and lead to amputation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/20\">",
"     20",
"    </a>",
"    ]. Pulses distal to these sites should be monitored regularly. In addition, arrest of the growth plate resulting in skeletal deformity in adolescence is reported rarely after arterial cannulation of the femoral, brachial, and radial arteries in infancy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/12\">",
"     12",
"    </a>",
"    ]. Patient related factors (eg, shock, peripheral vascular disease, Raynaud phenomenon, systemic vasoconstrictor therapy) may also increase the risk of embolic complications [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/2,21\">",
"     2,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following measures may reduce the risk of arterial thrombosis or embolism:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      When possible, perform arterial cannulation in the distal radial site. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Site selection and equipment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Ensure adequate collateral circulation with the modified Allen or Allen test prior to radial artery cannulation.",
"     </li>",
"     <li>",
"      Use the proper catheter size based upon the child&rsquo;s weight (",
"      <a class=\"graphic graphic_table graphicRef74881 \" href=\"UTD.htm?2/20/2380\">",
"       table 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Avoid excess trauma during arterial cannulation by using ultrasound guidance and a guidewire method to increase success rate on the first attempt. (See",
"      <a class=\"local\" href=\"#H903781\">",
"       'Ultrasound guidance'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H902584\">",
"       'Guidewire method'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Provide a continuous flush with heparinized (eg, 2 units",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/39/7801?source=see_link\">",
"        heparin",
"       </a>",
"       /mL)",
"      </span>",
"      saline [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/2,22\">",
"       2,22",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In patients with signs of compromised distal circulation (eg, decreased or absent pulse, blanched or mottled skin, delayed capillary refill, cold distal extremity) and evidence of arterial thrombosis or embolism on imaging (eg, Doppler ultrasound, angiography, magnetic resonance imaging), arterial catheter removal and prompt consultation with a vascular surgeon is imperative [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1861554\">",
"    <span class=\"h3\">",
"     Iatrogenic blood loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;For every blood sample obtained from an arterial line, up to 2 to 4 mL of blood, depending upon the infusion tubing length, has to be first removed to clear the line of flush solution.",
"   </p>",
"   <p>",
"    Continuous intra-arterial blood gas monitors do provide accurate measures in children and infants and can decrease the amount of blood sampling but typically require placement of a femoral artery catheter in children. (See",
"    <a class=\"local\" href=\"#H21\">",
"     'Blood gas monitors'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1861572\">",
"    <span class=\"h3\">",
"     Air embolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although rare, cerebral air embolism can occur after intermittent flushing of radial and axillary artery catheters (particularly those catheters placed on the right side) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17361639\">",
"    <span class=\"h1\">",
"     SPECIMEN HANDLING AND ANALYSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The results of arterial blood gases are affected by the following (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15894?source=see_link&amp;anchor=H9#H9\">",
"     \"Arterial blood gases\", section on 'Specimen care'",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Type of syringe",
"      </strong>",
"      &ndash; Both plastic and glass syringes are available for blood glass collection. Gas diffusion through plastic syringes may introduce errors in blood gas analysis. However, studies vary regarding the magnitude of error. As a general rule, the error is not significant if the sample is analyzed within 15 minutes. Placement of the specimen on ice also reduces this error.",
"     </li>",
"     <li>",
"      <strong>",
"       Air bubbles",
"      </strong>",
"      &ndash; Air bubbles that occupy more than 1 to 2 percent of the blood volume in the syringe may introduce error, leading to an artificially high arterial PO2 and an underestimation of the true arterial PC02. The error can be decreased by gentle removal of bubbles without agitation and by rapid sample analysis.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/39/7801?source=see_link\">",
"       Heparin",
"      </a>",
"      <strong>",
"       use",
"      </strong>",
"      &ndash; Heparin is added to the syringe as an anticoagulant. The change in pH that results from the addition of acidic heparin is small. However, the dilutional effect of the heparin solution can produce significant reductions in the PCO2, depending directly upon the amount of heparin solution relative to the amount of blood. Thus, the amount of heparin solution should be kept to a minimum, and no less than 2 mL of blood should be obtained.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The blood gas sample should be placed on ice during transport, primarily to reduce oxygen consumption by leukocyte metabolism. Oxygen consumption is most pronounced in patients with profound leukocytosis. Rapid cooling of specimens obtained from these patients is necessary to avoid factitious hypoxemia. This error also can be reduced by rapid specimen analysis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15894?source=see_link&amp;anchor=H10#H10\">",
"     \"Arterial blood gases\", section on 'Transport'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Analysis of arterial blood samples usually is performed using automated blood gas analyzers. Rigorous quality control with standardized testing materials is essential to assure the accuracy of results. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15894?source=see_link&amp;anchor=H11#H11\">",
"     \"Arterial blood gases\", section on 'Analysis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Arterial blood gas analyzers operate at 37&ordm;C, which may differ from the body temperature of the patient from whom the blood sample was taken. Although the total content of carbon dioxide and oxygen in the blood do not change, the pH, PCO2, and PO2 of a blood sample all vary with temperature in a predictable way because gas tensions and hydrogen ion concentration decline with temperature (",
"    <a class=\"graphic graphic_table graphicRef59630 \" href=\"UTD.htm?5/45/5852\">",
"     table 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15894?source=see_link&amp;anchor=H11#H11\">",
"     \"Arterial blood gases\", section on 'Analysis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Modern automated blood gas analyzers are capable of reporting values at either 37&ordm;C (the temperature at which the values are measured by the machine) or at the patient's temperature. Whether values of pH, PCO2, and PO2 should be \"corrected\" to the patient's actual body temperature remains controversial, and \"corrected\" blood gas values should be interpreted with this in mind. Because of this uncertainty, most clinicians recommend using uncorrected values to guide therapy, recognizing that these results correspond to the arterial blood gas values that would have been present if the patient's temperature were 37&ordm;C. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15894?source=see_link&amp;anchor=H11#H11\">",
"     \"Arterial blood gases\", section on 'Analysis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3877028\">",
"    <span class=\"h1\">",
"     BLOOD PRESSURE INTERPRETATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blood pressure measurements obtained directly from an arterial catheter usually are higher (by 5 to 20 mmHg) than those measured by sphygmomanometry. In non-shock states, this increase results from the alteration in pulse contour as the pressure wave moves peripherally. The ascending portion of the wave becomes steeper, and the systolic reading becomes higher. However, the diastolic measurement usually is lower, leading to an unchanged mean arterial pressure. In shock states with a high systemic vascular resistance, the generated Korotkoff sounds may be inaudible by conventional sphygmomanometry, leading to erroneously low measurements.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     BLOOD GAS MONITORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Continuous intraarterial blood gas monitors have been used successfully in infants and children [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/23-26\">",
"     23-26",
"    </a>",
"    ]. Such monitors use fiberoptic and fluorescent dye technology for determination of PO2, PCO2, and pH through either an indwelling, continuous monitoring catheter or an external, intermittent sensor supplied with arterial blood through a tubing loop [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although reliable blood gas measurements can be obtained, the size of the monitors and the associated dampening of blood pressure waveforms frequently encountered at the radial arterial site typically limit their use to femoral artery catheters [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2009/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H904231\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In children, arterial puncture is frequently performed to assess acid-base status and oxygenation, to correlate arterial with less invasive measurements (eg, venous blood gas or pulse oximetry), or to obtain a blood sample when venipuncture is unsuccessful. Arterial cannulation instead of puncture is advisable in patients for whom multiple arterial measurements or continuous arterial blood pressure monitoring will be required. (See",
"      <a class=\"local\" href=\"#H17361471\">",
"       'Indications, contraindications, and precautions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that children have arterial puncture performed at the distal radial arterial site (",
"      <a class=\"graphic graphic_figure graphicRef77612 \" href=\"UTD.htm?40/6/41060\">",
"       figure 1",
"      </a>",
"      ) rather than at other sites (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Alternative sites include the posterior tibial (",
"      <a class=\"graphic graphic_figure graphicRef66126 \" href=\"UTD.htm?39/42/40609\">",
"       figure 3",
"      </a>",
"      ), the dorsalis pedis (",
"      <a class=\"graphic graphic_figure graphicRef74882 \" href=\"UTD.htm?8/11/8371\">",
"       figure 4",
"      </a>",
"      ), the brachial, and the femoral (",
"      <a class=\"graphic graphic_figure graphicRef57455 \" href=\"UTD.htm?1/36/1604\">",
"       figure 5",
"      </a>",
"      ) arteries. Of these, the dorsalis pedis can be tested for collateral circulation. (See",
"      <a class=\"local\" href=\"#H17361270\">",
"       'Site selection and equipment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The equipment and technique for performing arterial puncture in children is provided. (See",
"      <a class=\"local\" href=\"#H17361270\">",
"       'Site selection and equipment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H18834970\">",
"       'Technique'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Arterial cannulation is indicated in children who require frequent measurements of arterial blood gases, close monitoring of blood pressure, or continuous monitoring of cardiac output. We suggest that children have arterial cannulation performed at the distal radial site (",
"      <a class=\"graphic graphic_figure graphicRef77612 \" href=\"UTD.htm?40/6/41060\">",
"       figure 1",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Primary alternative sites include the femoral (",
"      <a class=\"graphic graphic_figure graphicRef57455 \" href=\"UTD.htm?1/36/1604\">",
"       figure 5",
"      </a>",
"      ), posterior tibial (",
"      <a class=\"graphic graphic_figure graphicRef66126 \" href=\"UTD.htm?39/42/40609\">",
"       figure 3",
"      </a>",
"      ), and dorsalis pedis (",
"      <a class=\"graphic graphic_figure graphicRef74882 \" href=\"UTD.htm?8/11/8371\">",
"       figure 4",
"      </a>",
"      ) arteries. Of these, the dorsalis pedis can be tested for collateral circulation. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Site selection and equipment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The necessary equipment and techniques for arterial cannulation in children are provided. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Site selection and equipment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H902504\">",
"       'Techniques'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest that, when equipment and expertise are available, children undergoing arterial cannulation have the procedure performed using a guidewire (",
"      <a class=\"graphic graphic_figure graphicRef74903 \" href=\"UTD.htm?14/17/14616\">",
"       figure 8",
"      </a>",
"      ) rather than by the direct method (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H902584\">",
"       'Guidewire method'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H902563\">",
"       'Direct method'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Complications of arterial cannulation in children in descending order of frequency include arterial obstruction, hematoma formation, infection, arterial thrombosis, arterial embolism, and iatrogenic blood loss. Rare complications include air embolism, pseudoaneurysm and arteriovenous fistula. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infection risk may be decreased by the use of the radial arterial site, careful sterile technique during placement, and when possible, limiting the duration of arterial cannulation. (See",
"      <a class=\"local\" href=\"#H1861538\">",
"       'Infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risk of arterial thrombosis and ischemic complications may be reduced by use of the radial arterial site with assessment of collateral blood flow, use of the proper size catheter based upon the child&rsquo;s weight (",
"      <a class=\"graphic graphic_table graphicRef74881 \" href=\"UTD.htm?2/20/2380\">",
"       table 1",
"      </a>",
"      ), avoidance of excess trauma during arterial cannulation, and continuous flushing of the catheter with heparinized (eg, 2 units",
"      <span class=\"nowrap\">",
"       <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/39/7801?source=see_link\">",
"        heparin",
"       </a>",
"       /mL)",
"      </span>",
"      saline. (See",
"      <a class=\"local\" href=\"#H1861546\">",
"       'Arterial thrombosis and embolism'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most accurate measurement of blood gases occurs when all air bubbles are manually removed from the blood gas syringe, the specimen is placed on ice, and the analysis is performed within 15 minutes of drawing the sample. (See",
"      <a class=\"local\" href=\"#H17361639\">",
"       'Specimen handling and analysis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Torrey SB, Saladino RA. Arterial puncture and catheterization. In: Textbook of Pediatric Emergency Procedures, 2nd edition, King C, Henretig FM.  (Eds), Lippincott, Williams &amp; Wilkins, Philadelphia 2008. p.715.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/2\">",
"      Brzezinski M, Luisetti T, London MJ. Radial artery cannulation: a comprehensive review of recent anatomic and physiologic investigations. Anesth Analg 2009; 109:1763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/3\">",
"      Brotschi B, Hug MI, Latal B, et al. Incidence and predictors of indwelling arterial catheter-related thrombosis in children. J Thromb Haemost 2011; 9:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/4\">",
"      Schindler E, Kowald B, Suess H, et al. Catheterization of the radial or brachial artery in neonates and infants. Paediatr Anaesth 2005; 15:677.",
"     </a>",
"    </li>",
"    <li>",
"     King C, Henretig FM. Pocket Atlas of Pediatric Emergency Procedures, Lippincott Williams &amp; Wilkins, Philadelphia 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/6\">",
"      Schwemmer U, Arzet HA, Trautner H, et al. Ultrasound-guided arterial cannulation in infants improves success rate. Eur J Anaesthesiol 2006; 23:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/7\">",
"      Ganesh A, Kaye R, Cahill AM, et al. Evaluation of ultrasound-guided radial artery cannulation in children. Pediatr Crit Care Med 2009; 10:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/8\">",
"      Yildirim V, Ozal E, Cosar A, et al. Direct versus guidewire-assisted pediatric radial artery cannulation technique. J Cardiothorac Vasc Anesth 2006; 20:48.",
"     </a>",
"    </li>",
"    <li>",
"     Tegtmeyer, K, Brady, G, Lai, S, et al. Placement of an arterial line. file://content.nejm.org/cgi/video/354/15/e13 (Accessed on April 17, 2007).",
"    </li>",
"    <li>",
"     Barker WJ. Clinical Procedures in Emergency Medicine, 3rd, Roberts.  (Ed), WB Saunders, Philadelphia 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/11\">",
"      Miyasaka K, Edmonds JF, Conn AW. Complications of radial artery lines in the paediatric patient. Can Anaesth Soc J 1976; 23:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/12\">",
"      Macnicol MF, Anagnostopoulos J. Arrest of the growth plate after arterial cannulation in infancy. J Bone Joint Surg Br 2000; 82:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/13\">",
"      Dumond AA, da Cruz E, Almodovar MC, Friesen RH. Femoral artery catheterization in neonates and infants. Pediatr Crit Care Med 2012; 13:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/14\">",
"      Wong AF, McCulloch LM, Sola A. Treatment of peripheral tissue ischemia with topical nitroglycerin ointment in neonates. J Pediatr 1992; 121:980.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/15\">",
"      Vasquez P, Burd A, Mehta R, et al. Resolution of peripheral artery catheter-induced ischemic injury following prolonged treatment with topical nitroglycerin ointment in a newborn: a case report. J Perinatol 2003; 23:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/16\">",
"      Baserga MC, Puri A, Sola A. The use of topical nitroglycerin ointment to treat peripheral tissue ischemia secondary to arterial line complications in neonates. J Perinatol 2002; 22:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/17\">",
"      Venkataraman ST, Thompson AE, Orr RA. Femoral vascular catheterization in critically ill infants and children. Clin Pediatr (Phila) 1997; 36:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/18\">",
"      King MA, Garrison MM, Vavilala MS, et al. Complications associated with arterial catheterization in children. Pediatr Crit Care Med 2008; 9:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/19\">",
"      Sheridan, RL, Weber, JM, Tompkins, RG. Burns 1994; 20:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/20\">",
"      Mourot JM, Oliveira HM, Woodson LC, et al. Complications of femoral artery catheterization in pediatric burn patients. J Burn Care Res 2009; 30:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/21\">",
"      Borrego R, L&oacute;pez-Herce J, Menc&iacute;a S, et al. Severe ischemia of the lower limb and of the intestine associated with systemic vasoconstrictor therapy and femoral arterial catheterization. Pediatr Crit Care Med 2006; 7:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/22\">",
"      Randolph AG, Cook DJ, Gonzales CA, Andrew M. Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials. BMJ 1998; 316:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/23\">",
"      Haller M, Kilger E, Briegel J, et al. Continuous intra-arterial blood gas and pH monitoring in critically ill patients with severe respiratory failure: a prospective, criterion standard study. Crit Care Med 1994; 22:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/24\">",
"      Weiss IK, Fink S, Harrison R, et al. Clinical use of continuous arterial blood gas monitoring in the pediatric intensive care unit. Pediatrics 1999; 103:440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/25\">",
"      Coule LW, Truemper EJ, Steinhart CM, Lutin WA. Accuracy and utility of a continuous intra-arterial blood gas monitoring system in pediatric patients. Crit Care Med 2001; 29:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/26\">",
"      Hatherill M, Tibby SM, Durward A, et al. Continuous intra-arterial blood-gas monitoring in infants and children with cyanotic heart disease. Br J Anaesth 1997; 79:665.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2009/abstract/27\">",
"      Shapiro BA, Mahutte CK, Cane RD, Gilmour IJ. Clinical performance of a blood gas monitor: a prospective, multicenter trial. Crit Care Med 1993; 21:487.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6327 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.248-1F43DE5731-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_61_2009=[""].join("\n");
var outline_f1_61_2009=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H904231\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ARTERIAL PUNCTURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17361471\">",
"      Indications, contraindications, and precautions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17361270\">",
"      Site selection and equipment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18834970\">",
"      Technique",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H903487\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      ARTERIAL CANNULATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3876994\">",
"      Indications, contraindications, and precautions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Site selection and equipment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H902504\">",
"      Techniques",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H903781\">",
"      - Ultrasound guidance",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H902584\">",
"      - Guidewire method",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H902563\">",
"      - Direct method",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1861506\">",
"      - Arterial obstruction (vasospasm)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1861514\">",
"      - Hematoma",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1861538\">",
"      - Infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1861546\">",
"      - Arterial thrombosis and embolism",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1861554\">",
"      - Iatrogenic blood loss",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1861572\">",
"      - Air embolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17361639\">",
"      SPECIMEN HANDLING AND ANALYSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3877028\">",
"      BLOOD PRESSURE INTERPRETATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      BLOOD GAS MONITORS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H904231\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6327\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6327|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/6/41060\" title=\"figure 1\">",
"      Radial artery puncture site",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/61/4049\" title=\"figure 2\">",
"      Modified Allen test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/42/40609\" title=\"figure 3\">",
"      Posterior tibial artery puncture site",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/11/8371\" title=\"figure 4\">",
"      Dorsalis pedis arterial puncture site",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/36/1604\" title=\"figure 5\">",
"      Femoral artery puncture site and position",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/46/43744\" title=\"figure 6\">",
"      Posterior tibial artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/5/18520\" title=\"figure 7\">",
"      Structures of the axilla",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/17/14616\" title=\"figure 8\">",
"      Radial artery catheterization techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6327|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?39/52/40771\" title=\"picture 1\">",
"      The Allen test",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/14/9443\" title=\"picture 2\">",
"      Position for radial artery puncture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?0/41/661\" title=\"picture 3\">",
"      Arterial catheter with continuous flush",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6327|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?2/20/2380\" title=\"table 1\">",
"      Arterial needle catheter size",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?36/14/37099\" title=\"table 2\">",
"      Nonabsorbable sutures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/45/5852\" title=\"table 3\">",
"      Temperature and blood gas",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15894?source=related_link\">",
"      Arterial blood gases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/51/26424?source=related_link\">",
"      Arterial catheterization techniques for invasive monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/57/33689?source=related_link\">",
"      Infiltration of local anesthetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/8/33925?source=related_link\">",
"      Oxygenation and mechanisms of hypoxemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43384?source=related_link\">",
"      Procedural sedation in children outside of the operating room",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/32/9736?source=related_link\">",
"      Pulse oximetry",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/41/27288?source=related_link\">",
"      Simple and mixed acid-base disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/50/43817?source=related_link\">",
"      Topical anesthetics in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_61_2010="Intracranial large artery atherosclerosis";
var content_f1_61_2010=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Intracranial large artery atherosclerosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/61/2010/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/61/2010/contributors\">",
"     As'ad Ehtisham, MD, MBBS, FAHA",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/61/2010/contributors\">",
"     Cathy A Sila, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/61/2010/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/61/2010/contributors\">",
"     Scott E Kasner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/61/2010/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/61/2010/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/61/2010/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 15, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Atherosclerotic stenosis of the major intracranial arteries (carotid siphon, middle cerebral artery, vertebral artery, and basilar artery) is an important cause of ischemic stroke, especially in blacks, Asians, and Hispanics [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/1-9\">",
"     1-9",
"    </a>",
"    ]. In the United States, intracranial stenosis causes approximately 50,000 ischemic strokes annually. This topic focuses on the epidemiology, prognosis, diagnosis, and treatment of intracranial arterial stenosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies performed in the 1960s first established the importance of atherosclerotic intracranial large artery occlusive disease as a cause of stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. One of the largest, the Joint Study of Extracranial Arterial Occlusion, evaluated 3788 patients (84 percent of whom were white) with signs and symptoms of ischemic cerebrovascular disease using four vessel angiography [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The following observations were reported [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Isolated intracranial occlusive disease was observed in 6.1 percent of all patients",
"     </li>",
"     <li>",
"      Stenotic lesions were found in 7.7 percent of basilar arteries, 4.4 percent of intracranial vertebral arteries, 6.7 percent of intracranial carotid arteries, 3.8 percent of middle cerebral arteries (MCA), 3.2 percent of anterior cerebral arteries (ACA), and 2.6 percent of posterior cerebral arteries (PCA).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Subsequent studies confirmed that approximately 5 to 10 percent of ischemic strokes in whites are caused by intracranial stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/6,10-13\">",
"     6,10-13",
"    </a>",
"    ]. These studies probably underestimate the true frequency of intracranial stenosis as a cause of stroke because angiography, the most reliable method for establishing this diagnosis, was only performed in 38 to 75 percent of patients.",
"   </p>",
"   <p>",
"    Several studies suggest that intracranial large artery atherosclerosis is more likely to develop in blacks than whites [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/2,3,6-8,14,15\">",
"     2,3,6-8,14,15",
"    </a>",
"    ]. In one series of patients with anterior circulation ischemia, MCA occlusion at arteriography was observed in 9 of 10 black men (90 percent) and 8 of 65 white men (12 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/16\">",
"     16",
"    </a>",
"    ]. In another series of 27 white and 24 black patients with symptomatic posterior circulation ischemia, distal basilar artery and intracranial branch lesions were significantly more frequent in blacks, whereas severe extracranial vertebral artery disease was significantly more frequent (fivefold more likely) in whites [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In black patients, stenosis of a major intracranial artery accounts for 15 to 29 percent of transient ischemic attack (TIA) or stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. In one study of 45 consecutive black patients with TIAs referable to the carotid distribution who were evaluated with angiography, 13 patients (29 percent) had isolated stenosis of the ipsilateral carotid siphon (six patients), MCA stem (four patients), or an MCA branch (three patients). In comparison, 12 patients (27 percent) had extracranial internal carotid artery stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Among patients with stroke or TIA, those of Japanese, Chinese, South Asian, and Hispanic origin also have a higher frequency of intracranial atherosclerosis than whites [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/4,6,9,18-20\">",
"     4,6,9,18-20",
"    </a>",
"    ]. A study of 64 patients with symptomatic anterior circulation ischemia found that 10 of 12 (83 percent) severely stenotic lesions in Japanese patients involved the intracranial arteries; in contrast, 17 of 20 (85 percent) of severely stenotic lesions in white Americans involved the extracranial internal carotid artery [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/18\">",
"     18",
"    </a>",
"    ]. Another study found that Chinese patients living in the United States had significantly higher rates of intracranial carotid artery and MCA stenoses than white patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The explanation for the variance in the distribution of cerebral atherosclerosis in different races is uncertain. One hypothesis is that blacks, Hispanics, and Asians have a genetic susceptibility to intracranial large artery disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/19,21\">",
"     19,21",
"    </a>",
"    ]. An alternative hypothesis is that racial and ethnic differences in lifestyle and risk factor profiles (eg, higher rates of diabetes and hypercholesterolemia in some populations) play a more important role in determining the distribution of atherosclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/6,22,23\">",
"     6,22,23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29925682\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors associated with symptomatic intracranial large artery atherosclerosis include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/24-29\">",
"     24-29",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hypertension",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Hyperlipidemia/dyslipidemia",
"      </span>",
"     </li>",
"     <li>",
"      Smoking",
"     </li>",
"     <li>",
"      Diabetes",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An analysis of data from the WASID study showed that risk factors were more prevalent than reported for other stroke subtypes and that a history of a lipid disorder was independently associated with severe intracranial stenosis (odds ratio 1.62, 95% CI1.09-2.42) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/30\">",
"     30",
"    </a>",
"    ]. Black race is also associated with intracranial large artery stenosis as discussed above. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Epidemiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several diagnostic procedures are currently used to identify intracranial stenosis. These include conventional angiography, transcranial Doppler ultrasound (TCD), magnetic resonance angiography (MRA), and computed tomography angiography (CTA).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Catheter angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The gold standard for establishing the diagnosis of intracranial large artery disease is conventional cerebral angiography. Angiography enables an accurate measurement of the degree of stenosis of the diseased artery [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/31\">",
"     31",
"    </a>",
"    ], differentiation of arterial occlusion from a very severe stenosis, assessment of collateral flow patterns, and evaluation of other intracranial and extracranial arteries.",
"   </p>",
"   <p>",
"    The major drawback of angiography is the risk of stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/32,33\">",
"     32,33",
"    </a>",
"    ], which was as high as 1.2 percent in the Asymptomatic Carotid Atherosclerosis Study (ACAS) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Noninvasive neurovascular imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Noninvasive tests to identify intracranial atherosclerosis such as transcranial Doppler ultrasonography (TCD) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/34-36\">",
"     34-36",
"    </a>",
"    ], magnetic resonance angiography (MRA) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/37-39\">",
"     37-39",
"    </a>",
"    ], and computed tomographic angiography (CTA) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/38,40\">",
"     38,40",
"    </a>",
"    ] are in widespread use. These procedures offer less expensive and safer methods for evaluating the intracranial circulation than catheter angiography.",
"   </p>",
"   <p>",
"    While all of these modalities are useful for excluding clinically significant (50 to 99 percent) stenosis of large proximal intracranial arteries, they are not sufficiently accurate to differentiate an occlusion from pseudo-occlusion with critical stenosis. In addition, they not accurate enough to confirm the severity of a clinically significant stenosis. In a prospective multicenter trial, both TCD and MRA had high negative predictive values (86 and 91 percent) and low positive predictive values (36 and 59 percent) for the detection of intracranial stenosis compared with catheter angiography [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/41\">",
"     41",
"    </a>",
"    ]. Therefore, TCD and MRA are useful tests for ruling out intracranial stenosis but catheter angiography remains the gold standard for confirming intracranial large artery stenosis when the diagnosis is suggested by TCD or MRA.",
"   </p>",
"   <p>",
"    Available data from single-center studies suggest that TCD may have a sensitivity as low as 75 percent and a specificity as low as 80 percent compared with conventional angiography for detecting intracranial stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/34-36,42\">",
"     34-36,42",
"    </a>",
"    ]. Similarly, MRA may have a sensitivity as low as 86 percent and a specificity as low as 67 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/37-39,42,43\">",
"     37-39,42,43",
"    </a>",
"    ]. One single-center study suggests that CTA may be more accurate than MRA for diagnosing intracranial stenosis, but this conclusion should be considered preliminary until validated in a multicenter prospective study [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    TCD cut-points for detecting severe, &ge;70 percent intracranial stenosis were developed in the SONIA trial [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/42\">",
"     42",
"    </a>",
"    ]. In the SAMMPRIS trial, these TCD cut-points were modified and employed for trial eligibility and performance of angiography. The values chosen were &ge;220",
"    <span class=\"nowrap\">",
"     cm/sec",
"    </span>",
"    for the middle cerebral artery and &ge;120",
"    <span class=\"nowrap\">",
"     cm/sec",
"    </span>",
"    for the intracranial internal carotid artery, vertebral artery and basilar artery [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/44\">",
"     44",
"    </a>",
"    ]. These TCD cut-points warrant further validation in large clinical-radiologic series. While CTA shows promise as a screening test for diagnosing intracranial stenosis, more prospective data are needed to confirm the accuracy of this method.",
"   </p>",
"   <p>",
"    In summary, available data suggest that noninvasive testing may not be sufficiently reliable to diagnose intracranial arterial stenosis accurately. Additionally, methods have not been established using TCD, MRA, or CTA to accurately measure the percent stenosis of an intracranial artery, whereas conventional angiography does permit such measurements.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In medically treated patients with 50 to 99 percent stenosis of a major intracranial artery, data from retrospective studies suggest that the annual risk of stroke is 3 to 15 percent in any vascular territory and 2 to 11 percent in the territory of the stenotic artery [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/6,9,45-50\">",
"     6,9,45-50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similar rates are suggested by prospective studies [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/51,52\">",
"     51,52",
"    </a>",
"    ], as illustrated by findings in a randomized controlled trial (WASID) that compared",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    in 569 patients with symptomatic stenosis (50 to 99 percent) of a major intracranial artery [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/51\">",
"     51",
"    </a>",
"    ]. In both treatment groups, the ischemic stroke rate in the territory of the stenotic artery at one year was 11 to 12 percent.",
"   </p>",
"   <p>",
"    In patients with symptomatic intracranial artery stenosis, subsequent strokes are usually in the territory of the symptomatic artery and nonlacunar, with a high proportion being disabling. Over a mean 1.8 years of follow-up in the WASID cohort, there were 106 ischemic strokes [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/53\">",
"     53",
"    </a>",
"    ]. Stroke occurred in the territory of the symptomatic artery in 77 patients (73 percent). Among the 77 in-territory strokes, 70 (91 percent) were nonlacunar and 34 (44 percent) were disabling.",
"   </p>",
"   <p>",
"    Although the issue is not settled, there may be subgroups of patients with intracranial arterial stenosis who are at particularly high risk of stroke:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with severe intracranial large artery stenosis [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/45\">",
"       45",
"      </a>",
"      ]. In the prospective WASID trial, severe stenosis (&ge;70 percent) was associated with a significantly higher risk of stroke in the same territory compared with stenosis &lt;70 percent (hazard ratio [HR] 2.03, 95% CI 1.29-3.22) (",
"      <a class=\"graphic graphic_figure graphicRef73498 \" href=\"UTD.htm?18/58/19374\">",
"       figure 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Patients with recent ischemic symptoms [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/45\">",
"       45",
"      </a>",
"      ]. WASID also demonstrated that patients with symptoms within the prior 17 days were at significantly higher risk of stroke in the same territory compared with patients whose symptoms were more remote (HR 1.67, 95% CI 1.1-2.9) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/54\">",
"       54",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Women. The WASID trial found that the frequency of the combined end point of stroke or vascular death in patients with symptomatic intracranial arterial stenosis was greater in women than in men (28.4 versus 16.6 percent respectively; HR 1.58, 95% CI 1.01-2.48) [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/55\">",
"       55",
"      </a>",
"      ]. In addition, women had a higher risk of recurrent ischemic stroke than men (HR 1.85; 95% CI 1.14-3.01).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Earlier retrospective studies suggested that high-risk groups also included patients with vertebrobasilar disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/56\">",
"     56",
"    </a>",
"    ], and those who developed recurrent ischemic cerebrovascular events or died despite the use of antithrombotic therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/57\">",
"     57",
"    </a>",
"    ]. However, the prospective WASID trial found no increased stroke risk associated with vertebrobasilar disease (HR 1.05, 95% CI 0.66-1.68) or use of antithrombotic therapy at the time of the qualifying ischemic event (HR 1.06, 95% CI 0.66-1.69) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Intracranial stenosis considered \"hemodynamically significant\" purely on clinical grounds emerged as another potential risk factor for recurrent ischemic stroke in the GESICA study, a prospective observational report that enrolled 102 patients with &ge;50 percent symptomatic intracranial large artery atherosclerotic stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/52\">",
"     52",
"    </a>",
"    ]. Intracranial stenosis was classified as hemodynamic in GESICA if symptoms related to the stenosis occurred during a change in body position from supine to prone, during",
"    <span class=\"nowrap\">",
"     effort/exertion,",
"    </span>",
"    or with the introduction or increase of antihypertensive medication. Patients with a hemodynamic stenosis had a significantly higher frequency of recurrent ischemic stroke or TIA in the territory of the stenotic artery than those without a hemodynamic stenosis (60.7 versus 31.7 percent).",
"   </p>",
"   <p>",
"    A clear limitation of the GESICA study is that there was no analysis to see if the clinically designated hemodynamic intracranial stenoses correlated with the degree of stenoses seen on angiographic studies. Further study is needed to determine whether clinical features suggestive of hemodynamic compromise are independent indicators of high risk or poor prognosis.",
"   </p>",
"   <p>",
"    High-risk subgroups of patients with intracranial large artery stenosis may be the target groups to enroll in future randomized trials comparing new therapies (eg, stenting) with medical therapy. Given the available data cited above, patients with a recent stroke or TIA due to 70 to 99 percent stenosis of a major intracranial artery appear to be reasonable candidates for such trials. Conversely, patients with TIA and 50 to 69 percent stenosis appear to be at low risk of stroke in the territory. These data were used to identify a population at sufficiently high risk for stroke with medical therapy to consider revascularization strategies with intracranial angioplasty with or without stenting, and excluding such patients in trials of intracranial stenting may be justified because the up-front risk of this procedure may exceed any potential subsequent benefit in these low-risk patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ANTITHROMBOTIC THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optimal antithrombotic therapy for patients with intracranial stenosis is uncertain. Prospective randomized clinical trials have found no statistically significant difference between antiplatelet and anticoagulant therapy for ischemic stroke risk reduction in this and other stroke populations [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/51,58\">",
"     51,58",
"    </a>",
"    ]. In addition, the risk of major hemorrhage and death appears to be higher with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Of historical interest, anticoagulation was first suggested as a treatment in 1955 based upon the observation that 21 patients with vertebrobasilar ischemic symptoms on",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    therapy had a lower mortality rate compared with 23 patients not anticoagulated (14 versus 43 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/59\">",
"     59",
"    </a>",
"    ], and later retrospective studies suggested that warfarin was more effective than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/45,56,57\">",
"     45,56,57",
"    </a>",
"    ]. However, these results were upended by the findings from randomized trials, as described in the next section.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Warfarin versus aspirin",
"    </span>",
"    &nbsp;&mdash;&nbsp;The WARSS trial found that oral anticoagulation is no better than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    for noncardioembolic stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/58\">",
"     58",
"    </a>",
"    ]. WARSS was a double-blind randomized controlled trial that compared aspirin (325",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    (international normalized ratio [INR] 1.4 to 2.8) in 2206 patients with noncardioembolic ischemic stroke. Overall, the study found similar rates of ischemic stroke, death, or major hemorrhage for both warfarin and aspirin treatment. Analogous results were found in a subgroup of 259 patients with large artery stenosis or occlusion that included both extracranial carotid artery occlusion and intracranial stenosis, although this small subset analysis was not powered to address question of which antithrombotic therapy was better for large artery disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The double-blind WASID trial confirmed that oral anticoagulation is no better than",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    for preventing ischemic stroke in patients with intracranial large artery stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/51\">",
"     51",
"    </a>",
"    ]. In WASID, patients with transient ischemic attack (TIA) or nondisabling stroke caused by an angiographically verified 50 to 99 percent stenosis of a major intracranial artery were randomly assigned to treatment with either",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    (target INR 2.0 to 3.0) or aspirin (1300",
"    <span class=\"nowrap\">",
"     mg/day).",
"    </span>",
"    The study was stopped prematurely because of safety concerns for patients in the warfarin arm after enrolling 569 patients with an average follow-up of 1.8 years.",
"   </p>",
"   <p>",
"    The following observations were made [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/51\">",
"     51",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the primary outcome measure of combined ischemic stroke, brain hemorrhage, or death from vascular cause other than stroke, there was no difference between",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      treatment (22.1 versus 21.8 percent, hazard ratio [HR] aspirin relative to warfarin 1.04, 95% CI 0.73-1.48)",
"     </li>",
"     <li>",
"      The rate of ischemic stroke recurrence in the territory of the stenotic intracranial artery was high for both",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      treatment (15.0 versus 12.1 percent, HR 1.26, 95% CI 0.81-1.97) and primarily occurred within the first year from the qualifying event",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       Aspirin",
"      </a>",
"      treatment was associated with a significantly lower rate of death than",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      (4.3 versus 9.7 percent, HR 0.46, 95% CI 0.23&ndash;0.90)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       Aspirin",
"      </a>",
"      treatment was associated with a significantly lower rate of major hemorrhage (mostly systemic) than",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      (3.2 versus 8.3 percent, HR 0.39, 95% CI 0.18-0.84)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Based on these data, the authors concluded that",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    should be used in preference to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    for patients with symptomatic intracranial arterial stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a post-hoc analysis of WASID, the only subgroup for which there was a statistically significant difference between",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    was patients with basilar artery stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/60\">",
"     60",
"    </a>",
"    ]. The rationale for undertaking this analysis was that some retrospective studies had suggested that warfarin may have efficacy in certain subgroups of patients with intracranial stenosis as discussed above. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Prognosis'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The following results were reported:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the subgroup of patients with basilar artery stenosis,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      treatment was associated with a higher risk of stroke or vascular death, the primary endpoint in the trial, than",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      (HR 2.28, 95% CI 1.02-5.08). However, there was no statistically significant difference in time to recurrent stroke within the territory of the symptomatic basilar artery between aspirin and warfarin treatment (HR 1.84, 95% CI 0.67&ndash;5.06).",
"     </li>",
"     <li>",
"      There were no significant differences in the primary endpoint between",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      in any other subgroups, including those with stenosis &ge;70 percent, those on antithrombotic therapy at qualifying ischemic event, those with vertebral artery stenosis, and those with stenoses of multiple intracranial arteries.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite the finding that patients with basilar artery stenosis in this study had a higher risk of stroke or vascular death on",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    , the similar rates of stroke in the territory of the basilar artery and lack of benefit of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    in patients with vertebral artery stenosis suggest that no specific subgroup in WASID benefited from warfarin [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Antiplatelet drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antiplatelet agents for ischemic stroke prevention include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"     clopidogrel",
"    </a>",
"    , and combination aspirin with extended-release",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/25/41366?source=see_link\">",
"     dipyridamole",
"    </a>",
"    . These medications have been established as effective for prevention of recurrent ischemic stroke in the patients with a history of noncardioembolic ischemic stroke or TIA of atherothrombotic, lacunar (small vessel occlusive), or cryptogenic type. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/35/2618?source=see_link\">",
"     \"Antiplatelet therapy for secondary prevention of stroke\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Since antiplatelet drugs are effective in this larger group of patients with noncardioembolic ischemic stroke of all types, they are likely to be effective in the subgroup of patients with intracranial large artery atherosclerosis, a subgroup that appears to be at particularly high risk of recurrent ischemic stroke. However, antiplatelet drugs have not been compared with placebo or with each other in randomized controlled trials specifically for patients with symptomatic intracranial large artery atherosclerosis.",
"   </p>",
"   <p>",
"    Of note, it is possible but not established that the temporary use of dual antiplatelet therapy with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"     clopidogrel",
"    </a>",
"    for the first 90 days after enrollment of recently symptomatic patients may have contributed to the relatively low rate of combined stroke and death at one year of 12.2 percent that was observed in the aggressive medical treatment arm of the SAMMPRIS trial (see",
"    <a class=\"local\" href=\"#H87797058\">",
"     'SAMMPRIS trial'",
"    </a>",
"    below). In contrast, patients with the same entry criteria as SAMMPRIS who were treated with aspirin or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    in the WASID trial had a combined stroke and death rate at one year of 25 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/61\">",
"     61",
"    </a>",
"    ]. However, this comparison is indirect and therefore must be considered as hypothesis-generating, particularly because other trials have found that the combined use of aspirin and clopidogrel does not offer greater benefit for stroke prevention than either agent alone but does substantially increase the risk of bleeding complications. Despite this uncertainty, we nevertheless suggest dual antiplatelet therapy with aspirin plus clopidogrel for 90 days for patients with recently symptomatic intracranial large artery disease, followed by antiplatelet monotherapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/35/2618?source=see_link&amp;anchor=H7#H7\">",
"     \"Antiplatelet therapy for secondary prevention of stroke\", section on 'Aspirin plus clopidogrel'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/38/38502?source=see_link\">",
"     Cilostazol",
"    </a>",
"    is a phosphodiesterase III inhibitor and antiplatelet agent with vasodilating and possible antiatherogenic effects [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/62\">",
"     62",
"    </a>",
"    ]. Preliminary data from a randomized clinical trial suggest that cilostazol plus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    may slow the progression of intracranial large artery occlusive disease (as measured by magnetic resonance angiography) compared with aspirin monotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/63\">",
"     63",
"    </a>",
"    ]. Further clinical trial data are needed to confirm the effectiveness of cilostazol for intracranial occlusive disease and to determine whether this treatment has benefit for stroke risk reduction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     INTERVENTIONAL THERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;While endovascular therapy with angioplasty and stenting for intracranial large vessel lesions appeared promising in nonrandomized studies and registries [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/64\">",
"     64",
"    </a>",
"    ], results from the SAMMPRIS trial published in 2011 indicate that aggressive medical management is superior to stenting for patients with recently symptomatic high-grade intracranial large artery stenosis (see",
"    <a class=\"local\" href=\"#H12\">",
"     'Stenting'",
"    </a>",
"    below) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/65\">",
"     65",
"    </a>",
"    ]. Prior to SAMMPRIS, guidelines for stroke prevention issued in 2011 by the American Heart",
"    <span class=\"nowrap\">",
"     Association/American",
"    </span>",
"    Stroke Association",
"    <span class=\"nowrap\">",
"     (AHA/ASA)",
"    </span>",
"    concluded that endovascular therapy for intracranial disease remains investigational and efficacy is uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/66\">",
"     66",
"    </a>",
"    ]. Guidelines for intracranial endovascular procedures published in 2009 by the AHA recommended that patients with intracranial stenoses first receive lifestyle modification advice and optimal medical treatment (ie, statins, angiotensin-converting enzyme inhibitors, and antithrombotics) for secondary stroke prevention [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/67\">",
"     67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the United States, the policy of the Centers for Medicare and Medicaid Services is",
"    <strong>",
"     not",
"    </strong>",
"    to reimburse for intracranial angioplasty with or without stenting outside the context of a clinical trial [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/68\">",
"     68",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Angioplasty",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angioplasty for intracranial large artery disease is technically feasible, but data are limited to mainly retrospective single-center observational reports, most of which had fewer than 30 patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/69-78\">",
"     69-78",
"    </a>",
"    ]. The periprocedural rate of stroke or death with angioplasty varied between 4 and 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/69-78\">",
"     69-78",
"    </a>",
"    ]. The highest periprocedural complication rates occurred in studies that included symptomatic and unstable patients felt to be at high risk of recurrent events [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/77,78\">",
"     77,78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A systematic review of studies of angioplasty for intracranial artery stenosis (with or without stent placement) published through March 2006 identified 79 open-label case series with three or more cases [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/79\">",
"     79",
"    </a>",
"    ]. No randomized controlled trials were found. The following overall perioperative complication rates were observed:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Stroke, 7.9 percent (95% CI 5.5-10.4 percent)",
"     </li>",
"     <li>",
"      Death, 3.4 percent (95% CI 2.0-4.8 percent)",
"     </li>",
"     <li>",
"      Stroke or death, 9.5 percent (95% CI 7.0-12.0 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A later retrospective review of 74 patients from four centers treated with angioplasty for intracranial atherosclerotic disease reported similar results [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Very few studies have evaluated the long-term clinical outcome following intracranial angioplasty. One that did was a retrospective study of 23 patients with a mean follow-up of 35.4 months; the annual stroke rate in the territory of the treated artery was 3.2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are numerous drawbacks to intracranial angioplasty, including immediate elastic recoil of the artery, dissection, acute vessel closure, residual stenosis &gt;50 percent following the procedure, and high restenosis rates. These limitations, coupled with the success of stenting in the coronary circulation, have led to the emergence of stenting as the preferred interventional technique for treating intracranial stenosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Stenting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prospective nonrandomized studies and registries using bare metal stents (NEUROLINK and Wingspan) provided encouraging data on the safety and potential efficacy of stenting for intracranial arterial stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/61,81-85\">",
"     61,81-85",
"    </a>",
"    ]. However, the only randomized trial &ndash; SAMMPRIS &ndash; found that the 30-day rate of stroke or death was significantly higher for patients treated with angioplasty and stenting compared with those who received medical therapy alone [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given these randomized trial data [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/65\">",
"     65",
"    </a>",
"    ], we recommend intensive medical therapy rather than intracranial stenting for patients with recently symptomatic intracranial large artery stenosis of 70 to 99 percent. The efficacy of intracranial angioplasty and stenting for stroke prevention in symptomatic intracranial stenosis is uncertain and warrants further study [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/86,87\">",
"     86,87",
"    </a>",
"    ]. Outside of clinical trials, angioplasty and stenting should be reserved as a last resort for patients with high-grade intracranial stenosis who have multiple symptomatic ischemic events due to hemodynamic failure that is unresponsive to any medical therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H87797058\">",
"    <span class=\"h3\">",
"     SAMMPRIS trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;The multicenter SAMMPRIS trial enrolled patients with 70 to 99 percent intracranial large artery stenosis who had a TIA or ischemic stroke within 30 days prior to study entry [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/65\">",
"     65",
"    </a>",
"    ]. Patients were randomly assigned to treatment with intracranial angioplasty and stenting using the Wingspan system plus aggressive medical management, or to treatment with aggressive medical management alone. Aggressive medical therapy consisted of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    325 mg daily,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"     clopidogrel",
"    </a>",
"    75 mg daily for 90 days after enrollment, and intensive risk factor management with a target blood pressure of",
"    <span class=\"nowrap\">",
"     &lt;140/90",
"    </span>",
"    mmHg (or",
"    <span class=\"nowrap\">",
"     &lt;130/80",
"    </span>",
"    mmHg if diabetic) and an LDL target of &lt;70",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (&lt;1.81",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    The following outcomes were reported [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/65\">",
"     65",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Trial enrollment was halted prematurely after recruitment of 451 of the planned 764 patients because the combined rate of stroke or death within 30 days of enrollment &ndash; the primary outcome &ndash; was significantly higher for patients treated with angioplasty and stenting compared with those treated with medical therapy alone (14.7 versus 5.8 percent). The investigators noted that the periprocedural rate of stroke was higher than expected for the stenting group, and lower than estimated for the medical management group.",
"     </li>",
"     <li>",
"      Of the 33 early stroke events in the stenting group, 25 occurred within one day of the procedure and the remaining 8 occurred within six days of the procedure. Of the early strokes, symptomatic intracranial, subarachnoid, or intraventricular hemorrhage occurred in 10 patients (4.5 percent), resulting in death in 4 patients (1.8 percent). In contrast, there were 12 early strokes in the medical management group and none were hemorrhagic. In the stenting group, the main cause of the early ischemic strokes was occlusion of perforating vessels [",
"      <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/88\">",
"       88",
"      </a>",
"      ]. Of the early hemorrhagic strokes, approximately one-half involved predominantly subarachnoid bleeding that was evident immediately after the procedure, while the rest were intraparenchymal hemorrhages that were attributed to reperfusion. However, we do not know whether some of these early hemorrhagic strokes in the stenting group represented periprocedural vessel injury, dissection, or hyperperfusion syndrome.",
"     </li>",
"     <li>",
"      The rate of stroke and death at one year was also significantly higher for the group assigned to angioplasty and stenting (20 versus 12.2 percent). The difference at one year between the treatment groups was driven by the 30 day outcomes, since the rates of stroke and death beyond 30 days were similar for the two groups. However, fewer than one-half of the subjects had follow-up of one year or more, and two-year follow-up is planned.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Intracranial bypass surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;While intracranial bypass surgery is a therapeutic option for patients with intracranial arterial stenosis, enthusiasm for bypass waned after the extracranial-intracranial (EC-IC) bypass study results were reported in 1985 [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/50\">",
"     50",
"    </a>",
"    ]. In that study, 1377 patients with symptomatic extracranial carotid occlusion, distal carotid occlusive disease, or middle cerebral arteries (MCA) stenosis were randomly assigned to either medical therapy alone (usually",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    1300",
"    <span class=\"nowrap\">",
"     mg/day",
"    </span>",
"    in four divided doses) or to extracranial-intracranial anastomosis surgery (joining the superficial temporal artery and the middle cerebral artery) combined with medical therapy. The mean follow-up was 55.8 months.",
"   </p>",
"   <p>",
"    The results demonstrated that EC-IC bypass was ineffective for preventing stroke in these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/50\">",
"     50",
"    </a>",
"    ]. Subgroup analyses showed that EC-IC bypass was ineffective in patients with distal carotid stenosis, and was actually hazardous in patients with MCA stenosis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/47,50\">",
"     47,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In 149 patients with &ge;70 percent carotid siphon stenosis, stroke rates were similar for patients assigned to medical and EC-IC bypass (36 versus 38 percent)",
"     </li>",
"     <li>",
"      In 109 patients with &ge;70 percent MCA stenosis, stroke frequency was significantly higher for patients who had EC-IC compared with medically-treated patients (44 versus 24 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Bypass surgery or endarterectomy has also been used occasionally for the treatment of intracranial vertebral artery occlusive disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/89,90\">",
"     89,90",
"    </a>",
"    ], but the efficacy of these procedures has not been evaluated systematically.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     RISK FACTOR MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Management of hypertension, hyperlipidemia, diabetes, and smoking is a critical component of the treatment of patients with vascular disease, including those with stroke. Post-hoc analyses from the WASID trial showed that patients with intracranial stenosis and poorly controlled blood pressure or elevated cholesterol during follow-up had a significantly higher rate of stroke, myocardial infarction, or vascular death compared with patients with good control of these risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/91\">",
"     91",
"    </a>",
"    ]. In addition, the lower than expected rate of stroke in the aggressive medical arm of the SAMMPRIS trial (see",
"    <a class=\"local\" href=\"#H87797058\">",
"     'SAMMPRIS trial'",
"    </a>",
"    above) may have resulted from intensive risk factor management with lowering of LDL, cholesterol and systolic blood pressure in addition to antiplatelet therapy.",
"   </p>",
"   <p>",
"    While there are no prospective studies focusing on the treatment of risk factors for patients with intracranial large artery atherosclerosis, it is likely that effective risk factor management would reduce the burden of stroke-related disability in such patients. Therefore, we recommend maximal medical therapy that includes treatment with antiplatelet therapy, antihypertensive agents and statins for patients with symptomatic intracranial large artery atherosclerosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/61/30682?source=see_link\">",
"     \"Secondary prevention of stroke: Risk factor reduction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Target blood pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The target blood pressure in patients with intracranial artery stenosis is uncertain. Some stroke experts are willing to accept high normal or mild hypertensive levels",
"    <span class=\"nowrap\">",
"     (140/85",
"    </span>",
"    to",
"    <span class=\"nowrap\">",
"     150/90)",
"    </span>",
"    in these patients on the premise that many have flow-limiting stenoses of intracranial large arteries that require a higher perfusion pressure to prevent ischemia.",
"   </p>",
"   <p>",
"    However, the optimal blood pressure in these patients has not been examined systematically. A post-hoc analysis of the WASID data set found that systolic blood pressure &ge;140 mmHg was associated with an increased risk of recurrent ischemic stroke, and that higher blood pressure did not decrease the risk of recurrent ischemic stroke in the territory of the stenotic vessel [",
"    <a class=\"abstract\" href=\"UTD.htm?1/61/2010/abstract/92\">",
"     92",
"    </a>",
"    ]. Taken together, these findings suggest that the Joint National Committee (JNC) 7 guidelines, which recommend a target blood pressure lower than",
"    <span class=\"nowrap\">",
"     140/90",
"    </span>",
"    mmHg in most patients, should also be followed in patients with intracranial stenosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/57/17305?source=see_link\">",
"     \"Antihypertensive therapy to prevent recurrent stroke or transient ischemic attack\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The blood pressure should be lowered gradually to minimize side effects including hypotensive symptoms due to failure of autoregulation of cerebral blood flow. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/57/17305?source=see_link\">",
"     \"Antihypertensive therapy to prevent recurrent stroke or transient ischemic attack\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/61/30682?source=see_link\">",
"     \"Secondary prevention of stroke: Risk factor reduction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Statin therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The SAMMPRIS trial chose an aggressive LDL target of &lt;70",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.8",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    for patients with symptomatic intracranial large artery atherosclerosis. As discussed above, the lower than expected rate of stroke in the aggressive medical arm of the SAMMPRIS trial (see",
"    <a class=\"local\" href=\"#H87797058\">",
"     'SAMMPRIS trial'",
"    </a>",
"    above) may have resulted from intensive risk factor management aimed at lowering LDL, cholesterol and systolic blood pressure in addition to antiplatelet therapy. Therefore, we suggest an LDL goal of &lt;70",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (1.8",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    for patients with symptomatic intracranial large artery atherosclerosis.",
"   </p>",
"   <p>",
"    More general recommendations for patients with TIA, ischemic stroke of atherosclerotic origin, or asymptomatic atherosclerotic cerebrovascular disease are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/61/30682?source=see_link&amp;anchor=H35#H35\">",
"     \"Secondary prevention of stroke: Risk factor reduction\", section on 'Cholesterol and statin therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Atherosclerotic stenosis of the major intracranial arteries (carotid siphon, middle cerebral artery, vertebral artery, and basilar artery) is an important cause of ischemic stroke, especially in blacks, Asians, and Hispanics. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The gold standard for establishing the diagnosis of intracranial large artery disease is conventional cerebral angiography. Noninvasive studies such as transcranial Doppler ultrasound, magnetic resonance angiography, and computerized computed tomography (CT) angiography may also be used to rule out intracranial stenosis, but angiography is still needed to confirm the presence of intracranial stenosis and to accurately measure the percent stenosis. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In medically-treated patients with 50 to 99 percent stenosis of a major intracranial artery, the annual risk of ischemic stroke is as high as 15 percent in any vascular territory and as high as 12 percent in the territory of the stenotic artery. Patients with severe intracranial artery stenosis (&ge;70 percent) may be at particularly high risk of stroke in the territory of the affected vessel. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no established effective treatment for symptomatic intracranial large artery atherosclerosis. The WASID trial compared antiplatelet therapy with oral anticoagulation therapy and found that",
"      <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"       warfarin",
"      </a>",
"      treatment resulted in higher rates of death and major hemorrhage but no additional benefit. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Antithrombotic therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with symptomatic intracranial large artery atherosclerosis, we recommend initial treatment with antiplatelet agents (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Reasonable choices include",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"       aspirin",
"      </a>",
"      , combination extended-release",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/25/41366?source=see_link\">",
"       dipyridamole",
"      </a>",
"      with aspirin (ER-DP; Aggrenox), and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"       clopidogrel",
"      </a>",
"      . For patients with recently symptomatic intracranial large artery disease, we suggest dual antiplatelet therapy with aspirin plus clopidogrel for 90 days, followed by antiplatelet monotherapy (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Antithrombotic therapy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/35/2618?source=see_link\">",
"       \"Antiplatelet therapy for secondary prevention of stroke\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Management of hypertension, hyperlipidemia, diabetes, and smoking is a critical component of the treatment of patients with vascular disease. For patients with symptomatic intracranial large artery atherosclerosis, we recommend maximal medical therapy in addition to antiplatelet therapy. With regard to antihypertensive therapy and statin therapy, we make the following specific recommendations (see",
"      <a class=\"local\" href=\"#H14\">",
"       'Risk factor management'",
"      </a>",
"      above):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For patients with a history of hypertension who have had a transient ischemic attack (TIA) or ischemic stroke in the preceding two weeks to five years, who are stable, and who have no contraindication to blood pressure lowering, we recommend antihypertensive therapy (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). The target blood pressure in patients with intracranial artery stenosis is uncertain, but limited available data suggest that a systolic blood pressure &lt;140 mm Hg is an appropriate goal for most patients with intracranial stenosis. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Target blood pressure'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with TIA, ischemic stroke of atherosclerotic origin, or asymptomatic atherosclerotic cerebrovascular disease who have a baseline low-density lipoprotein (LDL) &gt;100",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (&gt;2.6",
"      <span class=\"nowrap\">",
"       mmol/L),",
"      </span>",
"      we recommend statin therapy (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ).",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/37/35417?source=see_link\">",
"       Atorvastatin",
"      </a>",
"      (80",
"      <span class=\"nowrap\">",
"       mg/day)",
"      </span>",
"      was the agent used in the randomized trial showing a benefit for secondary ischemic stroke prevention, but other factors may influence the choice of statin and the dose. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/61/30682?source=see_link&amp;anchor=H15#H15\">",
"       \"Secondary prevention of stroke: Risk factor reduction\", section on 'SPARCL trial'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/35/32314?source=see_link\">",
"       \"Statins: Actions, side effects, and administration\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients with symptomatic intracranial large artery atherosclerosis, we suggest an LDL goal of &lt;70",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (1.8",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Statin therapy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For patients with recently symptomatic intracranial large artery stenosis of 70 to 99 percent, we recommend intensive medical therapy rather than intracranial stenting (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). The efficacy of intracranial angioplasty and stenting for stroke prevention in symptomatic intracranial stenosis is uncertain and warrants further study. Outside of clinical trials, angioplasty and stenting should be reserved as a last resort for patients with high-grade intracranial stenosis who have multiple symptomatic ischemic events due to hemodynamic failure that is unresponsive to any medical therapy. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Interventional therapies'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H12\">",
"       'Stenting'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5128424\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The authors and editors of UpToDate would like to acknowledge Dr. Marc Chimowitz, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/1\">",
"      Hass WK, Fields WS, North RR, et al. Joint study of extracranial arterial occlusion. II. Arteriography, techniques, sites, and complications. JAMA 1968; 203:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/2\">",
"      McGarry P, Solberg LA, Guzman MA, Strong JP. Cerebral atherosclerosis in New Orleans. Comparisons of lesions by age, sex, and race. Lab Invest 1985; 52:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/3\">",
"      Moossy J. Cerebral infarction and intracranial arterial thrombosis. Necropsy studies and clinical implications. Arch Neurol 1966; 14:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/4\">",
"      Kieffer SA, Takeya Y, Resch JA, Amplatz K. Racial differences in cerebrovascular disease. Angiographic evaluation of Japanese and American populations. Am J Roentgenol Radium Ther Nucl Med 1967; 101:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/5\">",
"      Gorelick PB. Distribution of atherosclerotic cerebrovascular lesions. Effects of age, race, and sex. Stroke 1993; 24:I16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/6\">",
"      Sacco RL, Kargman DE, Gu Q, Zamanillo MC. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study. Stroke 1995; 26:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/7\">",
"      Qureshi AI, Safdar K, Patel M, et al. Stroke in young black patients. Risk factors, subtypes, and prognosis. Stroke 1995; 26:1995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/8\">",
"      Weisberg LA. Clinical characteristics of transient ischemic attacks in black patients. Neurology 1991; 41:1410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/9\">",
"      Wong KS, Li H. Long-term mortality and recurrent stroke risk among Chinese stroke patients with predominant intracranial atherosclerosis. Stroke 2003; 34:2361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/10\">",
"      Naylor AR, Sandercock PA, Sellar RJ, Warlow CP. Patterns of vascular pathology in acute, first-ever cerebral infarction. Scott Med J 1993; 38:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/11\">",
"      Wityk R, Lehman D, Klag M, et al. Racial differences in extracranial and intracranial atherosclerosis. Neurology 1995; Suppl 4:A461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/12\">",
"      Passero S, Rossi G, Nardini M, et al. Italian multicenter study of reversible cerebral ischemic attacks. Part 5. Risk factors and cerebral atherosclerosis. Atherosclerosis 1987; 63:211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/13\">",
"      Bogousslavsky J, Van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke. Stroke 1988; 19:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/14\">",
"      Gorelick PB, Caplan LR, Hier DB, et al. Racial differences in the distribution of anterior circulation occlusive disease. Neurology 1984; 34:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/15\">",
"      Inzitari D, Hachinski VC, Taylor DW, Barnett HJ. Racial differences in the anterior circulation in cerebrovascular disease. How much can be explained by risk factors? Arch Neurol 1990; 47:1080.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/16\">",
"      Heyden S, Heyman A, Goree JA. Nonembolic occlusion of the middle cerebral and carotid arteries--a comparison of predisposing factors. Stroke 1970; 1:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/17\">",
"      Gorelick PB, Caplan LR, Hier DB, et al. Racial differences in the distribution of posterior circulation occlusive disease. Stroke 1985; 16:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/18\">",
"      Nishimaru K, McHenry LC Jr, Toole JF. Cerebral angiographic and clinical differences in carotid system transient ischemic attacks between American Caucasian and Japanese patients. Stroke 1984; 15:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/19\">",
"      Feldmann E, Daneault N, Kwan E, et al. Chinese-white differences in the distribution of occlusive cerebrovascular disease. Neurology 1990; 40:1541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/20\">",
"      De Silva DA, Woon FP, Lee MP, et al. South Asian patients with ischemic stroke: intracranial large arteries are the predominant site of disease. Stroke 2007; 38:2592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/21\">",
"      Gorelick PB, Caplan LR, Langenberg P, et al. Clinical and angiographic comparison of asymptomatic occlusive cerebrovascular disease. Neurology 1988; 38:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/22\">",
"      Williams AO, Resch JA, Loewenson RB. Cerebral atherosclerosis--a comparative autopsy study between Nigerian Negroes and American Negroes and Caucasians. Neurology 1969; 19:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/23\">",
"      Arenillas JF, Molina CA, Chac&oacute;n P, et al. High lipoprotein (a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology 2004; 63:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/24\">",
"      RESCH JA, BAKER AB. ETIOLOGIC MECHANISMS IN CEREBRAL ATHEROSCLEROSIS. PRELIMINARY STUDY OF 3,839 CASES. Arch Neurol 1964; 10:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/25\">",
"      Sacco RL, Kargman DE, Zamanillo MC. Race-ethnic differences in stroke risk factors among hospitalized patients with cerebral infarction: the Northern Manhattan Stroke Study. Neurology 1995; 45:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/26\">",
"      Ingall TJ, Homer D, Baker HL Jr, et al. Predictors of intracranial carotid artery atherosclerosis. Duration of cigarette smoking and hypertension are more powerful than serum lipid levels. Arch Neurol 1991; 48:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/27\">",
"      Rincon F, Sacco RL, Kranwinkel G, et al. Incidence and risk factors of intracranial atherosclerotic stroke: the Northern Manhattan Stroke Study. Cerebrovasc Dis 2009; 28:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/28\">",
"      Wityk RJ, Lehman D, Klag M, et al. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996; 27:1974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/29\">",
"      Sirimarco G, Deplanque D, Lavall&eacute;e PC, et al. Atherogenic dyslipidemia in patients with transient ischemic attack. Stroke 2011; 42:2131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/30\">",
"      Turan TN, Makki AA, Tsappidi S, et al. Risk factors associated with severity and location of intracranial arterial stenosis. Stroke 2010; 41:1636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/31\">",
"      Samuels OB, Joseph GJ, Lynn MJ, et al. A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 2000; 21:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/32\">",
"      Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 1995; 273:1421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/33\">",
"      Dion JE, Gates PC, Fox AJ, et al. Clinical events following neuroangiography: a prospective study. Stroke 1987; 18:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/34\">",
"      de Bray JM, Joseph PA, Jeanvoine H, et al. Transcranial Doppler evaluation of middle cerebral artery stenosis. J Ultrasound Med 1988; 7:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/35\">",
"      Rorick MB, Nichols FT, Adams RJ. Transcranial Doppler correlation with angiography in detection of intracranial stenosis. Stroke 1994; 25:1931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/36\">",
"      Arenillas JF, Molina CA, Montaner J, et al. Progression and clinical recurrence of symptomatic middle cerebral artery stenosis: a long-term follow-up transcranial Doppler ultrasound study. Stroke 2001; 32:2898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/37\">",
"      Dagirmanjian A, Ross JS, Obuchowski N, et al. High resolution, magnetization transfer saturation, variable flip angle, time-of-flight MRA in the detection of intracranial vascular stenoses. J Comput Assist Tomogr 1995; 19:700.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/38\">",
"      Katz DA, Marks MP, Napel SA, et al. Circle of Willis: evaluation with spiral CT angiography, MR angiography, and conventional angiography. Radiology 1995; 195:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/39\">",
"      Stock KW, Radue EW, Jacob AL, et al. Intracranial arteries: prospective blinded comparative study of MR angiography and DSA in 50 patients. Radiology 1995; 195:451.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/40\">",
"      Bash S, Villablanca JP, Jahan R, et al. Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol 2005; 26:1012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/41\">",
"      Feldmann E, Wilterdink JL, Kosinski A, et al. The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology 2007; 68:2099.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/42\">",
"      Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) Trail Investigators. Stroke outcome and neuroimaging of intracranial atherosclerosis (SONIA): design of a prospective, multicenter trial of diagnostic tests. Neuroepidemiology 2004; 23:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/43\">",
"      R&ouml;ther J, Wentz KU, Rautenberg W, et al. Magnetic resonance angiography in vertebrobasilar ischemia. Stroke 1993; 24:1310.",
"     </a>",
"    </li>",
"    <li>",
"     Sila CA. Personal communication. 2012.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/45\">",
"      Chimowitz MI, Kokkinos J, Strong J, et al. The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995; 45:1488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/46\">",
"      Marzewski DJ, Furlan AJ, St Louis P, et al. Intracranial internal carotid artery stenosis: longterm prognosis. Stroke 1982; 13:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/47\">",
"      Bogousslavsky J, Barnett HJ, Fox AJ, et al. Atherosclerotic disease of the middle cerebral artery. Stroke 1986; 17:1112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/48\">",
"      Qureshi AI, Ziai WC, Yahia AM, et al. Stroke-free survival and its determinants in patients with symptomatic vertebrobasilar stenosis: a multicenter study. Neurosurgery 2003; 52:1033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/49\">",
"      Moufarrij NA, Little JR, Furlan AJ, et al. Basilar and distal vertebral artery stenosis: long-term follow-up. Stroke 1986; 17:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/50\">",
"      Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial. The EC/IC Bypass Study Group. N Engl J Med 1985; 313:1191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/51\">",
"      Chimowitz MI, Lynn MJ, Howlett-Smith H, et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005; 352:1305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/52\">",
"      Mazighi M, Tanasescu R, Ducrocq X, et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology 2006; 66:1187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/53\">",
"      Famakin BM, Chimowitz MI, Lynn MJ, et al. Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis. Stroke 2009; 40:1999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/54\">",
"      Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006; 113:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/55\">",
"      Williams JE, Chimowitz MI, Cotsonis GA, et al. Gender differences in outcomes among patients with symptomatic intracranial arterial stenosis. Stroke 2007; 38:2055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/56\">",
"      Prognosis of patients with symptomatic vertebral or basilar artery stenosis. The Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Study Group. Stroke 1998; 29:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/57\">",
"      Thijs VN, Albers GW. Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy. Neurology 2000; 55:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/58\">",
"      Mohr JP, Thompson JL, Lazar RM, et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 2001; 345:1444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/59\">",
"      MILLIKAN CH, SIEKERT RG, SHICK RM. Studies in cerebrovascular disease. III. The use of anticoagulant drugs in the treatment of insufficiency or thrombosis within the basilar arterial system. Proc Staff Meet Mayo Clin 1955; 30:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/60\">",
"      Kasner SE, Lynn MJ, Chimowitz MI, et al. Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology 2006; 67:1275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/61\">",
"      Zaidat OO, Klucznik R, Alexander MJ, et al. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology 2008; 70:1518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/62\">",
"      Wang T, Elam MB, Forbes WP, et al. Reduction of remnant lipoprotein cholesterol concentrations by cilostazol in patients with intermittent claudication. Atherosclerosis 2003; 171:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/63\">",
"      Kwon SU, Cho YJ, Koo JS, et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 2005; 36:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/64\">",
"      Fiorella D, Woo HH. Emerging endovascular therapies for symptomatic intracranial atherosclerotic disease. Stroke 2007; 38:2391.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/65\">",
"      Chimowitz MI, Lynn MJ, Derdeyn CP, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med 2011; 365:993.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/66\">",
"      Furie KL, Kasner SE, Adams RJ, et al. Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association. Stroke 2011; 42:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/67\">",
"      Meyers PM, Schumacher HC, Higashida RT, et al. Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Circulation 2009; 119:2235.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Medicare &amp; Medicaid Services. Medicare coverage database. Decision memo for intracranial stenting and angioplasty (CAG-00085R5). www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=214&amp;ver=20&amp;NcaName=Intracranial+Stenting+and+Angioplasty&amp;DocID=CAG-00085R5&amp;bc=gAAAAAgAIAAA&amp; (Accessed on May 25, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/69\">",
"      Higashida RT, Tsai FY, Halbach VV, et al. Transluminal angioplasty for atherosclerotic disease of the vertebral and basilar arteries. J Neurosurg 1993; 78:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/70\">",
"      Clark WM, Barnwell SL, Nesbit G, et al. Safety and efficacy of percutaneous transluminal angioplasty for intracranial atherosclerotic stenosis. Stroke 1995; 26:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/71\">",
"      Touho H. Percutaneous transluminal angioplasty in the treatment of atherosclerotic disease of the anterior cerebral circulation and hemodynamic evaluation. J Neurosurg 1995; 82:953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/72\">",
"      Takis C, Kwan ES, Pessin MS, et al. Intracranial angioplasty: experience and complications. AJNR Am J Neuroradiol 1997; 18:1661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/73\">",
"      Marks MP, Marcellus M, Norbash AM, et al. Outcome of angioplasty for atherosclerotic intracranial stenosis. Stroke 1999; 30:1065.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/74\">",
"      Connors JJ 3rd, Wojak JC. Percutaneous transluminal angioplasty for intracranial atherosclerotic lesions: evolution of technique and short-term results. J Neurosurg 1999; 91:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/75\">",
"      Nahser HC, Henkes H, Weber W, et al. Intracranial vertebrobasilar stenosis: angioplasty and follow-up. AJNR Am J Neuroradiol 2000; 21:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/76\">",
"      Alazzaz A, Thornton J, Aletich VA, et al. Intracranial percutaneous transluminal angioplasty for arteriosclerotic stenosis. Arch Neurol 2000; 57:1625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/77\">",
"      Gress DR, Smith WS, Dowd CF, et al. Angioplasty for intracranial symptomatic vertebrobasilar ischemia. Neurosurgery 2002; 51:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/78\">",
"      Gupta R, Schumacher HC, Mangla S, et al. Urgent endovascular revascularization for symptomatic intracranial atherosclerotic stenosis. Neurology 2003; 61:1729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/79\">",
"      Cruz-Flores S, Diamond AL. Angioplasty for intracranial artery stenosis. Cochrane Database Syst Rev 2006; :CD004133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/80\">",
"      Nguyen TN, Zaidat OO, Gupta R, et al. Balloon angioplasty for intracranial atherosclerotic disease: periprocedural risks and short-term outcomes in a multicenter study. Stroke 2011; 42:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/81\">",
"      SSYLVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004; 35:1388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/82\">",
"      Bose A, Hartmann M, Henkes H, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007; 38:1531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/83\">",
"      Fiorella D, Levy EI, Turk AS, et al. US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke 2007; 38:881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/84\">",
"      Levy EI, Turk AS, Albuquerque FC, et al. Wingspan in-stent restenosis and thrombosis: incidence, clinical presentation, and management. Neurosurgery 2007; 61:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/85\">",
"      Nahab F, Lynn MJ, Kasner SE, et al. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology 2009; 72:2014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/86\">",
"      Marks MP. Is there a future for endovascular treatment of intracranial atherosclerotic disease after Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis (SAMMPRIS)? Stroke 2012; 43:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/87\">",
"      Abou-Chebl A, Steinmetz H. Critique of \"Stenting versus aggressive medical therapy for intracranial arterial stenosis\" by Chimowitz et al in the new England Journal of Medicine. Stroke 2012; 43:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/88\">",
"      Fiorella D, Derdeyn CP, Lynn MJ, et al. Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS). Stroke 2012; 43:2682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/89\">",
"      Sundt TM Jr, Whisnant JP, Piepgras DG, et al. Intracranial bypass grafts for vertebral-basilar ischemia. Mayo Clin Proc 1978; 53:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/90\">",
"      Ausman JI, Diaz FG, de los Reyes RA, et al. Anastomosis of occipital artery to anterior inferior cerebellar artery for vertebrobasilar junction stenosis. Surg Neurol 1981; 16:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/91\">",
"      Chaturvedi S, Turan TN, Lynn MJ, et al. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology 2007; 69:2063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/61/2010/abstract/92\">",
"      Turan TN, Cotsonis G, Lynn MJ, et al. Relationship between blood pressure and stroke recurrence in patients with intracranial arterial stenosis. Circulation 2007; 115:2969.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1101 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-5A6B11C91F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_61_2010=[""].join("\n");
var outline_f1_61_2010=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29925682\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Catheter angiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Noninvasive neurovascular imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ANTITHROMBOTIC THERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Warfarin versus aspirin",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Antiplatelet drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      INTERVENTIONAL THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Angioplasty",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Stenting",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H87797058\">",
"      - SAMMPRIS trial",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Intracranial bypass surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      RISK FACTOR MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Target blood pressure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Statin therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5128424\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/1101\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1101|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/58/19374\" title=\"figure 1\">",
"      Stroke probability by stenosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/57/17305?source=related_link\">",
"      Antihypertensive therapy to prevent recurrent stroke or transient ischemic attack",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/35/2618?source=related_link\">",
"      Antiplatelet therapy for secondary prevention of stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/61/30682?source=related_link\">",
"      Secondary prevention of stroke: Risk factor reduction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/35/32314?source=related_link\">",
"      Statins: Actions, side effects, and administration",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_61_2011="Categories of increased risk for diabetes";
var content_f1_61_2011=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F82479&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F82479&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Categories of increased risk for diabetes (prediabetes)*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        FPG 100 to 125 mg/dL (5.6 to 6.9 mmol/L) [IFG]",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2-h PG on the 75-g OGTT 140 to 199 mg/dL (7.8 to 11.0 mmol/L) [IGT]",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A1C 5.7 to 6.4 percent",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     FPG: fasting plasma glucose; IFG: impaired fasting glucose; PG: post glucose; OGTT: oral glucose tolerance test; IGT: impaired glucose tolerance; A1C: glycated hemoglobin.",
"     <br>",
"      * For all three tests, risk is continuous, extending below the lower limit of the range and becoming disproportionately greater at higher ends of the range.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted with permission from: American Diabetes Association. Standards of Medical Care in Diabetes 2011. Diabetes Care 2011; 34:S11. Copyright &copy; 2011 American Diabetes Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_61_2011=[""].join("\n");
var outline_f1_61_2011=null;
var title_f1_61_2012="Treatment options for refractory angina";
var content_f1_61_2012=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F61088&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F61088&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Summary of treatment options in refractory angina pectoris",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        Therapy",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\" rowspan=\"1\">",
"        Documented",
"effect",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        Strength of evidence",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Symptoms",
"       </td>",
"       <td class=\"subtitle2\">",
"        Ischemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        TENS",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        SCS",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        A",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        TMR",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        ?",
"       </td>",
"       <td>",
"        A",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        PLR",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        ?",
"       </td>",
"       <td>",
"        B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        LSGB",
"       </td>",
"       <td>",
"        +",
"       </td>",
"       <td>",
"        ?",
"       </td>",
"       <td>",
"        C",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     TENS: transcutaneous electrical nerve stimulation; SCS: spinal cord stimulation; TMR: transmyocardial laser revascularization; PLR: percutaneous laser revascularization; LSGB: left stellate ganglion blockade.",
"     <br>",
"      Strength of evidence is based upon amount of scientific documentation: A: Well-designed, well-conducted, controlled trials (randomized and non-randomized) with statistically significant results that consistently support the recommendations. B: Observational studies or controlled trials with less consistent results to support the guideline recommendations. C: Expert opinion that supports the guideline recommendation because the available scientific evidence did not present consistent results, or controlled trials were lacking.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from Mannheimer C, Camicci P, Chester MR, et al. Eur Heart J 2002; 23:355.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_61_2012=[""].join("\n");
var outline_f1_61_2012=null;
var title_f1_61_2013="Drugs causing anxiety Sxs";
var content_f1_61_2013=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F54521&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=51\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F54521&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=51\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Drugs that cause anxiety-like symptoms",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\" class=\"container\">",
"     <tbody>",
"      <tr>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Stimulants",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Amphetamine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Aminophylline",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Caffeine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cocaine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Methylphenidate",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Theophylline",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Sympathomimetics",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Ephedrine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Epinephrine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Phenylpropanolamine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Pseudoephedrine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Drug withdrawal",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Barbiturates",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Benzodiazepines",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Narcotics",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Alcohol",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Sedatives",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"       <td class=\"container\">",
"        <table cellspacing=\"0\">",
"         <tbody>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Anticholinergics",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Benztropine mesylate (Cogentin)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Diphenhydramine (Benadryl)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Meperidine (Demerol)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Oxybutynin (Ditropan)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Propantheline (Pro-Banthine)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Tricyclics",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Trihexyphenidyl (Artane)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Dopaminergics",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Amantadine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Bromocriptine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Levodopa (L-dopa)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Levodopa-carbidopa (Sinemet)",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Metoclopramide",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Neuroleptics",
"           </td>",
"          </tr>",
"          <tr>",
"           <td class=\"subtitle1_single\">",
"            Miscellaneous",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Baclofen",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Cycloserine",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Hallucinogens",
"           </td>",
"          </tr>",
"          <tr>",
"           <td>",
"            Indomethacin",
"           </td>",
"          </tr>",
"         </tbody>",
"        </table>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Goldberg, RJ. Practical Guide to the Care of the Psychiatric Patient. Mosby Year Book, St. Louis 1995.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_61_2013=[""].join("\n");
var outline_f1_61_2013=null;
var title_f1_61_2014="Hypogonadism in aging men";
var content_f1_61_2014=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F65074&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F65074&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hypogonadism in aging men",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 401px; height: 284px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bar height indicates the percent of men in each 10-year interval, from the third to the ninth decades, with at least one total testosterone &lt;325 ng/dL (11.3 nmol/L) (red bars), or T/SHBG (free T index) &lt;0.153 nmol/nmol (blue bars). The fraction of men who are hypogonadal increases progressively after age 50 by either criterion. More men are hypogonadal by free T index than by total T after age 50. The number of men studied in each decade is noted below the graph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Harman SM, Metter EJ, Tobin JD, Pearson J. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001; 86:724.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_61_2014=[""].join("\n");
var outline_f1_61_2014=null;
var title_f1_61_2015="Fifth metacarpal shaft fracture";
var content_f1_61_2015=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F56431&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F56431&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mid-shaft fracture of 5th metacarpal",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    An oblique mid-shaft fracture of 5th metacarpal is seen on the anteroposterior view (left panel) and also on the oblique radiograph (right panel).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Josh Bloom, MD, MPH.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_61_2015=[""].join("\n");
var outline_f1_61_2015=null;
